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ABSTRACT 
 
The human immunodeficiency virus depends on molecular pathways of the host for 
efficient replication and spread. The intricate network of host-virus interactions shapes 
the virus’ evolution by driving the pathogen to evade immune recognition and 
constraining it to maintain its capacity to replicate. Study of the HIV-host interactions 
provides important insights into viral evolution, pathogenicity and potential treatment 
strategies. This thesis presents an analysis of HIV-host interactions on several scales, 
ranging from individual protein interactions to whole genomes. 
On the scale of individual interaction we analyze structural and physical determinants of 
the interaction between host TRIM5α and virus capsid – an interaction of potential 
therapeutic interest due to the capacity of TRIM5α to block retroviral infections. On the 
scale of viral population we present two studies of a highly variable region of the virus 
genome involved in the interaction with host cell coreceptors upon virus cell entry. The 
studies provide insights into the virus evolution and the physicochemical and structural 
properties related to its interaction with cellular coreceptors. On the scale of the single 
cell we develop models of HIV cell entry involving virus, host and environmental factors. 
The models represent a comprehensive picture of the virus phenotype and allow one to 
view the variability of virus phenotypes on 2D phenotype maps. On the genomic scale 
we perform a large-scale analysis of all HIV-host interactions. This study reveals insights 
into general patterns of the host-pathogen evolution and suggests candidate host 
proteins involved in interactions potentially important for the infection and interesting for 
further study on other scales. 
Interactions and processes crucial for the HIV infection reemerge across the scales 
pointing to the importance of integrative, multi-scale studies of host-pathogen biology.
vi 
ZUSAMMENFASSUNG 
 
Das Humane Immundefizienz-Virus hängt von molekularen Mechanismen des Wirts für 
seine effiziente Replikation und Ausbreitung ab. Das komplizierte Netzwerk von Wirt-
Virus Interaktionen formt die Evolution des Virus, indem es den Erreger dazu bringt, sich 
der Erkennung durch das Immunsystem zu entziehen und seine Replikationskapazität 
aufrecht zu erhalten. Das Studium der HIV-Wirt-Interaktionen erlaubt wichtige Einblicke 
in die viralen Evolution, die Pathogenität des Virus, sowie mögliche 
Behandlungsstrategien.  
Diese Arbeit stellt eine Analyse der HIV-Wirt-Interaktionen in mehreren 
Größenordnungen vor, von einzelnen Protein-Interaktionen bis hin zur Analyse ganzer 
Genome. In Hinblick auf einzelne Interaktionen untersuchen wir strukturelle und 
physikalische Determinanten der Interaktion zwischen dem Wirtfaktor TRIM5α und dem 
viralen Kapsid - eine Interaktion, die von therapeutischem Interesse ist wegen der 
Fähigkeit von TRIM5α, retrovirale Infektionen zu blockieren. In Hinblick auf virale 
Populationen präsentieren wir zwei Studien einer hochvariablen Region des viralen 
Genoms, die in der Interaktion des Virus mit zellulären Rezeptoren des Wirts beim 
viralen Zelleintritt involviert sind. Diese Studien geben Einblick in die virale Evolution und 
die physikalisch-chemischen und strukturellen Eigenschaften des Virus bezüglich 
dessen Interaktion mit zellulären Ko-Rezeptoren. Auf der Skala der einzelnen Zelle 
entwickeln wir Modelle des HIV Zelleintritts welche das Virus, den Wirt und 
Umgebungsfaktoren berücksichtigen. Diese Modelle bieten ein umfassendes Bild des 
viralen Phänotyps und erlauben es, die Variabilität des Virus auf 2D-Phänotyp-Karten zu 
visualisieren. Im genomweiten Maßstab führen wir eine groß angelegte Analyse aller 
HIV-Wirt-Interaktionen durch. Diese Studie erlaubt Einblicke in allgemeine Muster der 
Wirt-Pathogen-Evolution und identifiziert Kandidaten für Wirtsproteine, deren 
Interaktionen potenziell wichtig für die virale Infektion sind und deren weitere 
Untersuchung in anderen Größenordnungen von Interesse ist.  
Interaktionen und Prozesse, die von entscheidender Bedeutung für die HIV-Infektion 
sind zeigen sich wiederholt in allen untersuchten Maßstäben und unterstreichen die 
Bedeutung einer integrativen und multi-skalaren Untersuchung der Wirt-Pathogen-
Biologie.
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CHAPTER 1 – Introduction 
 
Viruses cause a wide range of diseases. They can give rise to chronic or acute infection, 
generate no symptoms or result in death, can be persistent or recur in periodic fashion, 
spread easily in a restricted fashion and infect any type of tissue. Developments in the 
field of virology incited a revision of the concept of living matter and provoked questions 
central to understanding all life processes. Virus replication is dependent on regulatory 
pathways of the host cellular system and is hampered by effective action of the immune 
system. Study of viruses contributed to our understanding of molecular biology and the 
origins of infectious diseases (Knipe, Howley et al. 2006). 
With the development of technologies for acquisition of molecular data, virology has 
shifted from a descriptive, observation-based to an integrative and quantitative field of 
research based on large amounts of measured viral data. Technologies such as DNA 
microarrays, phenotypic resistance testing, small interfering RNA screens, or deep 
sequencing underscore the need for computational methods and models capable of 
handling and integrating the large-scale virus data. Data analysis and modeling advance 
virology research and support treatment of infectious diseases. 
This thesis presents several computational studies of the human immunodeficiency virus 
(HIV). Basing on a range of methods and data, virus interactions with the host are 
examined on different scales – from specific proteins to entire genomes, from molecular 
interactions to the spread of disease. The analyses presented in this thesis contribute to 
our knowledge about the HIV-host interactions. The results help our understanding of 
the critical HIV-host interactions involved in blocking the infection, explain the evolution 
and determinants of interaction phenotypes having an impact on the disease 
progression and targeted by the anti-HIV treatment, and point to new candidate 
interactions for further investigation. This chapter presents a brief introduction into the 
HIV* biology and computational approaches in HIV research. A detailed outline of the 
thesis is provided at the end of this chapter. 
1.1 The unique nature of HIV  
The isolation of a T lymphotropic retrovirus in 1983 (Barre-Sinoussi, Chermann et al. 
1983) and in 1984 (Montagnier, Gruest et al. 1984) from a lymph node of an individual 
with lymphadenopathy marked the beginning of three decades of intense research on 
the pathogenesis of the virus causing the Acquired Immune Deficiency Syndrome 
(AIDS). The disease that was first recognized in patients in the USA in 1981 was 
indicated by a wide array of deleterious effects that HIV was causing in every component 
of the host immune system. Further research allowed for recognizing the mode of virus 
                                                 
*  Unless otherwise stated, HIV is used for HIV type 1 (HIV-1) throughout this thesis. 
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transmission, its origin in African primate species (Sharp, Bailes et al. 2000), the effect of 
the virus on the immune system and its interactions with the host (Ptak, Fu et al. 2008). 
Despite the advances in our understanding of HIV pathogenesis and immunology after 
the discovery of the virus, a protective vaccine or an effective cure of the disease remain 
elusive. Here we present several virus properties that contribute to the specific nature of 
the HIV infection. The description is incomplete, and is only designed to give a 
background and motivation for the problems addressed further in this thesis. 
1.1.1 HIV is a retrovirus  
HIV is a member of the genus Lentivirus in the Retroviridae family. Retroviruses are so 
called because their genome is encoded in RNA that is transcribed into DNA using the 
viral enzyme reverse transcriptase (RT) after the virus entry into a host cell. This DNA is 
then transported to the cell nucleus and integrated into the cellular genome. Figure 1.1 
illustrates the lifecycle of HIV. 
 
Figure 1.1 HIV life cycle involving cell entry, reverse transcription, replication and budding. Adapted from 
(Weiss 2001). 
A retrovirus, once retro-transcribed into the genome of its host is copied with each host 
cell division. In effect the HIV infection is life-long. Integrated silent copies of the viral 
DNA are rapidly established in cellular reservoirs of various tissues and persist 
throughout the host life. An archive of forms of the virus that evolved thoughout the 
infection is retained in the host DNA and these forms on occasion can re-emerge 
(Korber, Theiler et al. 1998; Shankarappa, Margolick et al. 1999; Korber, Muldoon et al. 
2000) presumably under changing selection pressures in the host exerted by drugs and 
the immune system. The integration of the HIV genome into the genome of the host 
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represents an important impediment to achieving complete eradication of the virus in 
infected individuals, which points to vaccines for preventing infection or to cellular 
mechanisms blocking viral replication as ways for suppressing the spread of the virus. 
1.1.2 HIV replicates in the immune system cells 
The hallmark of the HIV infection is its destructive effect on the host immune system. 
Following transmission, HIV disseminates rapidly in the absence of preexisting immune 
pressures leading to a burst of viremia and a rapid depletion of CD4+ T cells in the initial 
phase of the infection (Figure 1.2). After this acute phase host immune response causes 
the viral load to rapidly decline and reach a steady state termed the virus set point (Little, 
McLean et al. 1999; Fiebig, Wright et al. 2003) which marks the beginning of the chronic 
phase of the infection. While CD4+ T cell counts rebound to their initial level, the immune 
system remains chronically activated (Goonetilleke, Liu et al. 2009) due to the virus 
replication in the lymphoid tissue. By targeting the major constituent of the immune 
system, HIV gradually destroys and dysregulates its functionality. 
 
Figure 1.2 Progression of a typical HIV infection. After the initial acute phase characterized by a strong 
immune response and rapid virus replication comes the chronic phase when the virus can remain 
undetected for many years. AIDS is characterized by a high immune activation, low number of CD4+ 
T cells and high virus replication (Forsman and Weiss 2008). 
As immune cells are activated they become targets for HIV, so an active immune system 
paradoxically contributes to a higher viral load. A pool of productively infected cells is 
constantly replenished and the continuous exposure to viral antigens during the chronic 
phase of infection leads to T and B cell exhaustion and ultimately to a broad and severe 
dysfunction of immune responses (Trautmann, Janbazian et al. 2006). Although the 
underlying causes of HIV-induced cellular hyperactivity remain debatable, the 
pathogenic consequences of such activity are fairly well understood and include 
increased cell turnover leading to cellular exhaustion, senescence and low renewal 
potential. In the absence of antiretroviral treatment (ART) the vast majority of HIV-
infected individuals experience progressive loss of CD4+ T cells, increased 
immunodeficiency leading to AIDS and subsequent development of opportunistic 
infections and cancers. With the increased availability of ART, there has been a dramatic 
reduction in the number of people who progress to AIDS. Yet, long-term pathogenic 
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consequences of living with HIV persist in most individuals due to incomplete 
immunologic recovery and the loss of the immune system’s ability to replenish itself. HIV 
is also known to induce immunologic dysfunction of other immune cells such as CD8+ T 
cells B cells and natural killer (NK) cells through mechanisms that include increased cell 
turnover, activation, differentiation and response to infection.  
Replication in the immune system cells is not a property unique to HIV. Another human 
retrovirus, human T-lymphotropic virus type I (HTLV-1) also infects CD4+ lymphocytes, 
however it does not have the same detrimental effects on the target cells (Jeang 2010). 
The persistent replication and spread of HIV (Perelson, Essunger et al. 1997) result in 
the progressive loss of immune system cells. In contrast, HTLV establishes a continuous 
culture in the target cells not causing their increased turnover. The molecular basis of 
the chronic activation of the immune system in the pathogenic HIV infection is still not 
known. 
1.1.3 High mutation rate of HIV 
HIV is characterized by an exceptionally high genetic diversity. An HIV infection starts 
out with a homogeneous viral population (Zhang, MacKenzie et al. 1993; Wolinsky, 
Korber et al. 1996). Over its course, however viruses showing more than 10% mutated 
DNA bases in the envelope gene arise (Lukashov, Kuiken et al. 1995; Wolinsky, Korber 
et al. 1996; Shankarappa, Margolick et al. 1999).  
The lack of a proof-reading mechanism in the viral RT, and the consequential high error 
rate (0.2–2 mutations per genome per cycle) (Drake 1993) can explain only part of this 
diversity. For example, HTLV-1, like HIV, goes though a reverse transcription step, but is 
far less variable. This has been previously attributed to differences in the dynamics of 
the two viruses (Wodarz and Bangham 2000). A high replication rate accompanied by 
rapid viral turnover (Perelson, Essunger et al. 1997), as well as pressure for adaptation 
and host recognition evasion might be additional forces driving virus genomic change. 
Beyond the immune escape that can drive selection of specific HIV epitopes (Borrow, 
Lewicki et al. 1997; Goulder, Sewell et al. 1997; Price, Goulder et al. 1997; Allen, 
O'Connor et al. 2000) neutral mutations and genetic drift can also contribute to the 
overall diversity of the virus (Sala and Wain-Hobson 2000; Yang, Nielsen et al. 2000). In 
addition to base-substitutions, HIV is subject to recombination and relatively large 
insertions and deletions (indels), which rapidly generate radically divergent forms.  
Consequently, instead of a single virus clone, an individual is infected with a virus 
population termed viral quasispecies. The concept of quasispecies assumes that the 
prevalence of viral clones in a population is dictated by their relative fitness (Eigen 
1996). Under circumstances of selective pressure, such as therapy (Condra 1998) or 
immune pressure (Price, Goulder et al. 1997; Poignard, Sabbe et al. 1999; Allen, 
O'Connor et al. 2000), the clone profile in the viral population can shift.  
The high variability of HIV represents a major challenge for the immune response and 
development of an effective vaccine. The challenge is even greater than that presented 
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by influenza, which is also antigenically variable. A comparison of HIV and influenza A 
evolution reveals very different patterns. HIV evolution is characterized by a radial 
spread outward from an ancestral node, while influenza is characterized by bottlenecks 
and global drift from year to year (Grenfell, Pybus et al. 2004). Within a single nine-
month flu season, little variation is typically found between geographically distinct 
influenza isolates after the emergence of the epidemic strain. HIV, on the other hand, 
shows increasing genetic diversity within a population through time. The diversity of 
influenza sequences world-wide in any given year appears to be roughly comparable to 
the diversity of HIV sequences found within a single infected individual at one time point 
(Korber, Gaschen et al. 2001). Thus, while influenza does have a relatively fast rate of 
mutation when measured over decades, the vaccine for any given year is targeted 
towards a relatively homogeneous viral population. Even a small number of changes in 
the viral amino acid sequence at antigenic sites requires a change in the vaccine strain 
to induce an immunologically appropriate response for currently circulating strains. This 
small number of amino acid substitutions that result in a loss of influenza vaccine 
efficacy indicates the challenge in developing an effective HIV vaccine. The viral 
diversity which an HIV vaccine must counter is far greater than the diversity countered 
by the influenza vaccine which underscores the necessity of innovative methods of HIV 
prevention. 
1.1.4 HIV establishes a chronic infection 
Most human respiratory and enteric viruses cause short but acute infections. The 
pathogen multiplies mainly at and around its portal of entry; induces transmission-
promoting symptoms such as sneezes, coughs, or diarrhea; kills its target cells; is 
countered by innate immune responses and cleared by adaptive immune responses that 
protect against reinfection with the same viral strain (Knipe, Howley et al. 2006).  
In contrast, HIV belongs to class of human viral pathogens that are less transmissible 
but induce persistent rather than acute infections. This class includes all herpes virus 
family members, the hapatotropic hepatitis B and C viruses (HBV and HCV), the 
tumorigenic papilloma and polynoma viruses and retroviruses such as HTLV or HIV. 
Although diverse in nature and in replicative properties, all of these viruses share an 
ability of escaping adaptive immune responses, affording persistence in the host. How 
the virus achieves this, however, varies greatly. Herpes simplex virus (HSV) escapes 
clearance by establishing latency within cells of the central nervous system and 
undergoes only sporadic reactivation (Efstathiou and Preston 2005). In contrast, HCV 
does not become dormant but shields from and antagonizes immune responses 
(Guidotti and Chisari 2006). With HBV age at the time of infection is determinant: infants 
typically develop chronic infections because their immature immune system is overly 
tolerant to the virus, whereas infection later in life is spontaneously cleared in 95% of 
cases (Guidotti and Chisari 2006).  
HIV always induces a persistent infection irrespective of the age and immune status of 
the host. The virus becomes latent in a fraction of infected cells, yet never stops 
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replicating in others. Together, these features allow for viral persistence despite ART 
capable of keeping viremia undetectable for years (Chun, Nickle et al. 2005).  It is this 
combination of the characteristics of a retrovirus rapidly mutating and replicating in the 
immune system cells which make HIV a unique pathogen particularly difficult to 
eradicate and treat. The ineffectiveness of HIV vaccine trials (Barouch 2008) calls for 
novel approaches in the search for the cure of which computational analyses and 
mathematical models are an essential part. 
1.2 Computational approaches to understanding and treating the HIV infection 
Almost three decades of HIV research and the rapid development of data acquisition 
technologies resulted in an accumulation of large amounts of molecular and clinical data 
on HIV. Mathematical and bioinformatics tools are of invaluable support not only for the 
storage and integration of the growing volume of information but also by providing 
predictive and explanatory models in situations where biological knowledge is 
inaccurate, missing or cannot be directly inferred. In this section we review several 
computational studies of high importance for HIV research. These example studies 
represent a restricted part of the broad field of HIV research. However, they illustrate 
how each of the characteristics of the virus biology described in the previous section can 
be analyzed in computational studies on different scales – from individual proteins to 
interspecies genomic comparisons. Additionally, the work presented in this thesis was 
partially motivated by several shortcomings of these studies summarized in the last part 
of this section. 
1.2.1 Host restriction factors 
Defence against a pathogen begins at the first virus-cell interaction. A mechanism 
termed intrinsic resistance implies immediate cellular responses to the infection acting 
before the innate and adaptive immune responses are triggered. Some of the intrinsic 
immunity processes involve so called restriction factors – proteins constitutively 
expressed in some cell types or induced as a part of the innate immune response in 
others (Bieniasz 2004). The proteins of this front line of antiviral defense exhibit 
substantial genetic variation among species due to selection pressures of ancient 
pathogens. HIV is a new pathogen in the human population, therefore human restriction 
factors fail to prevent the spread of this recently acquired retrovirus. Yet the interspecies 
variation of host restriction factors and their species-specific responses to lentiviruses 
suggest that they represent a potential prevention mechanism for the HIV infection in 
humans. 
Several studies analyzed the evolutionary history of the host restriction factors known to 
block lentiviruses in primates: tripartite motif 5-α (TRIM5α) (Stremlau, Owens et al. 2004; 
Sawyer, Wu et al. 2005), apolipoprotein B editing complex 3G (APOBEC3G) (Bieniasz 
2004; Sawyer, Emerman et al. 2004) and tetherin (BST-1, CD317) (Neil, Zang et al. 
2008; McNatt, Zang et al. 2009). Via interactions of still unknown nature with the viral 
capsid, and the viral proteins Vif and Vpu, respectively, these factors account for 
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resistance to lentiviruses transmitted from other primate host species (Malim and 
Emerman 2008). The comparative analyses of primate sequences of each of the three 
restriction factors (Sawyer, Emerman et al. 2004; Sawyer, Wu et al. 2005; McNatt, Zang 
et al. 2009) pointed to positive selection acting on these proteins and predating the origin 
of lentiviruses. Statistical models of positive selection (Yang, Wong et al. 2005) identified 
specific sequence regions showing high levels of positive selection that might form 
points of physical contacts with the respective viral proteins.  
Sequence analyses of individual proteins participating in an early defense can point to 
specific domains involved in the interactions blocking the infection. Even though the role 
of these domains in the virus restriction can be tested through mutagenic studies 
(Sawyer, Wu et al. 2005) such sequence analyses do not provide insights into the actual 
mechanism of interaction. Recognizing the structural and physicochemical determinants 
of the interaction of a host protein with a highly mutating virus protein necessitates 
studies of both interaction partners expanding beyond the sequence analysis. 
1.2.2 Prediction of HIV drug resistance 
Several drug classes have been developed which target different stages of the HIV 
replication cycle (Nicol and Kashuba 2010). High mutation rates of HIV allow the virus to 
evolve resistance to any single drug. Combination therapies known as highly active 
antiretroviral therapy (HAART) were introduced after it became apparent that no single 
drug could be expected to achieve durable viral suppression and clinical benefits. 
Combination therapies proved more effective in the long term as multiple mutations 
required for resistance to three or more drugs are harder for the virus to acquire 
(Colgrove and Japour 1999). 
Virus resistance to antiretroviral drugs can be quantified in experimental phenotypic 
tests. In such tests the replication of the patient’s virus is compared to the replication of a 
reference wild type strain in a cell culture in the presence of a varying concentration of a 
given drug. In the experiment, resistance only to a single drug can be measured, it has 
to be performed in specialized laboratories, its costs are elevated and the results are 
only available within weeks. In constrast, genotyping of patient viral samples is a 
standardized and affordable measurement that is performed routinely in any type of 
laboratory. Accessibility and utility of genotypic testing motivated introduction into clinical 
practice of genotype-based methods for prediction of drug resistance.  
The increasing number of anti-HIV drugs and their possible combinations contribute to 
the complexity of regimens and the pathways of the virus evolution to resistance. 
Computational systems replace currently the manually compiled resistance mutation 
tables used to derive successful treatment strategies (Lengauer and Sing 2006). These 
systems base on genotype of an individual virus or a virus population (Altmann, Däumer 
et al. 2009) and apply statistical learning methods to predict viral resistance to an 
individual compound measured in phenotypical tests in vitro (Beerenwinkel, Däumer et 
al. 2003) or their combinations observed in vivo (Larder, Wang et al. 2007). With the 
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concerted effort to accumulate data on virus resistance and treatment outcome, 
computational models for predicting virus response to drug regimens become both 
essential and accurate. Flexibility of the HIV genome results in countless possible 
mutation pathways and genetic variants among which resistance patterns are hard to 
discern without the assistance of mathematical tools.  
The use of viral resistance models in clinical practice underscores the importance of 
genotypic resistance analyses. These analyses are based the viral genotype only and do 
not currently consider additional host and environmental factors which might also play 
role in the effectiveness of the treatment (Tozzi, Libertone et al. 2008). Although HAART 
is highly effective, critical questions remain about how patients respond to treatment: 
genetic and environmental variation among individuals may cause considerable 
variability in drug pharmacokinetics and pharmacodynamics. In particular, since anti-HIV 
medicines are used for life, even modest differences in susceptibilities are important. 
Consequently, identification of host parameters that play role in the HAART could allow 
for tailoring of the drugs to minimize the long-term toxicities and result in not only virus- 
but also patient-targeted therapies. 
1.2.3 Studies of virus populations 
Ever since the first sequencing of the DNA genome of coliphage phiX174 by Fred 
Sanger in 1977, sampling, sequencing and computer technologies provided the means 
to identify and sequence entire viral communities without the intervention of costly 
techniques of isolation and characterization of individual viruses (Wang, Urisman et al. 
2003; Edwards and Rohwer 2005; Suttle 2005). Insights into the diversity of virus 
populations in an environment are essential as studies of isolated viruses in the 
laboratory do not provide information necessary to accurately assess virus impact on 
human health.  
Recent development of next generation sequencing technologies (Metzker 2010) 
allowed for study of virus populations on a yet unprecedented level of detail. Next-
generation or deep sequencing platforms are now capable of reading millions of base 
pairs in a more cost-effective and faster way than traditional Sanger sequencing. This 
technology has already been used to address such topics as resistance mutations in 
minority populations (Hoffmann, Minkah et al. 2007; Wang, Mitsuya et al. 2007; 
Johnson, Li et al. 2008; Simen, Simons et al. 2009), evolution of virus population (Poon, 
Swenson et al. 2009) or coreceptor usage of entire within-patient populations (Archer, 
Braverman et al. 2009).  
The forces shaping virus quasispecies cannot be explained based on virus sequences 
exclusively. Recognizing the determinants of virus population structure and evolution is 
not possible without considering host and environmental factors having potential impact 
on the virus. This calls for integrative studies of not only virus but also host and 
environment variability and their mutual interactions. 
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1.2.4 Phylogenetics of lentiviruses  
Despite the lack of ancient virus sequences and epidemiologic data on lentivirus spread 
among human and monkey species in Africa, much insight into the evolution of the virus 
can be gained through comparative genomic analyses of contemporary lentivirus 
sequences. Mathematical methods such as maximum likelihood (Felsenstein and 
Churchill 1996) or Bayesian (Drummond, Rambaut et al. 2005) models were applied to 
the estimation of virus phylogenies (Van Heuverswyn, Li et al. 2007) and the rate of its 
evolution (Korber, Muldoon et al. 2000; Wertheim and Worobey 2009). These studies 
allowed not only to trace the origin of human immunodeficiency viruses (HIV-1 and HIV-
2) in the African primates (Sharp, Bailes et al. 2000) but also to estimate the 
approximate date of virus transmission to humans at the beginning of the century 
(Korber, Muldoon et al. 2000). 
Phylogenetic and molecular clock studies show how computational models can generate 
hypotheses about the missing knowledge based on the incomplete data. Comparative 
genetic analyses on the interspecies genomic scale allow for building models of the virus 
past based on the contemporary virus data. Even though dating of the virus transmission 
generated hypotheses on the social and economic factors that facilitated the virus 
spread (Hahn, Shaw et al. 2000), purely phylogenetic analyses give limited information 
on the biological determinants of the virus interspecies transmission, on the factors and 
means of a pathogen adaptation to a new host species. An integrative approach of 
analyzing both host and virus factors determining the infection affords means of 
explaining the specific transmission pathways of lentiviruses and of providing knowledge 
potentially important for future prevention of virus transmissions (Garten, Davis et al. 
2009). 
1.2.5 Aspects addressed in this thesis 
The studies described above address different aspects of the host (host restriction 
factors) and virus (drug resistance, virus population structure, origins of HIV) playing a 
role in the infection. As critical as the studies are in recognizing, classifying and 
predicting patterns in the host and virus evolution separately, they provide limited insight 
into their interdependence and underlying reciprocal host-pathogen mechanisms. 
Viruses express only few proteins essential for their replication, spread and escape from 
host recognition (Figure 1.3). Having no metabolism of their own, viruses are obliged to 
invade cells and make use of the cellular machinery of the host, subverting it to their own 
purposes. The replicative cycle of the HIV is largely known. It comprises elaborate 
interactions between the viral genome, viral proteins and the molecular processes of the 
host (Knipe, Howley et al. 2006). 
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Figure 1.3 Organization of the HIV genome. Gray-shaded proteins Gag, Pol and Env are initially synthesized 
as polyprotein precursors, cleaved into mature proteins represented by colored boxes. From (Freed 
2004). 
Drug treatment is only one among many factors shaping HIV evolution. The virus is 
involved in a constant struggle to escape recognition by the host immune system while 
simultaneously being subject to functional constraints ensuring its efficient replication 
and transmission. As an example of immune system influence shaping the evolution of 
the virus, human leukocyte antigen B (HLA-B) alleles were recognized that are 
associated with slow disease progression (Heeney, Dalgleish et al. 2006; Fellay, Ge et 
al. 2009). Such alleles offer protection by binding to highly conserved HIV proteins that 
are essential to the virus function and mutation of which comes at a cost of the virus 
fitness. Less protective alleles supposedly bind to pieces of proteins that HIV can 
change by mutation without affecting its replication capacity. Studies of the host and 
virus interactions can result in a more complete view of the mechanisms underlying 
disease progression, virus evolution and spread. 
In addition to understanding forces shaping virus evolution, the study of host factors 
involved in the infection can provide insights into new avenues of treatment and 
prevention based on host proteins critical for the HIV infection. First drugs targeted at the 
host proteins – drugs blocking C-C chemokine receptor type 5 (CCR5) one of the 
coreceptors used by HIV in the cell entry (Chan and Kim 1998) – have been recently 
introduced into clinical use (Dorr, Westby et al. 2005). Drugs targeted at host factors 
crucial for the virus replication could potentially be more efficient than those targeted at 
the virus as they would require the virus to evolve new interaction mechanisms instead 
of modifying drug attachment sites. This highlights the importance of developing models 
of HIV-host interactions in addition to the current HIV drug resistance analyses. 
Integrated study of host-pathogen interactions allows for the paired recognition of host 
defense components and viral gene products that counter them. The variety of 
interactions in which the host and pathogen are involved throughout the course of 
infection includes virus restriction by the host restriction factors (Malim and Emerman 
2008), virus binding to cellular membrane proteins upon cell entry (Chan and Kim 1998), 
virus down- or up-regulation of host immune system (Kirchhoff 2009) or virus binding to 
antigens (Barouch 2008). Investigating the combined host and pathogen responses 
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might therefore improve our understanding of the pathogenesis of HIV in humans and 
provide insights into potential diagnostic and therapeutic targets for viral infections. 
1.3 Thesis outline 
The high complexity of the HIV interactions with the host can be viewed synoptically by 
integrating studies at different scales, ranging from individual interactions to interspecies 
comparisons of many interactions. In this thesis we approach the analysis of HIV-host 
interactions on four distinctive scales.  
In chapter 2, we present an analysis on the scale of a specific interaction – the 
interaction between host protein TRIM5α and the virus capsid. We perform an in-depth 
analysis of the structural and physical features of both interaction partners in the search 
of determinants of the restriction. The study is based on the experimental data collected 
in the lab of Prof Tatsuo Shioda at the Department of Viral Infections, Research Institute 
for Microbial Diseases at Osaka University in Japan. The importance of this analysis on 
the individual interaction scale is underlined by the capacity of TRIM5α to block retroviral 
infection and the potential impact of this interaction in prevention of the HIV infection. 
In chapter 3 we present two studies on the virus population scale of a highly variable 
region of the virus genome that is involved in the interaction with host cell coreceptors in 
the process of cell entry. The studies implicitly include the host partner of the interaction 
by distinguishing between virus variants that interact with a specific coreceptor. Both 
studies expand beyond sequence-based classification models and provide insights into 
the virus evolution driven by or resulting from the interaction with the coreceptor as well 
as the physicochemical and structural properties involved in it. 
In chapter 4 we describe a study of the viral cell entry process on the single cell level. 
The model of HIV cell entry developed in this study includes virus, host and 
environmental factors playing role in the entry. It is a comprehensive analysis of a 
specific interaction based on a high-throughput experimental data generated in the lab of 
Prof. Dr. Hans-Georg Kräusslich and Dr. Barbara Müller at the Department of Virology, 
Heidelberg University and based on clinical samples provided by the lab of Dr. Rolf 
Kaiser, Institute of Virology, University of Cologne.  
In chapter 5 we perform a large-scale analysis of all HIV-host interactions on the 
genomic scale. We compare evolutionary patterns of interacting host and pathogen 
proteins in search of those that might be relevant for the infection and investigate the 
evolutionary patterns of the interacting host and pathogen proteins. This large-scale 
analysis presents candidate proteins potentially interesting for further study on other 
scales and insights into general patters of the host-pathogen evolution. 
Each of the studies presented in this thesis relate to different aspects of the HIV biology 
and its interaction with the host. Every chapter contains therefore an explanatory 
introduction into the biological aspects and the scale of analysis.
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CHAPTER 2 – Individual interaction scale:  
                        structural analysis of TRIM5α-CA interaction 
 
In this part of the thesis we present an analysis on the individual interaction scale of the 
interaction between host TRIM5α and virus capsid. The importance of this interaction 
manifested in the capacity of TRIM5α to block retroviral infections call for its better 
understanding. Work presented in this chapter was performed in collaboration with the 
experimental group of Prof Tatsuo Shioda at the Department of Viral Infections, 
Research Institute for Microbial Diseases at Osaka University in Japan. We analyzed 
computationally data from a cellular assay measuring TRIM5α viral restriction elaborated 
by Dr. Ken Kono, Dr. Kuroishi and Dr. MD Emi Nakayama.  
2.1 Background 
Persistently infected species evolved a range of cellular defense mechanisms against 
pathogens. The evolution of these mechanisms has been driven by ancient infections to 
which the host species were exposed in the past. The infection history varies among 
species which can have an effect on host response to current infections.  
The term intrinsic immunity has been assigned to the activity of specific antiviral factors 
that have evolved as a result of host exposure to pathogens in humans and other 
mammals. This kind of immunity has an advantage over the innate and acquired 
immune responses as it does not need to develop the capacity to combat viruses but is 
already active at the first virus-cell interaction. The host restriction factors being a part 
this type of immunity are sometimes constitutively expressed and provide an intrinsic 
pre-mobilized system of defense against retroviral infection (Bieniasz 2004). The 
importance of restriction factors in the virus response is underscored by their genetic 
variability accumulated as a result of species exposure to different pathogens and by the 
complex mechanisms the viruses have evolved in order to evade the antiviral activity of 
these proteins (Neil and Bieniasz 2009). As a result of the genetic variability of the host 
restriction factors, their capacity to restrict modern lentiviruses among primates is 
species-specific. As an example, HIV-1 efficiently enters the cells of Old World monkeys, 
but encounters a block before reverse transcription caused by an interference with 
uncoating of the retroviral capsid (CA) (Stremlau, Owens et al. 2004). The understanding 
of the interaction mechanisms conditioning specific lentivirus restriction by primate 
restriction factors is still incomplete. Such knowledge however could open ways for novel 
forms of therapeutic intervention in pathogenic retroviral infections, as well as the 
development of animal models of human disease, which advocates detailed studies on 
the scale of individual interaction of the interactions between restriction factors and 
respective lentivirus proteins. 
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An example of a retroviral restriction factor showing different restriction patterns against 
lentiviruses in primates is the tripartite motif (TRIM) 5. TRIM5 was shown to be 
responsible for various retrovirus restriction phenotypes that can be observed in human 
and nonhuman primate cells (Besnier, Takeuchi et al. 2002; Stremlau, Owens et al. 
2004; Towers 2005). The most studied antiviral TRIM protein, TRIM5α is a retroviral 
restriction factor that targets the early steps of cellular infection. It recognizes the viral 
capsid (CA) and promotes premature virus disassembly before its reverse transcription 
in the host cell (Stremlau, Owens et al. 2004). The TRIM5α-CA interaction is species-
specific: human TRIM5α has limited efficacy against HIV-1, whereas some primate 
TRIM5αs can potently restrict HIV-1. 
The TRIM family is a large family of proteins that are characterized by a structure 
comprising a RING domain, one or two B-box domains and a predicted coiled-coil region 
(Reymond, Meroni et al. 2001). Analyses of TRIM5α variation among primate species 
identified three variable regions (V1, V2 and V3) within the B30.2 (SPRY) domain that 
are the major determinants of its anti-HIV-1 potency (Figure 2.1) (Stremlau, Owens et al. 
2004). The genetic composition of these regions was shown to be reflected in the protein 
restriction specificity of different viruses (Ohkura, Yap et al. 2006). The variable regions 
in the SPRY domains of primate TRIM5α might have evolved independently to recognize 
various retroviruses, which resulted in the differing restriction phenotypes against 
modern immunodeficiency viruses. In the absence of a crystal structure of TRIM5α, and 
in particular its SPRY domain, the molecular mechanism behind these phenotypic 
differences remains unclear. Nonetheless, we have a rudimentary understanding of the 
molecular details by which TRIM5α proteins block retroviral infection. Specifically, a C-
terminal domain of the TRIM5α protein directly recognizes the incoming viral CAs 
(Sebastian and Luban 2005; Stremlau, Perron et al. 2006) and thereby governs 
antiretroviral specificity (Perez-Caballero, Hatziioannou et al. 2005; Stremlau, Perron et 
al. 2005; Yap, Nisole et al. 2005; Perron, Stremlau et al. 2006), while a central coiled-coil 
drives TRIM5α multimerization, which is essential for inhibition. 
 
Figure 2.1 TRIM5 protein domains. Three variable regions (V1, V2, V3) in the B30.2 (SPRY) domain are 
indicated. 
The identification of TRIM5α as the protein responsible for the resistance of certain cells 
to HIV stimulated studies of its evolution and mechanism of action. In this part of the 
thesis we describe an in-depth analysis of the structural and electrostatic determinants 
of the TRIM5α-CA interaction. Based on comparative analyses of protein structures and 
of the electrostatic potential on the surfaces of different variants of both TRIM5α and CA 
that were experimentally verified for their interaction phenotype, we aimed to identify the 
sequence and structure determinants of their interaction. The importance of the TRIM5α-
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CA interaction for the infection points to in-depth studies on the scale of an individual 
interaction as a potential means of understanding this restriction mechanism. 
2.2 First interaction partner – mutations in the TRIM5α SPRY domain resulting in 
different protein restriction capacities 
The results of the study described in this section are published in: Kono, K., Bozek, K., 
Domingues, FS., Shioda, T., Nakayama, EE. Impact of a single amino acid in the 
variable region 2 of the Old World monkey TRIM5alpha SPRY (B30.2) domain on anti-
human immunodeficiency virus type 2 activity. Virology. 2009 May 25;388(1):160-8. In 
this work we performed structural analysis of several chimeric TRIM5αs experimentally 
tested for their ability to restrict various HIV-1 and HIV-2 CA variants. The analysis was 
focused on the protein’s SPRY domain, given the evidence that this region is the major 
determinant of the protein restriction specificity (Perez-Caballero, Hatziioannou et al. 
2005; Stremlau, Perron et al. 2005). A 17-amino acid region of the African green monkey 
(AGM) TRIM5α SPRY domain (Nakayama, Miyoshi et al. 2005) as well as position 322 
of the human (Stremlau, Perron et al. 2005; Yap, Nisole et al. 2005), 386 and 389 of the 
orang-utan and gorilla TRIM5α (Ohkura, Yap et al. 2006) were shown to be important for 
inhibiting several HIV and SIV species.  
Previous experiments in the lab of Prof. Shioda testing rhesus monkey TRIM5α 
(TRIM5α-rh) and cynomolgus monkey TRIM5α (TRIM5α-cm) pointed to a broad 
spectrum of TRIM5α-rh restriction of HIV-2 as compared to TRIM5α-cm (Kono, Song et 
al. 2008). A chimeric study of the two proteins showed that the variable region 1 (V1) of 
the SPRY domain of TRIM5α-rh was determinant for the restriction. Additionally a 
baboon TRIM5α (TRIM5α-bab) V1 was tested in the TRIM5α-cm background and 
showed HIV-2 restriction capacity despite the fact that baboons are sensitive to HIV-2 
infection (Barnett, Murthy et al. 1994; Locher, Barnett et al. 1998; Locher, Witt et al. 
2001). A possible explanation for this discrepancy is that variable region 2 or 3 (V2 or 
V3) of SPRY domain also contributes to anti-HIV-2 activity of the protein.  
2.2.1 Experimental results 
In this study the regions V2 and V3 of TRIM5α SPRY domain were examined for their 
role in the HIV-2 restriction. Chimeric TRIM5αs composed of parts of the protein of three 
monkey species were constructed. The TRIM5α chimera was produced using a Sendai 
virus (SeV) expressing chimeric TRIM5αs composed of protein parts obtained using Sph 
and  BamH restriction enzymes (Figure 2.2). The restriction enzymes separated the 
protein into: the N-terminal fragment containing RING, B-box2, and coiled-coil domains, 
the central fragment containing V1 of the SPRY domain, and the C-terminal fragment 
containing V2 and V3 of the SPRY domains. To examine the roles of V2 and V3 region 
of the SPRY domain of TRIM5α in the HIV-2 restriction chimeric proteins were 
constructed composed of parts of cynomolgus monkey (C), baboon (B) and rhesus 
macaque (R) TRIM5α (Figure 2.3). Those TRIM5α constructs were tested for their ability 
to restrict X4-tropic HIV-1 strain NL4-3 and HIV-2 strains GH123 and GH123/Q. Strain 
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GH123/Q is an HIV-2 GH123 strain with a glutamine on the 120th CA position. This 
mutation has been previously shown (Kono, Song et al. 2008) to affect the TRIM5α 
restriction. Viruses were tested in two human T cell lines: MT4 and CEM-SS. 
 
Figure 2.2 Alignments of amino acid sequences of cynomolgus monkey (CM), rhesus monkey (Rh), and 
baboon TRIM5αs. The RING, B-box2, coiled-coil and SPRY (B30.2) domains are indicated by 
labelled bars above the sequences. Variable regions 1, 2, and 3 are indicated by dashed bars above 
the sequence. Inverted triangles denote Sph and BamH restriction enzyme site, respectively. Dots 
denote the amino acid residues identical to the cynomolgus monkey sequence, dashes deletions 
relative to rhesus and baboon TRIM5αs. The box marks the amino acid residue found in this study to 
affect anti-HIV-2 activity of TRIM5α. 
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Figure 2.3 Schematic representation of chimeric and mutant TRIM5αs, and summary of the experimental 
results. White and grey bars denote rhesus monkey (R) and cynomolgus monkey (C) sequences, 
respectively. B denotes a baboon sequence. The amino acid at the 385th or 383rd position in V2 of 
the SPRY domain is indicated in the construct. +++, ++, +, and – denote more than 1000-fold, 100- to 
1000-fold, 8- to 100-fold, and less than 8-fold suppression of virus growth, respectively, relative to the 
negative control lacking SPRY domain. Restriction of the described viruses in two tested cell lines is 
shown. 
In the MT4 cells all chimeric as well as rhesus monkey and cynomolgus monkey 
TRIM5αs almost completely restricted HIV-1 NL4-3 (Figure 2.3) and HIV-2 GH123. In 
the case of HIV-2 GH123/Q, rhesus monkey TRIM5α, CBC and RBR chimeric TRIM5αs 
but not cynomolgus monkey TRIM5α restricted the virus replication. This virus was also 
only moderately restricted by CBB chimeric TRIM5α (Figure 2.3) which indicates a 
weaker anti-HIV-2 GH123/Q activity of CBB as compared to CBC and RBR chimeric 
TRIM5αs. CBB differs from the RBR or CBC chimeric TRIM5αs in the SPRY domain is 
only at the 385th amino acid residue in V2, with a proline (P) in the baboon and serine 
(S) in the rhesus monkey and cynomolgous monkey sequences (Figure 2.2, box). These 
results suggest that the amino acid at this position of TRIM5α affects the protein 
restriction activity against HIV-2 GH123/Q infection.  
To confirm this hypothesis, a mutant CBB TRIM5α was constructed with a serine at the 
385th in the place of proline (CBB P385S TRIM5α, Figure 2.3) and compared in its ability 
to restrict HIV-2 GH123/Q with that of CBB TRIM5α. The inhibition of HIV-2 GH123/Q by 
the CBB P385S TRIM5α was stronger than that of the CBB chimeric TRIM5α (Figure 
2.3) indicating that a single amino acid substitution from S to P at the 385th position of 
baboon TRIM5α influences its anit-HIV-2 activity. 
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Subsequently, a cynomolgus monkey and rhesus monkey TRIM5αs were produced with 
an S-to-P mutation at the corresponding positions of the 385th chimeric protein sequence 
(383th for the cynomolgus monkey due to a 2-position deletion) (CM S383P TRIM5α and 
Rh S385P TRIM5α respectively). However, these mutant TRIM5αs did not show 
significant differences in the anti-HIV-2 activity from the wild types, which indicates that 
the restriction is an accumulative effect of different parts on the protein. 
In order to test the restriction activity of TRIM5αs in different physiological conditions 
another set of experiments was performed using the CEM-SS cell line. In this T cell line 
TRIM5α is expressed at lower levels of 0.2 of those in the MT4 cells. All TRIM5αs 
inhibited HIV-2 GH123 although the extent of inhibition varied among the TRIM5αs. The 
difference in anti-HIV-2 GH123/Q activity between CBB and CBC chimeric TRIM5α was 
also observed in CEM-SS cells. This indicates that the chimeric TRIM5αs containing 
baboon SPRY domain fail to restrict HIV-2 GH123/Q replication. 
2.2.2 Structural modeling – sequence alignment 
Given the evidence for the relevance of the V1 region and in particular the 385th position 
effect on the restriction capacity of TRIM5α against HIV-2, we performed structural 
analysis of the region and the residue of interest.  
Based on the sequence search of the protein data bank (PDB) (Berman, Westbrook et 
al. 2000), we identified four homologous protein structures: PRYSPRY domain of 
TRIM21 (2IWG) (James, Keeble et al. 2007), mouse TRIM21 (2VOK and 2VOL) 
(Keeble, Khan et al. 2008) and human PRYSPRY domain (2FBE) (Grutter, Briand et al. 
2006). All of the structures showed a highly significant e-value (Table 2.1) and about 
35% (2IWG, 2VOK, 2VOL) and 29% (2IWG) of their sequence identity with the human 
TRIM5α SPRY domain, respectively. All for four structures showed 45%-76% sequence 
similarity with 2VOK and 2VOL being 99% identical. 
 template e-value identity positions identity [%]  
 2IWG 2.1e-25 71/295 35  
 2VOK 3.1e-22 62/172 36  
 2VOL 8.2e-22 60/172 35  
 2FBE 7.2e-12 53/182 29  
Table 2.1 Similarity of the human SPRY domain to the template structures. 
A critical step of structural homology modeling is elaborating of an accurate alignment of 
the modelled protein to the structural templates. In order to assess the robustness of the 
alignment of the analyzed primate sequences and the templates we performed two 
additional alignments. The basic alignment apart from the four template sequences 
included six primate SPRY domain sequences: human, baboon (GenBank AAV91976),  
cynomolgus monkey (AB210052), rhesus macaque (AY523632), sooty mangabey 
(AY710303, EF551344) and African green monkey (AB210050). The enriched alignment 
included additional 289 sequences that scored e-value < 1.0e-12 in the BLAST (Altschul, 
Gish et al. 1990) search of GenBank (Benson, Karsch-Mizrachi et al. 2009). All  
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Figure 2.4 Maximum likelihood tree of the basic (top) and enriched (bottom) alignments. Seven primate 
sequences are labelled in red, template sequences in blue. Respective primate and template 
sequence clades are indicated with arrows colored accordingly on the enriched alignment tree. 
Additionally labelled 2FBE template shows the lowest similarity with the primate and other template 
sequences and is located in separation from other templates on the enriched alignment tree. 
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sequences in the enriched alignment appeared also among the first 1000 hits of the 
BLAST query of the used template sequences. Both alignments were computed using 
the Muscle method (Edgar 2004). In the enriched alignment iteratively sequences of long 
insertions or deletions (>10bp) relative to the templates were removed and the 
remaining sequences were realigned, which resulted in 168 homolog sequences used in 
this alignment.  
The homologous sequences of the enriched alignment filled the sequence space 
between the templates and the primate sequences (Figure 2.4, bottom) especially 
between the 2FBE template and other used sequences. 
We analyzed the difference in the alignment quality, calculated as the percentage of 
sequence identity, resulting from an increased number of homologous sequences in the 
enriched alignment (Table 2.2). It appears that the enriched alignment generally showed 
higher quality of the primate sequence alignment to the templates except for minor 
quality decrease (<0.20%) of three alignments of 2IWG and two of 2VOL (Table 2.2). 
 AGM baboon CM human RM SM 
2IWG 1.18 -0.14 -0.13 -0.14 0.81 0.04 
2VOK 1.25 1.92 1.45 0.42 1.42 1.92 
2VOL 0.72 1.31 0.82 -0.19 -0.14 1.49 
2FBE 1.35 1.66 2.15 2.77 1.66 2.15 
Table 2.2 Alignment difference [%] of the primate SPRY domains and templates between the enriched 
and basic alignments. Lower alignment quality of the enriched alignment is colored in red. 
Next, we inspected alignment of specific positions of TRIM5α SPRY domain (Ohkura, 
Yap et al. 2006) between the basic and enriched alignments (Figure 2.5). The 
comparison revealed that the major differences between the alignments occur close to 
the insertions in the primate SPRY domain relative to the template sequences which 
indicates that the alignments are less reliable close to the regions of these insertions 
(Figure 2.5). We therefore used both alignments in the further homology modeling to 
assess the structural variability of the differently aligned sequence regions. 
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                                   _________V1 region__________ 
human   RRYWVDVTVAPNNI-SCAVISEDKRQVSSPKPQIIYGARGT--RYQTFVNFNYCTGILGSQSITSGKHYWEVDVSKKT 
CM      RRYWVDVTLAPNNI-SHAVIAEDKRQVSSRNPQIVYQSPGT--LFQSLTNFNYCTGVLGSQSITSGKHYWEVDVSKKS 
RH      RRYWVDVTLATNNI-SHAVIAEDKRQVSSRNPQIMYQAPGTLFTFPSLTNFNYCTGVLGSQSITSGKHYWEVDVSKKS 
baboon  RRYWVDVTLAPNNI-SHAVIAEDKRQVSSRNPQITYQAPGTLFSFPSLTNFNYCTGVLGSQSITSGKHYWEVDVSKKS 
SM      ----VDVTLAPNNI-SHAVIAEDKRQVSSRNPQIMYQARGTLFSFPSHTNFNYCTGVLGSQSITSGKHYWEVDVSKKS 
2IWG    --HMVHITLDPDTANPWLILSEDRRQVRLGDTQQSIPGNEE--RFDS------YPMVLGAQHFHSGKHYWEVDVTGKE 
2VOK    HHHMVHITLDRNTANSWLIISKDRRQVRMGDTHQNVSDNKE--RFSN------YPMVLGAQRFSSGKMYWEVDVTQKE 
2VOL    --HMVHITLDRNTANSWLIISKDRRQVRMGDTHQNVSDNKE--RFSN------YPMVLGAQRFSSGKMYWEVDVTQKE 
2FBE    PEFQVDMTFDVDTANNYLIISEDLRSFRSGDLSQNRKEQAE--RFDT------ALCVLGTPRFTSGRHYWEVDVGTSQ 
            ____V2 region____             ___V3 region___ 
human   AWILGVCAGFQPDAMCNIEKNENY--PKYGYWVIGLEEGVKCSAFQDSSFHTPSVPFIVPLSVIICPDRVGVFLDYEACTV 
CM      AWILGVCAGFQSDAMCNIEQNENYQ-PKYGYWVIGLQEGVKYSVFQDGSLHTPFAPFIVPLSVIICPDRVGVFVDYEACTV 
RH      AWILGVCAGFQSDAMYNIEQNENYQ-PKYGYWVIGLQEGVKYSVFQDGSSHTPFAPFIVPLSVIICPDRVGVFVDYEACTV 
baboon  AWILGVCAGFQPDAMYNIEQNENYQ-PKYGYWVIGLQEGVKYSVFQDGSSHTPFAPFIVPLSVIICPDRVGVFVDYEACTV 
SM      AWILGVCAGFQPDAMYNIEQNENYQ-PKYGYWVIGLQEGVKYSVFQDGSSHTPFAPFIAPLSVIICPDRVGVFVDYEACTV 
2IWG    AWDLGVCRD-------SVRRKGHFLLSSKSGFWTIWLWNKQKYEA-----GTYP----QTPLHLQVPPCQVGIFLDYEAGM 
2VOK    AWDLGVCRD-------SVQRKGQFSLSPENGFWTIWLWQ-DSYEA-----GTSP----QTTLHIQVPPCQIGIFVDYEAGV 
2VOL    AWDLGVCRD-------SVQRKGQFSLSPENGFWTIWLWQ-KSYEA-----GTSP----QTTLHIQVPPCQIGIFVDYEAGV 
2FBE    VWDVGVCKE-------SVNRQGKIELSSEHGFLTVGCREGKVFAA-----STVP----MTPLWVSPQLHRVGIFLDVGMRS 
                                   _________V1 region__________ 
human   RRYWVDVTVAPNNI-SCAVISEDKRQVSSPKPQIIYG---ARGT--RYQTFVNFNYCTGILGSQSITSGKHYWEVDVSKKT 
CM      RRYWVDVTLAPNNI-SHAVIAEDKRQVSSRNPQIVYQSPGTL----F-QSLTNFNYCTGVLGSQSITSGKHYWEVDVSKKS 
RH      RRYWVDVTLATNNI-SHAVIAEDKRQVSSRNPQIMYQ---APGTLFTFPSLTNFNYCTGVLGSQSITSGKHYWEVDVSKKS 
baboon  RRYWVDVTLAPNNI-SHAVIAEDKRQVSSRNPQITYQ---APGTLFSFPSLTNFNYCTGVLGSQSITSGKHYWEVDVSKKS 
SM      ----VDVTLAPNNI-SHAVIAEDKRQVSSRNPQIMYQ---ARGTLFSFPSHTNFNYCTGVLGSQSITSGKHYWEVDVSKKS 
2IWG    ---MVHITLDPDTANPWLILSEDRRQVRLGDTQ---Q---SI----P-GNEERFDSYPMVLGAQHFHSGKHYWEVDVTGKE 
2VOK    HHHMVHITLDRNTANSWLIISKDRRQVRMGDTH---Q---NV----S-DNKERFSNYPMVLGAQRFSSGKMYWEVDVTQKE 
2VOL    ---MVHITLDRNTANSWLIISKDRRQVRMGDTH---Q---NV----S-DNKERFSNYPMVLGAQRFSSGKMYWEVDVTQKE 
2FBE    PEFQVDMTFDVDTANNYLIISEDLRSFRSGDLS---Q---NR----K-EQAERFDTALCVLGTPRFTSGRHYWEVDVGTSQ 
            ____V2 region____             ___V3 region___ 
human   AWILGVCAGFQPDAMCNIEKNENYQPKYGYWVIGLEEGVKCSAFQDSSFHTPSVPFIVPLSVIICPDRVGVFLDYEACTV 
CM      AWILGVCAGFQSDAMCNIEQNENYQPKYGYWVIGLQEGVKYSVFQDGSLHTPFAPFIVPLSVIICPDRVGVFVDYEACTV 
RH      AWILGVCAGFQSDAMYNIEQNENYQPKYGYWVIGLQEGVKYSVFQDGSSHTPFAPFIVPLSVIICPDRVGVFVDYEACTV 
baboon  AWILGVCAGFQPDAMYNIEQNENYQPKYGYWVIGLQEGVKYSVFQDGSSHTPFAPFIVPLSVIICPDRVGVFVDYEACTV 
SM      AWILGVCAGFQPDAMYNIEQNENYQPKYGYWVIGLQEGVKYSVFQDGSSHTPFAPFIAPLSVIICPDRVGVFVDYEACTV 
2IWG    AWDLGVCR----DSVRRKGH-FLLSSKSGFWTIWLWNKQKYEA--------GTYPQTPLHLQVPPCQVGIFLDYEAGMVS 
2VOK    AWDLGVCR----DSVQRKGQ-FSLSPENGFWTIWLW-QDSYEA--------GTSPQTTLHIQVPPCQIGIFVDYEAGVVS 
2VOL    AWDLGVCR----DSVQRKGQ-FSLSPENGFWTIWLW-QKSYEA--------GTSPQTTLHIQVPPCQIGIFVDYEAGVVS 
2FBE    VWDVGVCK----ESVNRQGK-IELSSEHGFLTVGCREGKVFAA--------STVPMTPLWVSPQLHRVGIFLDVGMRSIA 
Figure 2.5 Basic (top) and enriched (bottom) alignments of the primate and structure template sequences. 
For brevity only part of the SPRY domain is shown (residues 295-449) AGM and one of the SM 
sequences are not shown. Positions highlighted in red are those detected to be important for the 
TRIM5α lentivirus restriction in previous studies (Ohkura, Yap et al. 2006). Position analyzed in this 
study is highlighted. Variable regions are indicated by horizontal bars above each alignment. 
2.2.3 Structural modeling 
Using both alignments we constructed structural models of the primate TRIM5α SPRY 
domains focusing on the baboon domain due to its phenotypical characteristics found in 
the mutagenesis experiments. Models were built using Modeller 9v4 (Eswar, Webb et al. 
2006) and visualized with PyMol v1.0r2 (DeLano).  
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Figure 2.6 Baboon SPRY domain models based on basic (left) and enriched (right) alignments. The model 
structure is colored in yellow, the insertions relative to the 2IWG template are colored in blue. The 
backbone of the 2IWG template is traced with an orange line. Atoms of residues important for the 
restriction (Ohkura, Yap et al. 2006) are represented by spheres, atoms of the 385th residue are 
additionally colored in red. 
Comparison of the models based on different alignments showed visible differences 
especially in the regions close to the insertions relative to the templates (Figure 2.6). 
These regions are located on loops that are structurally flexible which hampers precise 
structure prediction. The insertions are short, hence, based on the models, it can be 
assumed that the inserted regions are located at the protein surface. In spite of their 
separation in sequence, regions V1 and V2, appear to be spacially close. The proline 
residue at the 385th position of baboon TRIM5α is directed towards V1 region.  
It was previously speculated that V1 and V2 are included in variable loops which form a 
binding interface of TRIM and other protein families with the SPRY domain (James, 
Keeble et al. 2007). A substitution involving proline is expected to affect local backbone 
conformation, and a P/S substitution in particular results in an additional hydrogen bond 
donor-acceptor. Overall, this indicates that position 385 is located at a putative binding 
site, where a P/S substitution might affect the local structure and surface chemistry. This 
result is consistent with the observed impact of these substitutions on TRIM5α anti-HIV-2 
activity. Nevertheless, it is not yet clear how these substitutions affect TRIM5α restriction 
activity and binding affinity in particular, which calls for further investigation of the protein 
interactions involving TRIM5α.  
2.2.3 Discussion 
The study presented here indicates that the anti-HIV-2 activity of chimeric TRIM5α 
containing the entire baboon SPRY domain is weaker than that of chimeric TRIM5α 
containing baboon V1 alone. These results are consistent with those of the previous in 
vivo studies (Barnett, Murthy et al. 1994; Locher, Barnett et al. 1998; Locher, Witt et al. 
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2001). Additionally a single amino acid in V2 of the SPRY domain was found to affect its 
anti-HIV-2 activity.  
An S-to-P mutation in the CM and baboon SPRY resulted in an enhanced restriction 
capacity against HIV-2 GH123/Q strain. In contrast to baboon and cynomolgus monkey 
TRIM5α, there was no evidence of an obvious contribution by the 385th amino residue 
for anti-HIV-2 activity in the case of rhesus monkey TRIM5α background. The specific 
combination of amino acids in V1 and V2 might therefore play an important role in 
determining specificity of restriction (Ohkura, Yap et al. 2006). The combination of amino 
acids in V1 and V2 of the SPRY domain of baboon and cynomolgus monkey TRIM5α 
appears to be more stringent in its anti-HIV-2 activity than that of rhesus monkey 
TRIM5α. 
The study adds to previous recombinant studies of TRIM5αs performed by the Osaka 
group (Nakayama, Miyoshi et al. 2005; Song, Nakayama et al. 2007; Kono, Song et al. 
2008) as well as other similar studies (Stremlau, Perron et al. 2005; Yap, Nisole et al. 
2005; Ohkura, Yap et al. 2006) that aimed at identifying key differences between 
homologous TRIM5αs that determine their restriction capacities. With the lack of 
knowledge on the precise mechanism of TRIM5α-CA binding, mutagenic studies of the 
SPRY domain supported by structural models provide hypotheses about the potential 
interaction site. The proposed structural model indicates that the position 385 is located 
at a putative binding site and the P/S substitution is expected to affect the local structure 
and protein surface chemistry. Knowledge of the exact binding mechanism would open 
new potential directions for HIV treatment. Analogous mutagenetic studies of the CA 
should follow in order to identify respective positions of the virus protein playing crucial 
role in this interaction. 
2.3 Second interaction partner - single substitution in HIV-1 CA affecting its 
sensitivity to the TRIM5α restriction  
The efficient restriction of lentviruses by the TRIM5α protein is dependent on the 
complementary binding site of both interaction partners. Given the rapid evolution of the 
virus, mutation of the virus CA might be the main force conditioning the restriction and 
the virus capacity to infect certain host species. In this study, we analyzed the structural 
impact of single CA mutations that affected virus restriction by primate TRIM5α. The 
results of the study described in this section are published in: Kuroishi, A., Bozek, K., 
Shioda, T., Nakayama, EE. A single amino acid substitution of the human 
immunodeficiency virus type 1 capsid protein affects viral sensitivity to TRIM5alpha. 
Retrovirology. 2010 Jul 7;7:58. 
2.3.1 Experimental results 
The HIV-1 CA protein consists of the N-terminal core and C-terminal dimerization 
domains (Gitti, Lee et al. 1996; Gamble, Yoo et al. 1997). The N-terminal of CA is 
composed of seven α-helices that are arranged together in a flat triangular shape 
connected by conformationally flexible loops (Tang, Ndassa et al. 2002). Previous 
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mutagenic experiments reported the importance of the loops between α-helices 4 and 5 
(L4/5) and between α-helices 6 and 7 (L6/7) for the virus replication in CM cells 
(Kuroishi, Saito et al. 2009). The same study showed that introduction of SIVmac L6/7 
into an HIV-1 CA resulted in an improved of viral growth in cynomolgus monkey (CM) 
cells and an attenuated growth in human cells. To gain more insight into the effects of 
CA loops on viral replication a virus construct was experimentally tested containing 
SIVmac L4/5, L6/7 and vif in an HIV-1 NL-43 genetic background (NL-4/5S6/7SvifS) 
(Figure 2.7). The virus was inoculated into CEMss cells and cultivated over 42 days. The 
progeny virus (NL-4/5S6/7SvifSd42) that was inoculated into fresh CEMss cells showed 
an increased replicative capability (Figure 2.8).  
 
Figure 2.7 Schematic representation of HIV-1 CA constructs. White and grey bars denote HIV-1 (NL4-3) 
and SIVmac239 sequences respectively. E indicates the amino acid residue at the 116th position of 
the CA protein. 
The progeny virus was next amplified using polymerase chain reaction (PCR) and 
cloned. Nucleotide sequence analysis of the resultant clones revealed that six out of six 
independent clones carried a single nucleotide substitution of a glycine (G) to glutamic 
acid (E) at the 116th position of CA (G116E). 
Analysis of 96 HIV-1 strains in Los Alamos HIV sequence database 
(http://www.hiv.lanl.gov/) including subtype A to subtype K of group M, revealed that 
there was no HIV-1 strain carrying glutamic acid at the 116th position of CA, although this 
position was occupied with variable amino acid residues (35 strains carried glycine, 36 
alanine, nine threonine, seven arginine, six glutamine, one isoleucine and one aspartic 
acid). 
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Figure 2.8 Adaptation of HIV-1 derivatives to human cells. NL-4/5S6/7SvifS (left panel), a virus with the 
SIVmac239 L4/5, L6/7 and vif was inoculated into CEMss cells which were then periodically assayed 
for the levels of p24 as an indicator of virus replication. Virus in the culture on day 42 after infection 
(NL-4/5SL6/7SvifSd42) was inoculated into fresh CEMss cells and assayed for the replication based 
on p24 (right panel). 
To validate the effect of the G116E mutation on the virus replication the mutation was 
introduced into the initial virus NL-4/5S6/7SvifS (NL-4/5SG116E6/7SvifS). In addition, to 
exclude the effects of SIVmac genomic parts on the TRIM5α mediated restriction, the 
same mutation was introduced into NL4-3 HIV-1 reference virus (NL-G116E) (Figure 
2.7). The two viruses were tested in CEMss cells expressing three types of TRIM5α – 
human, CM and a negative control TRIM5α with a truncated SPRY domain (CM-SPRY(-
)). The NL-4/5SG116E6/7SvifS virus could grow more efficiently in the TRIM5α 
expressing CEMss cells than the original NL-4/5S6/7SvifS virus. The virus could grow in 
the cells expressing CM TRIM5α although the levels of virus titer were less than 10% of 
those in the absence of TRIM5α (Figure 2.9). The growth of NL4-3 virus was not affected 
by human TRIM5α, while that of NL-G116E was slightly suppressed by human TRIM5α. 
   
 
Figure 2.9 Viral growth in the presence of TRIM5α. CEMss cells expressing CM (black diamonds), human (grey 
circles), or CM-SPRY(-) (white diamonds) TRIM5α were infected with HIV-1 derivatives and assayed for 
the levels of p24 indicating virus replication. 
This suggested the individual effect of the 116th amino acid residue of CA on the TRIM5α 
mediated restriction. The rescued replicative capability of the virus NL-4/5S6/7SvifSd42 
virus in human cells was due, at least partly, to the acquisition of G116E substitution in 
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CA. The G116E substitution that occurred during long-term virus cultivation in human 
cells appeared to render the virus more sensitive to TRIM5α restriction.  
2.3.2 Structural modeling 
In order to investigate the localization of the CA G116E single amino acid substitution 
and its potential effect on the protein structure, we performed a structural analysis of the 
capsid protein of NL-G116E. We used the structure of the N-terminal domain of NL4-3 
CA protein (1GWP) (Tang, Ndassa et al. 2002) as a template for this study. The goal of 
this analysis was to inspect the effect of one amino acid change relative to the template, 
No alignment was therefore needed for this structural modeling. We built the model of 
NL-G116E using Modeller 9v4 (Eswar, Webb et al. 2006) and visualized with PyMOL 
v1.0r2 (DeLano).  
The position 116 is located in the 6th helix near the L4/5 and L6/7 and is apparently 
exposed to the protein surface. (Figure 2.10, upper panels). The structural effects of the 
G-to-E substitution might be due to the long side chain of E in contrast to G lacking side 
chain. The mutation can result in two possible effects. First, if the residue belongs to the 
interaction site, it can change the local complementarity between CA and TRIM5α. 
Second, even if the residue is not directly in the binding site, the side chain and polarity 
change can influence the configuration of nearby loops and therefore affect the binding 
site that is located somewhere else on the protein. Notably, the loops being flexible parts 
of the protein are slightly repositioned in the modeled structure with the G116E 
substitution (Figure 2.10). 
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Figure 2.10 Structural model of the N-terminal domain of HIV-1 CA with G116E substitution. Left panels 
show the template structure of the N-terminal domain of the HIV-1 CA, right panels – of the domain 
structure with the G116E mutation. Red spheres represent G and E on the 116th position with their 
side chains. Bottom panels show surface views of the template and model structures with the 116th 
position indicated in red. The loops between α-helices 4 and 5 (L4/5) and 6 and 7 (L6/7) are labelled.  
2.3.3 Discussion 
In this study, through a long-term cultivation of human CEMss cells infected with an HIV-
1 derivative virus a mutation was found that improved the virus replication. The G-to-E 
single amino acid substitution at the 116th position of CA appeared to enable the virus to 
escape the TRIM5α recognition. Although this position is highly variable among natural 
HIV-1 strains from subtypes A to K, no virus with E at the 116th position was found in the 
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Los Alamos HIV sequence database (http://www.hiv.lanl.gov/), which suggests its 
importance for viral growth. It is located at the central position of the CA surface 
composed of L4/5 and L6/7, a structure considered to be important for TRIM5α binding 
(Kuroishi, Saito et al. 2009). The amino acid substitution of G to E at the 116th position 
caused an important change in the structure of the surface through exchanging of a lack 
of side chain by a long, negatively charged side chain (Figure 2.10). This change in the 
conformational structure of the L4/5 and L6/7 might affect the interaction between the 
CA and TRIM5α. Alternatively, this substitution might influence the configuration of 
surrounding loops by the changes in the side chain and polarity without directly involving 
the binding site of TRIM5α. 
Similar to the mutagenic study of the TRIM5α protein this study pointed to a residue of 
CA that is potentially involved in the interaction site. Even though the crystal structure of 
NL4-3 CA is a good template for homology modeling, the uncertainty of the TRIM5α 
model does not suggest hypotheses about the precise interaction mechanism. However, 
a comparative study of structural and biochemical properties of a broader spectrum of 
virus and host protein variants of known interaction phenotype could point to major 
determinants of the interaction. 
2.4 Two interaction partners together – compilation study of the experimentally 
tested TRIMα and CA sequences 
The two studies presented in the previous sections of this chapter analyzed individual 
genetic changes of each of the interaction partners separately and their effect on the 
TRIM5α-CA interaction. As the last step of the analysis of this host-virus interaction on 
the single interaction level we performed a compilation analysis of the experimental 
results collected by the Osaka group. The group gathered data on the capacity of 
different CA and TRIM5α pairs to interact by measuring the efficiency of virus carrying a 
specific CA to infect cells expressing different TRIM5αs. The protein variants were 
specific to species or obtained through mutagenesis studies. The compiled sequence 
and phenotype dataset of individually tested proteins allowed for a systematic and 
statistical search of the sequence and structural determinants of the TRIM5α restriction 
that might have not been observed in the studies of individual genetic changes. 
2.4.1 Sequence analysis 
First, we collected sequence data of the TRIM5α and CA variants that were 
experimentally tested by the Osaka group (Song, Nakayama et al. 2007; Kono, Song et 
al. 2008; Kuroishi, Saito et al. 2009; Kono, Song et al. 2010; Kuroishi, Bozek et al. 
2010). We obtained a list of 35 CA variants of HIV-2 and SIVmac239 that were tested for 
the restriction by several TRIM5α constructs (CA dataset). The TRIM5α dataset 
contained 14 sequences of cynomolgus monkey (CM) and rhesus macaque (RH) 
TRIM5αs and sequences composed of CM, RH and baboon TRIM5α genetic parts as 
described in the first part of this chapter. As the experiments were aimed at testing 
effects of a single protein position on the restriction, the datasets were incomplete and 
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biased in favor of mutations at specific sequence positions of special interest. 
Additionally, not all protein pairs were tested for their interaction. In order to perform 
statistical analyses of the sequence in relation to the phenotype we extracted a subset of 
the data that was fully characterized with the restriction phenotype. 
The resulting CA dataset consisted of 35 CA variants that were characterized for being 
restricted by CM and RH TRIM5α. Restriction was quantified as binary information with 1 
indicating more than 8-fold restriction of the virus replication. In the TRIM5α dataset we 
identified 14 protein constructs that were tested for their restriction of two HIV-2 CA 
variants: GH123 and GH123_Q. These two CA variants differ only at position 120, with P 
and Q in GH123 and GH123_Q respectively. Since GH123 was restricted more than 8-
fold by all of the 14 TRIM5α constructs, we could only search for TRIM5α positions 
related to the GH123_Q restriction. Nine of the TRIM5αs showed CA restriction, 
however, given the limited number of sequences originating from only three primate 
species and the very specific interaction partner they were tested against, the 
information obtainable from the TRIM5α dataset was limited. 
Both datasets of sequences characterized with their restriction phenotype information, 
were aligned using Muscle (Edgar 2004) and further analyzed. We performed two tests 
for relationship of each sequence position with the phenotype. Mutual information (MI) 
was used as an indicator of the significance of the relation between a change on a given 
sequence position with the phenotype, without defining which amino acid type 
corresponds to a specific phenotype. Fisher exact test (FET) was used to test the 
significance of co-occurrence of a specific amino acid type on each sequence position 
with the same restriction phenotype and this way to point to specific amino acid types 
that correspond to restriction.  
MI test indicated three CA positions significantly (p<0.05) related to the CM TRIM5α 
restriction and only one related to the RH TRIM5α restriction (Table 2.3). The highest MI 
was found between the CA 120th position and CM TRIM5α restriction. Other positions 
mostly in the region close to the first loop (L1) of the CA (residues 5-13) showed 
elevated MI (p<0.1) with the CM TRIM5α restriction. The only position significantly 
related to the RH TRIM5α restriction in the analyzed dataset is position 97, however 
other positions in the region of L4/5 showed elevated mutual information (p<0.1, Table 
2.3) with the RH TRIM5α restriction (residues 82-97). FET pointed to several amino acid 
types related to the restriction at these positions (Table 2.3). 
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CA position 
(amino acid) MI p-value  
CA position 
(amino acid) MI p-value 
5 0.194 0.027  82 (A) 0.148 0.072 
7 0.093 0.078  86 0.137 0.096 
11 (V) 0.185 0.026  90 (L) 0.128 0.061 
13 0.114 0.075  97 (D,E) 0.155 0.017 
29 0.093 0.076  124 0.090 0.089 
75 0.093 0.067  136 0.090 0.074 
111 0.104 0.059     
120 (P,Q) 0.951 0     
Table 2.3 CA positions with a high (p<0.1) MI indicating CM (left) and RH (right) TRIM5α restriction. 
Positions with a significant p-value (p<0.05) are indicated in bold. Amino acid types significantly 
(FET, p<0.05) related to the restriction are indicated in brackets. 
In the TRIM5α dataset significant (p<0.05) MI related to the GH123_Q restriction was 
found for positions 330 and 339-342. These positions are located in the V1 region of the 
protein. Region 339-342 includes an insertion of two amino acids in the RH and baboon 
proteins relative to CM TRIM5α (Figure 2.11). Notably, an insertion at positions 339 and 
340 was found to be significantly related to restriction (FET, p<0.05). Due to the low 
variability of the TRIM5α dataset, lack of the crystal structure of the SPRY domain and 
limited information on the phenotype of each protein variant, the information resulting 
from the analysis of this dataset is limited. It was therefore not analyzed in the further 
steps of this compilation study. 
 CM TRIM5α       QVSSRNPQIVYQSPGTLF--QSLTNFNYC  
 RH TRIM5α       QVSSRNPQIMYQAPGTLFTFPSLTNFNYC  
 BABOON TRIM5α   QVSSRNPQITYQAPGTLFSFPSLTNFNYC  
Figure 2.11 TRIM5α residues 320-350. Highlighted in red are positions significantly related to GH123_Q 
restriction (330, 339-342). 
2.4.2 Amino acid features 
The reason that so few CA positions and amino acid types were found as significantly 
related to the phenotype might lie in the limited size of the CA dataset. An insufficient 
variation of amino acid types on important sequence positions does not allow for 
detecting positions and amino acid types significantly related to the phenotype. A way to 
compensate the scarceness of sequence variants is to group amino acid types sharing 
certain properties and test for the relation of properties instead of amino acids to the 
phenotype. Additionally, properties of amino acids express their physicochemical 
similarities that are not encoded in the amino acid letter representation. 
We subjectively selected seven amino acid indices that might be important for protein-
protein binding from the AAIndex database (Kawashima, Ogata et al. 1999). This 
database catalogues amino acid properties previously tested and published. An index is 
a numerical quantification of a given physicochemical property of each amino acid type. 
The database contains about 500 indices many among them being redundant and 
strongly correlated. The seven indices were selected as an example set of properties 
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potentially relevant for binding and are mainly related to the amino acid structure and 
hydrophobicity (Table 2.4). 
Given a numerical representation of amino acids one can test the correlation of an 
amino acid property on each sequence position with the quantified phenotype. In this 
test we expanded the phenotype description to four values denoting the fold of the 
suppression of virus growth with 3 denoting more than 1000-fold, 2 – 100- to 1000-fold, 
1 – 8- to 100-fold, 0 – less than 8-fold. We calculated the correlation of the seven 
selected amino acid indices on each CA sequence position with the four-value 
phenotype description and tested for its significance by permutation of amino acid types 
on a given position in the dataset. 
Amino acid index (ID) Positions - CM TRIM5α restriction Positions - RH TRIM5α restriction 
Heat capacity 
(HUTJ700101) 7, 13, 27, 29, 75, 109, 111, 120, 124 61, 82, 97 
Hydrophobicity factor 
(GOLD730101) 86, 109, 120, 136 82, 86, 90 
Hydropathy index 
(KYTJ820101) 5, 7, 13, 109, 136 11, 86, 90, 120 
Side chain volume 
(KRIW790103) 11, 13, 27, 29, 109, 111, 124 82, 86, 97 
Percentage of buried 
residues (JANJ780102) 5, 7, 13, 29, 75, 109, 120, 136 11, 86, 97, 120 
Transfer free energy 
(JANJ790102) 5, 7, 13, 111, 120, 136 11, 62, 86, 97, 120, 150 
Average interactions per 
side chain atom 
(WARP780101) 
7, 27, 29, 75, 120, 124 11, 62, 86, 97 
Table 2.4 CA positions with a significant (p<0.05) correlation with the restriction by CM and RH TRIM5α. 
Colors indicate the type of correlation with positive in red and negative in blue. 
The amino acid indices analysis pointed to several positions significantly related to the 
phenotype additional to those inferred from the amino acid type analysis (Table 2.4). 
Positions important for the CM TRIM5α are located mainly close to the loops joining CA 
α-helices: L1 – positions 5, 7, 13, loop between helix 5 and 6 (L5/6) – positions 109, 111 
and L6/7 – positions 120, 124. Several other important positions seem to occur also in 
helices (27, 29, 75) however they show small amino acid variation among the CA 
variants. Positions related to the RH TRIM5α restriction lie mainly close to the L4/5 (82, 
86, 90, 97). Even though the specific amino acid properties and their relation to the 
phenotype are hard to interpret within a limited scope of the CA dataset (Figure 2.12), 
this analysis indicated the importance of the physicochemical constitution of the CA 
loops for the TRIM5α interaction. Four CA loops are pointing in the same direction and 
are in structural vicinity. Changes on the loops exposed to the protein surface (L1, L5/6 
and L6/7) might directly affect the binding site, changes on the less exposed loop parts 
might indirectly affect local configuration of the residues involved in binding. 
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GH123 SIVmac239 
  
  
Figure 2.12 Hydrophobicity factor property of the residues of the GH123 (left panels) and SIVmac239 (right 
panels) CA proteins. Structures are colored according to the amino acid hydrophobicity factor with 
red indicating high and yellow low values. Positions showing significant correlation to the CM or RH 
TRIM5α restriction are labeled on the upper panels. Bottom panels show the protein surface colored 
accordingly. The two CA variants show opposite phenotype with GH123 being restricted by both 
TRIM5αs and SIVmac239 by none. The hydrophophobicity factor values are generally lower on the 
loop surface of SIVmac239 which might prevent TRIM5α binding. 
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2.4.3 Structural analysis 
Next, we investigated the structural properties of the variants in the CA dataset. We 
used the structure of the N-terminal domain of HIV-1 CA protein (1GWP) (Tang, Ndassa 
et al. 2002) as a template and modeled the structures of each variant in this dataset 
using Modeller 9v4 (Eswar, Webb et al. 2006). Each variant was aligned to the template 
individually and the best model was chosen out of ten runs of the modeling procedure. 
  
Figure 2.13 Models of the CA variants. Template CA structure used in the modeling is shown on the left 
panel. Three exposed loops are indicated, side chains of residues significantly related to the 
phenotype based on MI test are pictured as sticks and labelled. Red side chains belong to residues 
related to the CM TRIM5α restriction, orange to the RH TRIM5α restriction. Right panel shows all 
modeled variants superposed. Variants restricted by CM TRIM5α are colored in red, not restricted in 
yellow. The backbone of the template structure is traced with blue line. 
The modeled structures showed certain variability, mainly in the loops (Figure 2.13). 
Visual comparison of individual variants of opposite phenotypes (Figure 2.12) pointed to 
specific differences among restricted and non-restricted variants. As an example 
SIVmac239 CA that is not restricted by any CM or RH TRIM5α appeared to have less 
extended loops and a more contracted structure than GH123 which is restricted by both 
TRIM5αs (Figure 2.12). In order to quantify this information for all CA variants, we 
elaborated a rough measure of loop extension as follows. For each of the loops L1, L4/5 
and L6/7 we defined start and end residues: 2 and 12 for L1, 83 and 101 for L4/5, 118 
and 126 for L6/7. We defined loop extension as the maximum distance of a loop residue 
to the loop start and end residues. The distances from the loop start and end of each of 
the three loops in the analyzed CA variants are plotted against each other in Figure 2.14. 
Variants are labeled and colored according to the CM TRIM5α restriction phenotype. 
The restricted variants tend to have more extended loops as their loop start and end 
distances are seemingly larger than those unrestricted on all three loops and on L6/7 in 
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particular (Figure 2.14) suggesting that an extended loop conformation facilitates 
TRIM5α binding. L6/7 is the central loop between L1 and L4/5 on the CA surface 
containing previously described (Song, Nakayama et al. 2007) position 120 that has a 
strong effect on the TRIM5α restriction. 
  
 
Figure 2.14 Extension of three exposed CA loops 
among analyzed CA variants. Extension is 
measured as a maximum distance of a loop 
residue from the loop start and end residues. 
Variants are labelled and colored according to 
the CM TRIM5α restriction, red indicating non-
restricted and green restricted variants. 
2.3.4 Electrostatic potential 
The previous steps of this compilation analysis pointed to specific positions and regions 
of CA, their physicochemical and structural properties that correspond to the TRIM5α 
restriction. Apart from the sequence and structural characteristics conditioning protein-
protein interaction, an important factor allowing for a molecular interaction is the 
electrostatic potential at the binding site. The electrostatic potential on protein surface is 
generated through redistribution of electrons according to local electrical fields. It is 
defined as the potential energy of a proton at a particular location near a molecule. 
Negative electrostatic potential results in attraction of the proton by the concentrated 
electron density. Positive electrostatic potential results in repulsion of the proton by the 
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atomic nuclei in regions where low electron density exists and nuclear charge is 
incompletely shielded. Electrostatic effects were shown to be a major factor in 
determining the nature and strength of the interaction between protein surfaces (Dong 
and Zhou 2002; Kortemme and Baker 2002). A complementary charge on the binding 
site of both proteins might result in an attraction force allowing for the binding to happen. 
In the last part of this study we performed an electrostatic potential analysis of the 
surface region of the three CA loops. For this analysis we selected two CA variants – 
GH123 and SIVmac239 as two example strains showing opposite phenotypes of 
interaction with primate TRIM5α proteins and the most strongly pronounced difference in 
the shape of the loops surface (Figure 2.15). SIVmac239 CA has a more contracted 
shape as compared to extended GH123 loop structure. To confirm that this shape 
difference is not due to modeling noise we remodeled both proteins using each one as a 
template for the other. The remodeled structures showed similar shape differences, 
which supports the view that the real structures differ. 
 
Figure 2.15 Superposition of the GH123 CA (yellow) and SIVmac239 (red) CA modeled structures. The 
three loops containing sites important for the TRIM5α interaction are labeled. 
As the initial step preceding electrostatic potential modeling we added missing hydrogen 
atoms and estimated the ionization (protonation) of the molecules. We used H++ server 
(Gordon, Myers et al. 2005) that adds protons to the input structure according to the 
calculated ionization states at the specified pH of the solvent. The H++ method models 
molecules as a medium with low dielectricity εin in a solvent with a high dielectric 
constant εout. It additionally allows the user to define the salt concentration of the medium 
and its pH. We used the biologically relevant parameters in human cells pH=7.2, salinity 
1%, molecule dielectric εin=10 and medium dielectric εin=80. The dielectric parameters 
were chosen according to the suggestions of the authors of the H++ method as 
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appropriate for modeling protonation of surface residues. We tested several other 
parameter combinations and verified visually if they result in radically different 
electrostatic potential profiles. Other parameter regimes did not produce strongly 
different electrostatic potentials in the region of interest we therefore chose the initial 
parameters as the most relevant in biological settings. 
Next, we applied two methods of electrostatic potential calculation: the Adaptive 
Poisson-Boltzmann Solver (APBS) (Baker, Sept et al. 2001) and the nonlocal 
electrostatics method (Hildebrandt, Blossey et al. 2007). In both methods electrostatic 
properties are described by Poisson-Boltzmann equation (PBE), a second-order 
nonlinear partial differential equation. The APBS method solves the equation using finite-
element techniques based on parameter discretization and iterative parallel refinement 
of the equation solution. The nonlocal electrostatics method allows for inclusion of the 
structure of water molecules in the calculation and describes the system as a continuum. 
This method captures the effects of the dipole polarization of the water molecules and 
the effects of surrounding hydrogen bond network and represents therefore a more 
accurate model of the electrostatic potential estimations close to the molecule-solvent 
interface.  
We visually inspected the results of the electrostatic potential using pymol (DeLano). A 
strong difference between the two molecules could be observed on the loops surface 
with the GH123 molecule having predominantly positive and SIVmac239 predominantly 
negative electrostatic potential on this part of their surface (Figure 2.16). 
  
Figure 2.16 Electrostatic potential on the GH123 and SIVmac239 surfaces. Structures are positioned as in 
Figure 2.15 with the loops directed towards upper right of the image. Electrostatic potential was 
calculated and visualized using the APBS plugin in pymol software (DeLano). 
In order to quantify this observation and to obtain more insight into the specific region 
where the electrostatic potential differences are strong we extracted the electrostatic 
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potential values on the surface of the two molecules. We used three different surface 
approximations: solvent-accessible surface (SAS) of two different sizes and solvent-
excluded surface (SES) (Figure 2.17). SAS is the surface of a molecule that is 
accessible to a solvent. It is estimated using a “rolling ball” approach (Shrake and 
Rupley 1973) in which a sphere of solvent of a particular radius is used to probe the 
surface of the molecule, the surface is then described by the center of the probing 
sphere. We used the approximate radius of water molecule of 1.4Å and an additional of 
3Å in order to see how the electrostatic potential changes with the distance from the 
molecule. SES uses the same “rolling ball” approach and describes the surface by the 
closest point of the probing sphere to the molecule atoms and this way represents the 
molecular surface not occupied by the solvent. In electrostatic potential calculations this 
surface defines the interface between molecule and the solvent where the dielectric 
constant changes from the εin of the molecule to the εout of the solvent. 
SES 
 
SAS 1.4Å 
 
SAS 3Å 
 
Figure 2.17 Three different protein surface estimations shown of the GH123 CA protein. 
From the electrostatic potential values estimated in a grid covering entire space around 
the molecules we extracted grid points adjacent to the points of the triangulation of each 
surface type (Figure 2.17). We grouped these electrostatic potential values according to 
the atoms of loop residue they lie the closest to (Figure 2.18 and 2.19, top-right). The 
comparison of this way grouped electrostatic potential values of corresponding residues 
of the two analyzed molecules allowed to confirm quantitatively the difference in the 
electrostatic potential in the region of interest and to point to specific residues around 
which the differences are stronger. 
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Figure 2.18 GH123 CA backbone and surface. Black lines trace the protein backbone by joining following 
Cα atoms. Loops are pointing downwards and numbered: 1 – L1, 2 – L4/5, 3 – L6/7. Gray dots mark 
the SAS of the protein. The coloring of the surface dots corresponds to: the partition of the surface 
according to the closest protein residue (top-right), electrostatic potential calculated using APBS 
(bottom-left), electrostatic potential calculated using nonlocal approach (bottom-right). Red color 
indicates negative and blue positive electrostatic potential. 
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Figure 2.19 Corresponding to Figure 2.18 plots of SIVmac239 backbone and surface. 
The strongest difference in electrostatic potential between both variants could be 
observed on the surface of loop 4/5 with GH123 showing positive and SIVmac239 
negative electrostatic potential. Six out of nine residues of this loop showed a significant 
difference in the mean electrostatic potential (Table 2.15) and a clear separation of the 
electrostatic potential values on the grid neighboring to the loop residues by both local 
ABPS and nonlocal methods (Figure 2.20).  
Residues of loop 6/7 showed similar to loop 4/5 electrostatic potential differences 
however over a smaller number of residues and showing less agreement between the 
two electrostatic potential methods. Loop 1 showed an opposite pattern with GH123 
having negative and SIVmac239 positive electrostatic potential. The differences were 
however smaller and only reported by the local APBS method. 
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Similar electrostatic potential differences although spanning a narrower range of values 
was observed on the SAS of the 3Å probe radius. This reflects the electrostatic potential 
decrease with the distance from the molecule surface.  
 
 
Figure 2.20 Electrostatic potential values on the SAS surrounding following residues on the three CA loops. 
Blue boxes represent electrostatic potential of GH123, red of SIVmac239. Upper plot shows values 
calculated using APBS, bottom the nonlocal method. 
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APBS nonlocal 
 
Residue (GH123 / 
SIVmac239) GH123 SIVmac329 p-value GH123 SIVmac329 p-value 
5 THR / 5 ILE  -0.206 0.064 <0.001 -1.049 -0.096 <0.001 
6 GLY / 6 GLY  0.025 -0.196 0.006 0.787 -0.805 <0.001 
7 GLY / 7 GLY  -0.315 0.024 <0.001 -1.283 -0.854 <0.001 
8 GLY / 8 ASN  -0.420 0.066 <0.001 0.058 -1.092 0.406 
9 ASN / 9 TYR  -0.463 -0.241 0.741 -5.668 2.697 <0.001 L
oo
p 
1 
10 TYR / 10 VAL  -0.782 0.021 <0.001 -8.827 -1.367 <0.001 
88 GLY / 87 ALA  0.147 -0.248 <0.001 2.906 -1.700 <0.001 
89 PRO / 88 PRO  0.355 -0.522 <0.001 2.879 -0.524 <0.001 
90 LEU / 88-89 -  -0.426 - - 6.567 - - 
91 PRO / 89 GLN  0.603 -0.133 <0.001 6.543 -0.673 <0.001 
92 ALA / 90 GLN  0.047 -0.051 <0.001 1.282 -0.418 <0.001 
93 GLY / 91 GLY  -0.230 -0.269 0.076 -2.761 3.070 <0.001 
94 GLN / 92 GLN  0.895 -0.735 <0.001 7.148 0.820 <0.001 
95 LEU / 93 LEU  -0.958 -1.433 0.046 -6.661 2.234 <0.001 
96 ARG / 94 ARG  0.090 -0.227 <0.001 5.805 -3.992 <0.001 
Lo
op
 4
/5
 
97 ASP / 95 GLU  -0.045 -1.599 <0.001 -8.336 -3.481 0.001 
117 MET / 115 MET  -0.765 0.799 <0.001 -6.437 -9.665 0.078 
118 TYR / 116 TYR  0.070 -0.069 0.167 -5.037 0.055 <0.001 
119 ARG / 117 ARG 1.022 0.405 <0.001 6.785 -2.802 <0.001 
120 PRO / 118 GLN  -0.094 -0.706 <0.001 -5.178 3.904 <0.001 
121 GLN / 119 GLN  0.802 -0.260 <0.001 4.308 0.340 <0.001 
122 ASN / 120 ASN  0.119 -0.674 <0.001 -4.078 -6.824 0.003 
123 PRO / 121 PRO  -0.782 -0.235 <0.001 -17.281 -11.590 <0.001 
124 VAL / 122 ILE -1.200 -1.906 <0.001 -6.233 -8.141 0.003 
Lo
op
 6
/7
 
125 PRO / 123 PRO  -0.250 0.455 <0.001 -4.804 -12.468 <0.001 
Table 2.5 Mean electrostatic potential on the surface surrounding residues of the three loops of GH123 and 
SIVmac239 CA variants calculated using the local APBS and nonlocal methods. Colors indicate 
significant difference (wilcoxon test) between the electrostatic potential of the two variants with 
positive electrostatic potential GH123 and negative SIVmac239 marked in red and negative GH123 
and positive SIVmac239 marked in blue. 
Precise calculations of the interaction electrostatics are very challenging because of the 
large surfaces involved and the large structural changes that can occur upon binding. 
Through this quantitative approach and with the use of two methods a trend could be 
observed of a positive electrostatic potential on the surface of the restricted CA variant 
and negative of the non-restricted. According to the experimental data SIVmac239 
variant was not restricted by neither of the RH or CM TRIM5α proteins as opposed to the 
GH123 variant that was strongly restricted by both primate TRIM5αs. Presence of 
electrons on the surface of loop 4/5 and 6/7 as indicated by the electrostatic potential of 
the GH123 CA might be therefore a prerequisite for the interactions with RH and CM 
TRIM5αs. These two loops form the most outward pointing part of the CA protein and 
share neighboring protein surface, while loop 1 is directed slightly apart. Complementary 
to GH123 surface charge distribution at the binding site of the host protein might be 
necessary for the binding. Similar studies of TRIM5α surface electrostatics could 
therefore help to point to the specific site of this interaction.  
2.4.5 Discussion 
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In the compilation study of the experimentally tested variants of the two interaction 
partners – viral CA and host TRIM5α we identified sequence, structure and electrostatic 
determinants of the interaction. This systematic analysis of an experimentally 
phenotyped sequence dataset pointed to specific sequence positions, sequence regions 
and their physicochemical features, structural shapes and surface electrostatics that 
appeared to be significantly related to the interaction. The analyzed dataset is highly 
incomplete with respect to phenotype and sequence variation, however the analysis of 
the entire datasets allowed for inferring specific features of the CA protein that were not 
observed in individual experimental studies. Moreover, the initial study of the entire CA 
dataset allowed to select specific examples for an in-depth electrostatic potential 
analysis. Due to the lack of TRIM5α crystal structure a similar search of significant 
structural features of TRIM5α is difficult to perform. The structural physicochemical 
determinants of the interaction could indicate potential drug strategies based on TRIM5α 
restriction. Following these results, more experimental testing will be performed in the 
Osaka lab. 
2.5 Conclusions 
Even though host and virus interact throughout the entire virus life cycle, the example of 
TRIM5α-CA interaction shows the importance of detailed studies of individual molecular 
interactions between the virus and its host. Specific mutations in the two interaction 
partners show a strong impact on the efficiency of infection.  
Mutation studies of the two proteins underscore that the barrier against interspecies 
transmission is potentially fragile. Studies of TRIM5α-CA can explain the host range of a 
given lentivirus species which indicates how on the scale of an individual interaction one 
can observe determinants of virus-host adaptation. Additionally, studies on the scale of 
an individual interaction can be of therapeutic interest, as knowing the exact interaction 
mechanism of the CA and TRIM5α could indicate potential ways of for inducing of the 
HIV restriction in humans. 
Among the downfalls of studies on the individual interaction scale is the limitation of the 
number of analyzed virus variants. Given the variability of the HIV and the cost of 
analyses of individual virus variants such as presented in this chapter, the results of 
studies of individual interactions might be difficult to scale to entire virus populations. 
The structural and biochemical determinants of an interaction of a low number of 
analyzed virus proteins might not be representative of large HIV populations.
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CHAPTER 3 – Virus population scale 
                         HIV-1 coreceptor tropism encoded in the V3 loop  
                         sequence and structure 
 
HIV is a highly mutating pathogen (Korber, Gaschen et al. 2001). The lack of a proof-
reading mechanism in the reverse transciptase (Drake 1993), the high replication rate, 
rapid viral turnover (Perelson, Essunger et al. 1997), selection pressure for adaptation 
and evasion of therapy (Condra 1998) or immune recognition (Price, Goulder et al. 1997; 
Poignard, Sabbe et al. 1999; Allen, O'Connor et al. 2000) generate virus populations of 
radically divergent virus forms. Each HIV-infected individual is exposed to a virus 
population of a diversity equal to that of influenza sequences world-wide in any given 
year (Korber, Gaschen et al. 2001). Given such a high level of virus variability 
computational models of entire virus populations are more representative of the host-
virus interactions than analyses of individual variants. In this chapter we describe two 
studies on the scale of virus population. Both studies comprise analyses of a highly 
variable part of the viral genome involved in an important interaction with the host upon 
virus cell entry. 
3.1 Background 
Among virus genes, the highest amount of genetic variability is observed in the envelope 
gene (Env) (Hahn, Gonda et al. 1985). The env protein is composed of two parts – 
glycoprotein 41 (gp41) anchored in the virus membrane and the exterior glycoprotein 
120 (gp120). The envelope glycoproteins form spikes displayed on the surface of the 
virion. The surface of the spike is composed of gp120, attached through non-covalent 
interactions to the gp41 glycoprotein (Kowalski, Potz et al. 1987; Lu, Blacklow et al. 
1995). Being exposed on the virus membrane, gp120 can elicit virus-neutralizing 
antibodies (Profy, Salinas et al. 1990). High genetic variability of this gene is therefore a 
way of the virus to elude the immune system and escape recognition. On the other hand, 
the same gene mediates virus entry into host cells. The parts of the gene sequence that 
involve host receptor binding sites are under selection pressure to preserve the capacity 
of host cell entry.  
HIV entry into human cells is a multi-step process (Figure 3.1). It is initiated through 
binding of the viral envelope glycoprotein gp120 to the cellular CD4 receptor (Chan and 
Kim 1998; Pierson and Doms 2003). CD4 binding induces conformational changes in the 
gp120 glycoprotein (Sattentau and Moore 1995), some of which involve the exposure 
and/or formation of a binding site for specific chemokine receptors. These chemokine 
receptors, mainly CCR5 and CXCR4 for HIV-1, serve as obligate second receptors for 
virus entry (Feng, Broder et al. 1996; Trkola, Dragic et al. 1996; Moore 1997). The 
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interaction of gp120 with the coreceptor induces a series of further rearrangements in 
the envelope glycoproteins that trigger fusion of virus and cell membranes (Chan and 
Kim 1998).  
 
Figure 3.1 Following steps of the HIV cell entry: binding to CD4 receptor, binding to coreceptor and fusion. 
Adapted from (Este and Telenti 2007). 
It has been shown that viruses binding to CCR5 (R5 viruses) are almost exclusively 
present during the early asymptomatic stage of the infection whereas CXCR4-binding 
viruses (X4 viruses) may emerge in later phases of the infection and are associated with 
a CD4+ T-cell decline and progression towards AIDS (Miedema, Meyaard et al. 1994; 
Berger, Murphy et al. 1999). The specificity of the virus to use one of the coreceptors is 
termed tropism. Before the coreceptors were identified, two phenotypic variants were 
recognized according to the virus ability of forming syncytia in MT-2 cells. Already at that 
time, syncytium-inducing (SI) and non-syncytium-inducing (NSI) viruses were observed 
to have a different impact on the disease progression in infected people (Schuitemaker, 
Kootstra et al. 1991). There is a high correlation between CCR5-tropic and NSI viruses, 
on the one hand, and between CXCR4-tropic and SI viruses, on the other hand. One of 
the big still unresolved questions of the HIV-tropism research is whether the emergence 
of X4 and SI virus is a cause of advanced progression towards CD4+ T-cell depletion 
and the rise of AIDS symptoms or appears as a result of these phenomena (or both). 
The evolutionary reasons for the development of these two HIV variants remain 
unknown.  
The finding that humans who lack CCR5 expression due to the Δ32 mutation are 
resistant to HIV-1 infection (Huang, Paxton et al. 1996) stimulated the research of CCR5 
inhibitors which culminated with the licensing of Maraviroc (MVC) (Dorr, Westby et al. 
2005) for clinical use in 2007. The unknown mechanism driving the coreceptor switch, its 
role in the disease progression and the new treatment strategies targeting R5 viruses 
call for efficient and accurate routine monitoring of coreceptor usage and for a better 
understanding of the determinants of the coreceptor binding. Phenotypic assays exist for 
experimental testing of viral tropism (Whitcomb, Huang et al. 2007). However 
phenotyping via such assays involves sending patient samples to specialized 
laboratories offering satisfying technological and security requirements. Phenotyping 
results are returned in ten or more days. This procedure of is therefore expensive for 
patient diagnosis in a daily clinical practice. In contrast to phenotyping, sequencing is 
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cheaper, more accessible and faster and thus has become a standard lab procedure 
throughout Europe. However sequence data requires the interpretation in terms of the 
viral tropism which can only be done with the use of computational methods. 
The principal determinant of the specificity of HIV to a chemokine receptor is the third 
variable (V3) loop of gp120 (Fouchier, Groenink et al. 1992; Shioda, Levy et al. 1992; 
Speck, Wehrly et al. 1997). Binding to CCR5 coreceptor only (R5 viruses), to CCR5 and 
CXCR4 (dual-tropic viruses) or to CXCR4 only (X4 viruses) is determined predominantly 
by the sequence and structure of this region (Jensen and van 't Wout 2003). The V3 loop 
is an extended structure protruding ~30Å from the CD4-bound gp120 core (Huang, Tang 
et al. 2005). It contains a conserved base, a flexible stem that rigidifies on binding and a 
tip in a β-hairpin conformation (Figure 3.2). 
 
Figure 3.2 V3 loop structure (PDB ID: 2B4C). The loop is colored in yellow, with atoms of residues on 
position 11 and 25 represented by red spheres. Other parts of the gp120 are traced by a blue ribbon.  
As an alternative to costly phenotypic assays for monitoring coreceptor usage, 
computational methods were developed aiming at predicting the viral tropism based on 
the V3 sequence. The 11/25 rule was proposed as an initial approach for inferring 
coreceptor usage. It is based on the observation that a positive charge at either of the 
11th or 25th residues in the V3 region is indicative of an X4 virus (Fouchier, Groenink et 
al. 1992; Shioda, Levy et al. 1992). Due to its simplicity, the 11/25 rule has been 
commonly used although it has been shown that for many V3 variants changes at 
positions 11 or 25 are neither necessary nor sufficient for the tropism switch (Jensen and 
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van 't Wout 2003). As more phenotypic data became available more sophisticated 
methods appeared based on position-specific scoring matrices (PSSM) (Jensen and van 
't Wout 2003), decision trees (Pillai, Good et al. 2003), neural networks (Resch, Hoffman 
et al. 2001) and support vector machines (SVM) (Sing, Beerenwinkel et al. 2004). The 
sequence-based methods of coreceptor usage prediction rely on binary encoding of the 
letter representation of amino acids at each position of the V3 loop and use statistical 
approaches to build predictive models and to infer residues strongly related to the 
phenotype. One drawback of the sequence-based methods of viral tropism prediction is 
the limited insight they offer into the sequence determinants and sequence features of 
the two virus types. Methods encode a classification rule in a form of a multidimensional 
hyperplane or decision algorithms that are not directly interpretable. The results of 
classification do not point to specific sequence characteristics of viruses of each class 
nor to the potential reasons for classification errors. Moreover, the binary encoding of the 
amino acids in the V3 loop sequence lacks the information on the actual 
physicochemical similarities among different amino acid types. The sequence-based 
methods do not account for the physicochemical and structural properties of the loop 
that might be determinant for coreceptor binding. 
Since the structures of gp120 including V3 were determined by x-ray crystallography 
(Huang, Tang et al. 2005; Huang, Lam et al. 2007) new coreceptor prediction methods 
were developed (Sander, Sing et al. 2007; Dybowski, Heider et al. 2010) integrating the 
structural information in the prediction process. Sander at al. (Sander, Sing et al. 2007) 
proposed a distance-based descriptor of the spatial arrangement of physicochemical 
properties of the loop. They found that providing the distance information coupled with 
modeling of the loop side-chains together with the binary sequence encoding 
outperforms the methods based on sequence alone. Dybowski et al. (Dybowski, Heider 
et al. 2010) developed a two-level approach that considers two physicochemical 
properties of the loops (electrostatic potential and hydrophobicity) on the first level and 
combines the results on the second level of the prediction procedure. This two-level 
approach resulted in improvement in prediction accuracy as compared to prediction 
based on sequence alone. Even though including the structural information into the 
prediction is a step forward to understanding HIV coreceptor usage, both methods have 
certain limitations. The method by Sander et al. is based on molecular distances that do 
not offer direct interpretation of the structural determinants of tropism. Dybowski et al. 
analyze only two physicochemical features in their method while a systematic analysis of 
a larger feature set of the V3 loop would allow for distinguishing other features important 
for tropism. Both methods involve costly computational operations as electrostatic 
potential calculation or side-chain modeling that reduce their efficiency in comparison to 
sequence-based approaches. With the increasing use of high-throughput sequencing 
technologies in HIV research and patient diagnosis these methods can be expected not 
to fulfill the growing efficiency requirement. 
All except one (Sing, Beerenwinkel et al. 2004) of the above mentioned methods 
sequence- and structure-based were developed and assessed on clonally derived data. 
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This type of data is inferred in lab conditions from amplified and cloned virus strains. In 
contrast to the clonal data, clinically derived virus data are obtained through bulk 
sequencing and phenotyping of virus populations obtained directly from patient blood 
plasma without prior amplification and cloning. Analysis of clinically derived data is 
burdened with two major problems. First, clinical data contain ambiguities in the 
sequence and phenotype reflecting the variability of the virus population. When two or 
more loci display variation, the information on whether and how often these variants 
occur on the same DNA molecule is lost. Second, small minorities of the virus population 
might be undetected through bulk sequencing. Sanger capillary sequencing can only 
detect the mutations of a mixed sample if their frequency exceeds a threshold of ~20%. 
Clinically derived sequence represents therefore a consensus amino acid composition of 
the the few dominating virus strains. This shortcoming can result in an inaccurate 
genotype-phenotype relationship, which cannot be rectified without additional 
experimental effort, such as individual virus cloning. These problems have been shown 
to pose additional challenges for in silico coreceptor prediction (Sing, Low et al. 2007). 
Nevertheless, correct prediction of the clonal data is crucial for successful patient 
surveillance and treatment. Computational methods of coreceptor prediction should 
therefore be aimed at classifying clinical data. 
Since the approval of the CCR5 inhibitor MVC, patients undergo treatment involving this 
new drug. What level of the X4 viruses in the patient virus population is acceptable for 
the therapy to succeed and whether the treatment would cause the emergence of the 
minority population and consecutive therapy failure is still debated. However with the 
increasing amount of data concerning MVC treatment computational methods should be 
developed targeted at predicting therapy outcome. 
In this chapter we present two studies of the HIV V3 loop on the virus population scale. 
The studies are aimed at characterizing and classifying virus sequences in relation to the 
phenotype while addressing the shortcomings of the methods mentioned above – 
interpretability of the prediction results, efficiency of the structure-based prediction, 
classification of the clinically-derived data and prediction of the therapy outcome. 
3.2 V3 loop sequence space analysis 
Here we present the results of a comprehensive analysis of the HIV V3 loop sequence 
space. This study was published in: Bozek, K., Thielen, A., Sierra, S., Kaiser, R., 
Lengauer, T. V3 loop sequence space analysis suggests different evolutionary patterns 
of CCR5- and CXCR4-tropic HIV. PLoS One. 2009 Oct 9;4(10):e7387. The aim of this 
project was to better understand the evolutionary mechanism driving the emergence of 
X4 viruses. We analyze all available phenotyped V3 loop sequences from the Los 
Alamos database (http://www.hiv.lanl.gov/). Using different sequence distance measures 
and visualization methods we describe the arrangement of the sequences in their 
multidimensional sequence space with regards to the phenotype. The results reveal a 
relatively high conservation of R5 and NSI strains as compared to more diverse X4 and 
SI strains evolving in an apparently unconstrained manner. We find that the arrangement 
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of the sequences imparts one of the reasons for the inaccuracy of sequence-based 
methods for coreceptor prediction. We also use the location of the V3 loop sequence in 
sequence space to improve the accuracy of the prediction of virus tropism. Finally, we 
investigate the relation between the location of V3 loop sequences in sequence space 
and the associated clinical markers such as CD4+ T-cell level. Sequences of patients 
with a functioning immune system tend to be located close to each other in sequence 
space and thus are likely to share common features whereas, with decreasing CD4+ T-
cell counts the conservation of the V3 loop among patients decreases and the diversity 
of possible viral genotypes increases. These results support the hypothesis of the 
immune system initially imposing strong selective pressure on the viral envelope gene. 
Once the immune system is compromised, this pressure diminishes which enables the 
virus to undergo less restrained variation. 
3.2.1 Data 
Using the Los Alamos database (http://www.hiv.lanl.gov/) we defined two sets of labelled 
V3 loop protein sequences: the labels of the first set (NSI/SI dataset) were attributed 
according to the annotation of non-syncytium-inducing (NSI) and syncytium-inducing (SI) 
strains. Those of the second set (R5/X4 dataset) were attributed according to the 
annotation of the sequences concerning coreceptor usage – CCR5-, CXCR4- and dual-
tropic (R5X4) strains. In order to prevent samples from a single patient to dominate any 
of the two sequence sets and to analyze viral evolution among hosts rather than patient-
specific selection pressures, we limited the datasets to contain one randomly chosen 
sequence from each patient. The two sets contain 1096 and 859 V3 loop amino acid 
sequences, respectively, with an 85% prevalence of NSI and CCR5-tropic strains, 
respectively. 
3.2.2 Distance distribution 
We used four sequence distance measures to compare the V3 sequences: Hamming 
distance, Blosum62 matrix (Henikoff and Henikoff 1992), difference in amino acid charge 
and size, and difference in amino-acid composition at positions significant for the 
phenotype, as reported by Sing et al. (Sing, Low et al. 2007). Different distance 
measures resulted in the same pattern of sequence separation. Therefore we used the 
Blosum62 matrix as the only distance measure in other parts of this analysis. 
For all considered sequence distance measures the following pattern among the V3 loop 
sequences was observed. R5 and NSI sequences were positioned close together while, 
in contrast, X4 as well as SI sequences were much more widely spread out in sequence 
space. The left panel of Figure 3.3 shows the distribution of Blosum62 distances 
between pairs of sequences from the NSI/SI dataset of the same and of different 
phenotypes. The mean distance of pairs of SI sequences (red curve) is almost twice the 
mean distance of the NSI sequences (blue curve). The distribution of the distances for 
pairs of SI sequences has also a larger variance than the one of the NSI sequences. 
The fact that the mean distance between pairs of sequences of opposite phenotypes is 
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smaller than the mean distance of pairs of SI sequences implies that the SI sequences 
are widely spread out throughout sequence space and show no apparent common 
pattern of evolution. Distances between sequences in the R5/X4 dataset exhibit a similar 
pattern (Figure 3.3, right panel) with the dual-tropic sequences spread out less, on 
average, than the exclusively CXCR4-tropic sequences and more than the R5 
sequences. The different distance measures result in the same pattern of sequence 
separation we therefore chose the Blosum62 matrix as the distance measure in all other 
parts of this analysis. 
  
Figure 3.3 V3 loop sequence distance distribution. Shown is the distribution of Blosum62 distances between 
pairs of sequences of the same (SI vs SI, NSI vs NSI) and different (SI vs NSI) phenotypes (left) and 
of the same (R5 vs R5, X4 vs X4, R5X4 vs R5X4) and different (R5 vs X4) tropisms (right). The 
mean value and standard deviation of each of the distributions are indicated in the inserted boxes. 
3.2.3 Clustering 
To further investigate the observations gained from the sequence distance distribution 
we performed sequence clustering. Both datasets were clustered hierarchically, using 
complete linkage clustering. We analyzed the tendency of viral sequences of different 
phenotypes to form clusters depending on the cluster diameter defined as the distance 
between the two most distant elements of the cluster. Clustering with a given upper limit 
for the diameter was achieved in an iterative procedure of merging two closest clusters 
in each step of the procedure until no two clusters can be merged without generating 
clusters of a diameter above the predefined limit. In complete linkage clustering, the 
distance between two clusters is defined as the largest distance between two elements, 
one in each cluster. Only clusters containing at least 1% of all sequences in the dataset 
were considered, the sequences belonging to smaller clusters as well as singletons were 
defined as unclustered. Additionally we used a notion of a cluster size to compensate for 
the imbalance between the amount of R5/NSI and X4/SI sequences. The number of 
sequences of a given type in a cluster is multiplied by the ratio of the number of 
sequences of all other types in the full dataset over the number of sequences of the 
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same type. This weighting scheme allows for considering smaller clusters of an 
underrepresented phenotype as significant. 
The measure of silhouette value (Rousseeuw 1987) was used to choose one clustering 
whose individual cluster structures should be investigated. The silhouette value of a 
sequence in a cluster is defined as the difference between the average distance of the 
sequence to sequences in other clusters and to sequences in the same cluster. The 
silhouette value of a cluster is the average silhouette value of its sequences. The 
silhouette value of a clustering is the average of the silhouette values of its clusters. This 
measure can be used as a quantitative indicator of the quality of a clustering - larger 
values represent partitions containing clearly separated clusters. We calculated the 
average silhouette values for partitions obtained in successive steps of the hierarchical 
clustering and selected the clustering showing a maximal silhouette value, among those 
that cluster more than 50% of the sequences in a dataset and contain more than one 
cluster. We called the clustering resulting from this procedure the selected clustering. 
  
Figure 3.4 Clustering of the V3 loop sequences. The plot illustrates clustering trends of sequences of the 
NSI and SI phenotype (left) and of R5, X4 and dual-tropic sequences (right). The diameter limit, 
plotted on the x-axis, is defined as the distance between the two most distant elements of a cluster. 
The y-axis indicates the fraction of sequences in the dataset falling into any of the clusters below the 
diameter limit. Minimal cluster size is 1% of all sequences in the dataset, sequences of clusters of a 
smaller size as well as singletons are considered as unclustered and are not counted. 
Clustering of the NSI/SI and R5/X4 datasets displayed a more pronounced grouping 
trend of the NSI and R5 sequences than of the SI and X4 sequences. In the initial steps 
of the iterative clustering procedure only tight clusters of highly similar sequences were 
formed. The clusters contained mainly R5 and NSI sequences. The X4/SI sequences 
are clustered only in clusters of a relatively large diameter – clusters of diameter large 
enough to contain 90% of the NSI sequences group only 50% of the SI sequences in the 
NSI/SI dataset (Figure 3.4, left panel). The clustering of the R5/X4 dataset showed that 
dual-tropic sequences cluster relatively less than R5 but more than X4 sequences – a 
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clustering containing from 50% to 80% of the CCR5 sequences included on average 
10% less of the dual-tropic sequences (Figure 3.4, right panel). 
Next, we inspected the selected clustering in detail. In the NSI/SI dataset we obtained 
one major cluster containing 60% of all sequences, most of them of the NSI phenotype, 
and two smaller clusters each one containing 15% of all sequences, the first including 
solely NSI sequences, the second including equal percentage of sequences of both 
phenotypes. In the R5/X4 dataset the clustering contained two main clusters comprising 
35% and 32% of all sequences respectively, containing mainly R5 and dual-tropic 
sequences, in the range of 19 to 38% of the sequences of each type in the R5/X4 
dataset. Details of individual clusters are listed in Table 3.1. We observed that clusters 
containing mainly X4/SI sequences are rare (only cluster 4 and 5 in the NSI/SI dataset); 
sequences of this phenotype tend to associate predominantly with clusters of R5 
sequences. Additionally, in both datasets X4/SI sequences are highly over-represented 
among the unclustered sequences (p-value < 0.001, chi-square test). 
 NSI/SI R5/X4 
cluster all NSI SI all R5 X4 dual 
1 0.59 0.65 0.33 0.35 0.38 0.09 0.30 
2 0.15 0.17 0.06 0.32 0.37 0.05 0.19 
3 0.14 0.14 0.15 0.06 0.07 0 0.04 
4 0.02 0 0.07 0.05 0.06 0 0.01 
5 0.01 0.01 0.03 0.05 0.06 0 0 
Table 3.1 Five largest clusters in the NSI/SI and R5/X4 dataset clustering. Numbers indicate what fraction of 
the whole dataset is grouped in a given cluster (column “all”) and what is the ratio of the sequences 
of a given phenotype to all sequences in the respective cluster. 
Subsequently, we used data density estimation to examine the structure of individual 
clusters in the selected clustering. Data density is an indicator of the sequence 
concentration in a given part of sequence space relative to the rest of the space. We 
used an unsupervised learning method of data density estimation via classification 
(Hastie, Tibshirani et al. 2001). This method allows for determining regions in sequence 
space in which the sequence density is significantly higher than average. For this 
purpose, we augmented the datasets with 500,000 random reference data points 
distributed uniformly over the high-dimensional sequence space. The number of the 
reference data points was chosen as a balance between the computational load and 
sufficient space population for accurate density estimation. A binary logistic regression 
model where true data points are assigned the value 1 and the generated reference data 
points are assigned value 0, was fitted using maximum likelihood (ML) estimation. The 
value returned by the fitted logistic regression for each of the true data points was 
treated as the probability of a point to be sampled by a distribution producing the 
analyzed dataset. The log-odds of this probability for each data point represent the local 
density of the original data relative to the generated reference data. Data density of a 
single cluster was calculated as the mean of log-odds of the cluster sequences. The 
larger the density of a cluster is, the more highly concentrated set of data points it 
contains. 
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Additionally, we measured the amount of positive selection among sequences in each 
cluster. For this purpose each of the protein sequences has been assigned its 
corresponding DNA sequence from the Los Alamos database. We defined as a cluster 
center the location of a sequence with minimal distance to all other sequences in the 
cluster. The amount of positive selection  exerted on a sequence  in a cluster is 
defined in terms of the mean of the ratio of non-synonymous to synonymous substitution 
rate  (Yang and Nielsen 2000) of the given sequence and other sequences  having 
a smaller distance  to the cluster center: 
, 
where  is the number of sequences in the cluster,  if and  otherwise. 
Non-synonymous to synonymous substitution rates were calculated using the Yang and 
Nielsen method (Yang and Nielsen 2000) implemented as a part of PAML software 
package (Yang 2007). 
 
Figure 3.5 Data density in clusters of the selected clustering. Mean data density of sequences in clusters of 
the selected clustering of the NSI/SI (left) and R5/X4 dataset (right) is plotted against the cluster size. 
Unclustered sequences are represented by dots at the value 1 on the x-axis with colors 
corresponding to their phenotype: NSI/R5 sequences in blue, SI/X4 in red, R5X4 in magenta. 
Clusters are represented by black dots, cluster sizes are displayed in log scale. Large clusters are 
formed in denser parts of the data space than unclustered sequences. SI/X4 sequences remain 
predominantly unclustered. 
The relation of the cluster size and the density in sequence space is illustrated in Figure 
3.5. Unclustered sequences occur in less dense parts of sequence space and are 
predominantly SI or X4. Detailed inspection of the individual cluster structures allowed 
for relating data density and the amount of positive selection on a sequence to the 
position of a given sequence within its cluster. The two largest clusters of the R5/X4  
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Figure 3.6 Structure of two largest clusters in the R5/X4 dataset. Cluster 2 (right panels) shows a clear 
correlation of the distance of a sequence to the cluster center with the amount of positive selection 
on this sequence (B) and with the data density of its sequences (D). Dots on diagrams are colored 
according to sequence tropism (R5 – blue, X4 – red, R5X4 – magenta). The plots indicate that 
cluster 2 contains a dense center composed of conserved R5 sequences and sparser brims 
composed of X4 and R5X4 sequences that are subject to weaker selection pressures. No such 
pattern can be observed in the case of cluster 1 (A and C) which seems not to contain a coherent 
centre but comprise a medium density region of sequences of various tropisms. 
dataset are depicted in Figure 3.6. In the case of cluster 2 we observed a strong 
correlation of the sequence distance from the cluster centre with the data density at the 
location of the sequence as well as with the amount of positive selection exerted on the 
sequence (correlation coefficient of -0.76 and 0.71, respectively). The results pointed 
that there was a dense center in cluster 2 grouping most of the cluster sequences and 
sparse brims where the concentration of sequences was smaller. The selection pressure 
in the center of such clusters was greater and reduced farther from its center. X4 and 
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dual-tropic sequences preferentially occupy the peripheral regions of the cluster (Figure 
3.6). However, no such cluster pattern could be observed in the case of cluster 1. Data 
density analysis showed that this cluster contained sequences spread over a similar 
density range independently of their position within the cluster. There was no clear 
distribution of variation in selection pressures in cluster 1 either. 
3.2.4 Phylogenetic analysis 
Next, we performed phylogenetic analysis of the V3 loop datasets. In this analysis we 
used the Splitstree software (Huson 1998). The split decomposition method (Bandelt 
and Dress 1992) relaxes the usual requirement of representing the data in tree form, in 
order to elicit where the underlying distance matrix does not reflect a tree structure. A 
Splitstree network is tree-like, in general, but also represents the divergence of the 
phylogenetic data from the tree form by sets of parallel edges that expand the tree to a 
more complex network. The Blosum62 matrix was used as the distance measure in the 
Splitstree analysis. 
The visualization of the V3 loop data via the Splitstree diagrams (Figure 3.7) showed the 
separation of viral strains of different coreceptor usage. Both datasets were too large to 
be displayed in one tree. We therefore generated trees of randomly sampled subsets of 
sequences. Figure 3.7, left panel shows an example Splitstree of a randomly sampled 
set of 25 sequences of each phenotype in the NSI/SI dataset. Both the lengths of splits 
(sets of parallel edges in the centre of the graph) and of single branches connecting data 
nodes to the rest of the tree clearly discriminate between these two types of sequences. 
SI sequences (represented by red dots) are located on long tree branches that reflect 
the larger evolutionary distance between them and other sequences in the dataset. NSI 
sequences (blue dots) are located on shorter branches and grouped in more tree-like 
clades. A similar tree generated for a sample of 20 sequences of each tropism from the 
R5/X4 dataset is shown in Figure 3.7, inset panel. The dual-tropic sequences 
(represented by magenta dots) showed an intermediate character between the R5 (blue 
dots) and X4-tropic (red dots) sequences. Both their branch lengths and localization on 
the tree supported the view of the dual-tropic sequences combining characteristics of the 
two other sequence types or being an intermediate form in their evolution. A test 
consisting of generating random trees of sequences in both datasets showed that in the 
R5/X4 dataset the average path joining two X4 sequences on a tree was about 1.35 
times longer than the one joining two R5 sequences. In the NSI/SI dataset an average 
path joining two SI sequences was 1.1 times longer that the one joining two NSI 
sequences. 
The above analysis indicates that both R5 and NSI sequences share common features 
and form coherent groups in sequence space. In the selected clustering 99% and 98% 
of the NSI and R5- sequences from each dataset, respectively, are clustered. In the 
following part of this study, we therefore used these sequences as reference points in 
sequence space. The mean distance of a sequence from all R5/NSI sequences was 
considered as a measure of its conservation. 
CHAPTER 3 – Virus population                                                                                                                      54 
 
 
 
Figure 3.7 Splitstrees of sampled subsets of the NSI/SI and R5/X4 datasets. The splitstree on the left 
diagram was generated on a randomly sampled set of 25 sequences of each phenotype. NSI 
sequences are represented by blue dots, SI by red dots. The splitstree on the inset diagram was 
generated for a randomly sampled set of 20 sequences of each tropism (R5 – blue dots, X4 – red 
dots, R5X4 – magenta dots). Branch lengths, the number and width of splits (set of parallel edges in 
the graph) illustrate the evolutionary distance between the parts of the tree they separate. An 
example split is indicated by two arrows in the left panel. In both cases the SI/X4 sequences are 
located on branches relatively longer than those of the NSI/R5 sequences and separated by wide 
splits from the NSI/R5 phenotype (an example is indicated by arrows). NSI/R5 sequences tend to 
form dense tree-like parts of the Splitstree network containing few short splits (example shown in 
dashed circle in the inset panel) which suggests their evolutionary proximity. 
3.2.5 Accuracy of genotypic coreceptor prediction in sequence space 
There is a range of computational methods that aim at distinguishing NSI/CCR5-only 
from SI/CXCR4-capable sequences based on the V3 loop sequence. We investigated 
the accuracy of several sequence-based coreceptor prediction methods (11/25 rule, 
Web PSSM, geno2pheno) (Fouchier, Groenink et al. 1992; Jensen and van 't Wout 
2003; Sing, Low et al. 2007) on both V3 loop datasets. Sequences that are incorrectly 
classified by all considered methods were identified and localized in sequence space 
using the same sequence distance, clustering and phylogenetic analysis.  
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Even though the distance distributions as well as the Splitstree diagrams exhibited 
discernable differences between sequences with different phenotypes, still some 
exceptions could be observed. We measured the average distance of sequences in the 
NSI/SI dataset to a reference set composed of NSI sequences from this dataset with a 
phenotype correctly predicted by all three methods. Figure 3.8 shows the distribution of 
the average distance of four different groups of sequences to this reference set. The four 
groups of sequences are: (i) correctly classified NSI sequences (left panel, blue curve), 
(ii) correctly classified SI sequences (left panel, red curve), (iii) NSI sequences 
misclassified by all three methods (right panel, blue curve) and SI sequences 
misclassified by all three methods (iv) (right panel, red curve). Sequences that failed to 
be correctly classified were located in untypical regions in sequence space – SI 
sequences classified in discordance with the Los Alamos annotation were closer to 
correctly predicted NSI sequences than the correctly predicted SI sequences (p-value < 
0.05) and, on the other hand, the misclassified NSI sequences were further apart from 
this reference set in sequence space than the correctly predicted NSI sequences (p-
value < 0.05). A similar significant pattern could be observed for the R5/X4 dataset. 
  
Figure 3.8 Distance distribution of incorrectly predicted V3 loop sequences. The plot contains the 
distribution of distances of the average distance of correctly (left panel) and incorrectly (right panel) 
predicted sequences to the set of NSI sequences with a phenotype correctly predicted by all 
analyzed coreceptor prediction methods (11/25 rule, Web PSSM, geno2pheno). NSI sequences are 
represented by the blue curve, SI by the red curve. 
The above observations were confirmed by the Splitstree analysis (Figure 3.9, left 
panel). The misclassified sequences showed evolutionary relationships characteristic for 
the opposite phenotype – NSI sequences occupied longer branches and were located 
among SI sequences on the tree while the misclassified SI sequences were 
evolutionarily less distant from NSI clades or lied on boundaries between both 
phenotypes. The right panel of Figure 3.9 illustrates the clustering patterns of sequences 
misclassified by geno2pheno as compared to those correctly classified. As observed in 
the previous analysis the misclassified sequences showed clustering trends uncommon 
for their phenotype. 
To investigate whether the classification error is due to data scarcity, we performed a 
test of the dependency of the accuracy of the predictions on the amount of data. In this 
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test we used support vector machine (SVM) with linear kernel implemented in the 
package libsvm and position-specific scoring matrix (PSSM) implemented according to 
the description in (Jensen and van 't Wout 2003). We examined the performance of two 
classification methods trained on datasets with various sizes. We sampled subsets of 
the original NSI/SI dataset, used them as training sets for the SVM and PSSM, and then 
verified the number of prediction errors of the trained model on the same sequence set. 
With the increasing size of the training and test dataset we could observe no tendency of 
a decreasing prediction error. Both methods failed on a similar percentage of sequences 
independently of the size of the underlying dataset. 
 
 
Figure 3.9 Location of the incorrectly predicted sequences in sequence space. The splitstree was generated 
for a sample of sequences containing misclassified NSI sequences represented by blue crosses and 
misclassified SI nodes by red crosses. Correctly classified sequences are represented by dots, colors 
are in accordance to the coloring scheme on previous figures. Right panel shows clustering patterns of 
sequences misclassified (dashed curves) by geno2pheno plotted against those correctly classified 
(solid curves). 
On the one hand, a possible reason for the errors of the coreceptor prediction tools 
might be the complexity of factors determining coreceptor usage. For example, other 
parts of the gp120 protein beside the V3 loop may play a role in coreceptor binding. We 
repeated a similar sequence space analysis on the sequences of the V2 loop. We 
analyzed a dataset of phenotyped sequence spanning both V2 and V3 regions. The 
dataset was retrieved from the Los Alamos database and contained 280 sequences with 
212 R5, 34 X4, and 34 dual-tropic. We compared the distribution of distances between 
sequences of the same and opposite tropisms of the full sequences and their V2 and V3 
parts separately. 
The analysis showed no clear separation of the two phenotypes in V2 sequence space. 
Diagrams in Figure 3.10 illustrate the distance distribution among the sequences 
spanning over both V2 and V3 regions as well as between their V2 and V3 parts 
separately. V2 sequences did not show the same pattern of distribution with highly 
divergent X4 and more conserved R5 sequences as the V3 sequences did. The joint V2 
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and V3 regions had a lower difference in distance distribution between both sequence 
types than their V3 part separately. 
 
Figure 3.10 Distance distribution of V2-V3 sequences. Shown is the distribution of Blosum62 distances 
between pairs of V2 (left panel), V3 (middle panel) and V2V3 (right panel) parts of sequences of the 
same (R5 vs R5, X4 vs X4) and different (R5 vs X4) tropisms. The mean value and standard 
deviation of each of the distributions are indicated in the inserted boxes. 
3.2.6 Coreceptor prediction based on sequence space analysis 
The study described above – distance, clustering and phylogenetic analysis showed a 
clear separation between NSI/R5 and SI/X4 sequences in terms of the distance 
distribution, clustering steps and locations in splitstrees. NSI/R5 sequences appeared to 
be more conserved and to form clusters while SI/X4 appeared to diverge in an 
apparently unconstrained manner occupying distant parts of sequence space. Based on 
the above observations we tested if the position of a sequence relative to conserved 
NSI/R5 V3 loop sequences in sequence space conveyed sufficient information for the 
effective prediction of coreceptor usage. We investigated the predictive power of the 
three aforementioned methods of characterizing sequence space based on distances, 
clustering and phylogeny on the NSI/SI and R5/X4 datasets separately. The proposed 
classification methods aimed at distinguishing NSI/CCR5-only from SI/CXCR4-capable 
sequences. Dual-tropic sequences were labeled as X4 in this section. The score of each 
classifier was based on the separation of the sequence from the NSI/R5 sequences in 
sequence space. Low scores characterized sequences less separated from NSI/R5 
sequences and therefore more conserved and probable to be NSI/R5. High scores 
indicated divergent sequences that, according to the sequence space analysis, are more 
likely to be SI/X4. 
The classifiers were evaluated on both the NSI/SI and R5/X4 datasets using ten times 
ten-fold (10x10) cross-validation. In the following steps of the cross-validation procedure 
training and test sets were sampled from the analyzed datasets. 
The first classifier was based on the distance measures and predicted the tropism of a 
sequence depending on its average distance from all NSI/R5 sequences in the training 
dataset. We constructed classifiers using three distance measures – Blosum62 matrix, 
Hamming distance and differences on positions significant for the coreceptor tropism 
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according to Sing et al. (Sing, Low et al. 2007). As the coreceptor prediction score we 
used the mean distance of a sequence to all the NSI/R5 sequences in the training set. 
The classification decision of the second classifier was based on the step of the 
hierarchical clustering algorithm in which the sequence ceases to be a singleton (termed 
here the clustering step). In order for the score to reflect the divergence of a sequence 
from the NSI/R5 sequences, only these sequences from the training set were used in the 
prediction procedure. 
The third classifier used the Splitstree method for estimating the phylogenetic distances 
between pairs of sequences. Due to the high computational cost of a large splitstree 
construction, the phylogenetic distance between two sequences of a large dataset was 
calculated as an average distance between those two sequences in trees of randomly 
sampled sequence subsets composed in half of NSI/R5 and in half of SI/X4 sequences. 
The training procedure consisted of 100 iterations of sequence sampling, tree 
construction and tree distances extraction. First, subsets of 100 sequences of the 
training dataset (50 NSI/R5 and 50 SI/X4) were sampled. Then a Splitstree was 
constructed for each of the sampled sets and for each sequence pair in the trees the 
information on phylogenetic distance between the two sequences was extracted. We 
tested the predictive power of two different measures of phylogenetic distance: the sum 
of the lengths of the splits separating two sequences and the number of splits between 
them. After the iterative sampling and tree construction procedure, additional trees were 
constructed containing the sequences in the training dataset that did not appear in any 
of the sampled trees. The distance between two sequences was estimated as the mean 
of distances between those two sequences in the trees in which both sequences 
appeared. This way a phylogenetic distance matrix of the training set was assembled. In 
the prediction step we selected a subset of 90 sequences from the distance matrix: 45 
NSI/R5 that were the most conserved (showed the least number of splits or shortest 
splits separating them from other sequences) and 45 SI/X4 that were the most diverse 
(showed the largest number of splits or longest splits separating them from other 
sequences). These sequences were used in the prediction procedure of the test set. In 
the prediction procedure subsets of 10 sequences from the test set were added to the 
selected 90 sequences of the training set and a splitstree was constructed for the 
merged set. The proportion of the test to train set sequences on this tree was chosen as 
optimal after testing several other proportions for the accuracy of predictions. The mean 
number of splits and the mean sum of lengths of splits between a sequence and the 
NSI/R5 sequences on the tree were used as the score predictive of the coreceptor 
usage. 
All three classifiers were tested on both the NSI/SI and R5/X4 datasets using ten times 
ten-fold (10x10) cross-validation. We compared performance of sequence space 
classifiers to three existing methods – SVM, PSSM and 11/25 rule. SVMs were trained 
using the package libsvm with linear kernel. PSSMs were implemented according to the 
description in (Jensen and van 't Wout 2003). All methods were evaluated using receiver 
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operating characteristic (ROC) curves focusing on the trade-off between false positive 
(FPR) and true positive rates (TPR). This trade-off can be controlled by choosing a 
prediction cutoff and turning the continuous scores into actual class predictions. The 
area under ROC curve (AUC) was taken as a cutoff-independent class separation 
criterion. Averaged ROC curves were estimated from the 10x10 individual cross-
validation curves using vertical averaging. In the analysis we used the ROCR package 
(Sing, Sander et al. 2005). 
All distance classifiers based on different distance measures showed comparable 
performance. At the FPR of the 11/25 rule (0.05 in the NSI/SI and 0.04 in the R5/X4 
dataset) the distance methods showed the TPR between 0.51 and 0.56 in both the 
NSI/SI and the R5/X4 dataset. The areas under the ROC curve (AUC) were between 
0.85 and 0.88 in both datasets. This performance was slightly worse than that of the 
SVM and PSSM methods that show TPR between 0.71 and 0.76 at the FPR of 11/25 
rule and the AUC of about 0.90 and 0.92 (SVM and PSSM respectively) in both datasets 
(Figure 3.11, left panel). 
The cluster-based classifier showed a similar performance to the distance based ones 
with the TPR of 0.54 and 0.53 and AUC 0.86 and 0.87 in the NSI/SI and R5/X4 datasets 
respectively. 
The classifier based on the number of splits separating a sequence from the R5 
sequences performed markedly worse than the distance-based methods. It yielded an 
AUC of 0.65 and 0.62 in the NSI/SI and R5/X4 dataset, respectively, and a TPR of 0.19 
and 0.07 respectively at the FPR of the 11/25 rule. This suggested that similar ranges of 
split numbers can separate the sequences of both classes from the conserved R5 
sequences. A better prediction performance was achieved with the use of the sum of 
lengths of splits that separate a sequence from these R5 sequences – TPR of 0.47 and 
0.45 in NSI/SI and R5/X4 datasets respectively with the AUC of 0.74 and 0.76 
respectively. However this result was lower then other sequence space-based methods. 
 
Figure 3.11 Performance of sequence space-based coreceptor prediction methods. Performance of the 
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individual coreceptor prediction methods (left panel) and their selected combinations (right panel) on 
the R5/X4 dataset is illustrated with ROC curves. The AUC of each method is indicated in the 
inserted box. 
No sequence space-based methods achieved the performance level of the commonly 
used methods such as SVM and PSSM (see Figure 3.11, left panel). We therefore 
tested if adding the sequence space information to the SVM or combining several 
prediction methods into one can result in improved predictions. In the first approach we 
added to the binary feature vector coding the given sequence for the SVM the 
description of its location in sequence space. As the description of the location in 
sequence space we tested both the output score of the proposed classifiers, quantifying 
the separation of a sequence from the NSI/R5 sequences, as well as the sequence and 
phylogenetic distance to each of the NSI/R5 sequences. In the second approach we 
combined scores of several predictors, trained on the same training set, into one score. 
The scores of each predictor were normalized to the 0-1 interval with the higher scores 
representing X4 sequences. We tested several methods of combining prediction scores, 
such as min, max, mean and Euclidian distance from the origin of the score space. We 
restricted the classifier combination methods to the simple, non-trainable combiners, 
bearing in mind their generally good performance (Altmann, Rosen-Zvi et al. 2008). 
The description of the position of a sequence in sequence space, either in terms of the 
score of each of the sequence space prediction methods or in terms of a vector of 
distances to each NSI/R5 sequence, coupled with the binary feature vector coding the 
given sequence for the SVM did not result in an improved performance over predictors 
based on the sequence only. 
In the test of combined scores of several prediction methods we first compared the 
scores returned by different classification methods within the same cross-validation run. 
All the methods showed a high correlation in the scoring (Pearson correlation coefficient 
> 0.8) with the exception of phylogeny-based and SVM classifiers (correlation of about 
0.25 and 0.7, respectively). Despite the low prediction power of the phylogeny-based 
method, we observed several sequences (about 15 in both datasets in each cross-
validation run) for which the score returned by this classifier was 50% more accurate 
than the score of the SVM. However, since the phylogeny-based classifier contained a 
stochastic step, the scores returned by this method showed a high variation between 
different cross-validation runs and this result was not reproducible in each run. Next, we 
tested several methods of combining prediction scores and found the Euclidian distance 
from the origin of the score space to be the method achieving the best discrimination 
between the two sequence classes. Finally, we examined the performance of all 
possible combinations of predictors. Combining classifiers improved their performance in 
general. Three distance-based classifiers coupled together achieved better results than 
each one individually (Table 3.2). Joining the phylogeny-based method with another 
classifier resulted in the highest improvement in the predictive power – up to 0.03 
increase in the AUC in the case of SVM (Figure 3.11, right panel). The largest predictive 
CHAPTER 3 – Virus population                                                                                                                      61 
 
power was achieved by merging the distance and phylogeny scores with the SVM 
methods (Table 3.2). 
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R5/X4 NSI/SI predictor  sensitivity AUC sensitivity AUC 
Blosum 0.5544 0.8747 0.5606 0.8647 
Hamming 0.5241 0.8842 0.5144 0.8644 
significant positions 0.5524 0.8765 0.5499 0.8532 
split number 0.0712 0.6245 0.1932 0.6486 
split length 0.4262 0.7591 0.4722 0.7449 
clustering 0.5510 0.8725 0.5399 0.8606 
SVM 0.7607 0.9038 0.7407 0.8887 
PSSM 0.7276 0.9199 0.7140 0.9131 
Blosum-Hamming-
significant positions 0.6014 0.8990 0.5808 0.8745 
Blosum-split lengths 0.5986 0.9063 0.6076 0.8768 
Blosum-SVM 0.7517 0.9062 0.7313 0.8944 
Split Length-SVM 0.8062 0.9355 0.7929 0.9156 
Blosum-split length-SVM 0.8076 0.9420 0.7778 0.9224 
all methods 0.7607 0.9404 0.7369 0.9178 
Table 3.2 Performance of coreceptor prediction methods and their combinations on the NSI/SI and R5/X4 
datasets. The performance is assessed as the sensitivity at specificity of 11/25 rule in the main 
dataset (0.05 in the NSI/SI and 0.04 in the R5/X4 dataset) and as the area under ROC curve. The 
table lists performances of several classification methods and their combinations. The predictions of 
the combined methods are calculated as the Euclidian distance from the origin of the prediction score 
space of each of the individual methods. 
3.2.7 CD4+ T cell counts in sequence space 
In the last part of the study we related the location of a patient V3 loop sequence in 
sequence space to the patient CD4+ T cell count. From the Los Alamos database we 
selected a set of 7003 V3 loop sequences with a reported CD4+ T cell count. In addition, 
we selected sequence samples and the corresponding CD4+ T-cell counts of 88 patients 
(225 sequences) from the University of Cologne. Since both Los Alamos and Cologne 
sequence sets exhibited similar patterns in the sequence space arrangement we merged 
the sets into a single dataset which we called the full dataset. For the purpose of the 
longitudinal study we allowed this dataset to contain more than one sequence of the 
same patient. From the full dataset we selected therapy-naïve patient samples (2213 
sequences). We termed this subset of the full dataset the therapy-naïve dataset. In both 
the full and the therapy-naïve datasets we distinguished longitudinal (time-series) data 
comprising sample sequences of the same patient spanning several years (72 patients 
in the full dataset, 16 therapy-naïve patients with an average of 3.1 and 3.9 sequences 
per patient respectively). We analyzed the longitudinal patient data in both datasets to 
investigate how sequences of viral variants of an individual patient trace paths in 
sequence space in association with the progression of the disease. 
As in the analysis of misclassified sequences in the NSI/SI and R5/X4 datasets, we used 
the mean distance to the sequences annotated as NSI or R5 in the full dataset (653 
sequences) as a measure of sequence conservation. For each sequence in the full 
dataset, we calculated this distance and plotted it against the CD4+ T cell count (Figure 
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3.12, top panels). Among sequences collected from highly immunosuppressed patients 
(T cell count below 200cells/mm3) we observed a large range of sequence conservation 
spanning conserved, NSI/R5-like, as well as highly divergent sequences. Among the 
patients with higher T cell counts this range was narrower and included only conserved 
sequences. 
Next, we analyzed the longitudinal patient data in the full datasets to see how 
divergence of viral variants inside an individual patient can change in association with 
the disease progression. In the full dataset we counted 76 patients (both therapy-naïve 
and therapy-experienced) with data occupying several time points. We examined the 
conservation of sequential measurements of each of the selected patients against the 
corresponding CD4+ T cell count. For 21 patients we observed an increase in sequence 
divergence with decreasing CD4+ T cell count to the immunodeficiency level – below 
200cells/mm3 (example in Figure 3.12, top-left). Five patients showed an opposite trend 
with a decrease in mutations co-occurring with a decrease of the number of CD4+ T cells 
(example in Figure 3.12, top-right). Remaining patients showed no or various 
conservation change with varying CD4+ T cell count level. 
In order to examine how drug therapies can influence the relationship between 
sequence conservation and CD4+ T cell levels, we performed the same study on the 
data of untreated patients included in the therapy-naïve dataset. This dataset contained 
2213 sequences, 112 of which are annotated as NSI or R5. Other sequences were 
annotated as SI/X4 or had no annotation. The NSI/R5 sequences were used as a 
reference set in the sequence space. In the therapy-naïve dataset the lack of 
conservation of the sequences of patients with an impaired immune system was more 
pronounced. Among severely immunosuppressed patients (CD4+ T cell count below 
200cells/mm3), almost no highly conserved sequences can be observed (Figure 3.12, 
bottom panels). Again, highly divergent viral strains were found uniquely in patients 
showing low T cell counts.  
In the longitudinal dataset, among 16 patients with more than one time point 
measurement, four showed an increase in the sequence divergence with the transition to 
the immunodeficiency state (T cell count below 200cells/mm3) (example in Figure 3.12, 
bottom-left). None of the patients showed the opposite trend. 
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Figure 3.12 Patient sequence evolution in sequence space. CD4+ T cell count is plotted against mean 
distance to NSI/R5 sequence set in the full (top panels) and the therapy-naïve (bottom panels) 
datasets. Sequences with annotated phenotype or tropism are marked with colors (blue for NSI/R5 
sequences, red for SI/X4). Sequential data points of the same patients are marked in black and 
connected with a solid line: top-left panel – therapy-experienced patient showing an increase in 
sequence variability with decreasing CD4+ T cell count, top-right panel – therapy-experienced patient 
with an opposite trend, bottom-left panel – therapy-naïve patient showing an increase in sequence 
variability with decreasing CD4+ T cell count, bottom-right panel – therapy-naïve patient with a mixed 
trend. Patient identifiers are indicated above the plots. 
As in the previous part of this study (sequence clustering) we selected a clustering of the 
full and therapy-naïve sequence sets using the silhouette value and associated a cluster 
sequence composition to the CD4+ T cell counts. Both sequence sets showed one major 
cluster containing 86% and 52% of all sequences, respectively, and three smaller 
clusters of about 3% and 5% in each set respectively. We observed an important 
overrepresentation of samples collected from ill patients (T cell count below 
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500cells/mm3) among the unclustered sequences (p<0.001, chi-square test) which 
reflected their high evolutionary divergence. 
3.2.8 Discussion 
In this study, by means of different distance measures, clustering and phylogenetic 
methods, we illustrated and interpreted patterns in V3 loop sequence space of the HIV-1 
envelope gene. The analysis confirmed a relatively high conservation of R5 and NSI viral 
sequences as compared to highly divergent X4 and SI sequences. According to this 
analysis, the NSI/R5 sequences appear to share common features and the SI/X4 
sequences to be highly divergent and not showing a unique mutation pattern. Previous 
studies reported at least several possible V3 loop mutation pathways (Milich, Margolin et 
al. 1993) and indicated the twofold larger heterogeneity of the X4 over the R5 viruses. 
The lack of common features among the X4 sequences, as well as their high 
divergence, render these sequences impossible to group in coherent clusters. A 
statistical model of X4 sequences is therefore difficult to obtain. This divergence pattern 
has already been reported in previous studies (Chesebro, Wehrly et al. 1992; Nelson, 
Fiscus et al. 1997; Resch, Hoffman et al. 2001), in contrast to these analyses done on 
small data samples, here we provided support for these hypotheses based on a large-
scale analysis of V3 loop sequence data. 
The analysis of cluster structure pointed to dense regions of sequence space occupied 
by R5 sequences sparsely surrounded and interspersed by X4 and dual-tropic 
sequences. The sparse outer boundaries of these regions are less highly conserved and 
undergo positive selection. The finding of such regions suggests that the coreceptor 
usage switch which is correlated with high sequence divergence might be driven by the 
lack of selective pressure on the viral V3 loop. This finding supports other studies that 
reported presence of selective pressure maintaining the relative homogeneity of the R5 
viruses as well as the correlation of the emergence of the X4 strains with the accelerated 
V3 loop evolution (Chesebro, Wehrly et al. 1992; Shankarappa, Margolick et al. 1999). 
Localization of the misclassified sequences in sequence space indicated a possible 
reason for errors of V3 loop sequence-based coreceptor prediction tools. These 
sequences are located in parts of the sequence space untypical for their phenotype and 
show an inverse pattern in their distances distribution as compared to the distances 
among correctly predicted sequences (Figures 3.8 and 3.9). Only sequences 
misclassified by the 11/25 rule were not characterized by such a distance inversion 
which suggests that in certain cases mutations at positions 11 and 25 are insufficient for 
the change of phenotype and that the accumulation of other mutations on the V3 loop 
might drive the coreceptor switch. Previous studies (Pillai, Good et al. 2003) reported 
dual-tropic V3 loop sequences as being predominant among the sequences 
misclassified by different prediction methods. The sequences observed in this study to 
be located in untypical for their tropism regions of sequence space might therefore 
represent an intermediate form between the two mono-tropic types. Other studies (Low, 
Marchant et al. 2008) pointed to dependence of the predictive value of positions 11 and 
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25 on CD4+ T cell level, suggesting that individual patient parameters might influence the 
viral coreceptor usage. Another possible reason for errors in predicting coreceptor usage 
on the basis of V3 sequence might be the occurrence of complementary mutations in 
other parts of the gp120 protein. However, a similar inspection of the sequence space of 
the V2-V3 sequences showed no separation between the R5 and X4 phenotypes in the 
V2 part (Figure 3.10). A similar observation was previously reported (Hoffman, Seillier-
Moiseiwitsch et al. 2002) in a study of the V1-C3 region of the gp120 protein sequences 
showing a relative conservation of the V2 region with only a few positions in the V1/V2 
stem being significant for the coreceptor usage. This strongly points to the V3 loop being 
the region of the gp120 protein crucial for the viral tropism that is under selection 
pressures driven by the interaction with the host. 
Sequence location in sequence space can be used for the coreceptor usage prediction. 
The prediction methods we presented in this study were based on sequence space 
location determined by the means of sequence distance measures, phylogenetic 
distance and clustering. The predictive power of the methods is below that of SVM and 
PSSM which is not surprising as the prediction score based on sequence space is 
obtained by averaging over many sequence distances – an operation in which 
information on a single position in a sequence is lost. Adding the sequence space 
location descriptor to the sequence-based SVM did not improve the accuracy of the 
prediction which might be due to the fact that the sequence space location is drawn from 
the genetic information already provided to the SVM. However combining prediction 
methods, in particular the phylogeny-based method with other classifiers, resulted in a 
performance increase. Nevertheless the stochastic step involved in the phylogeny-based 
method renders its predictions less reliable which is reflected by the weak predictive 
power of the method by itself. 
Relating patient clinical markers to the respective sequence position in sequence space 
showed higher sequence variability among patients with an impaired immune system. 
Other studies have reported the emergence of highly mutated viruses in the later stage 
of infection (McNearney, Hornickova et al. 1992; Shankarappa, Margolick et al. 1999). 
The presented analysis shows the association of this emergence with the drop in patient 
CD4+ T cell count. This association might be due to a selection pressure exerted on the 
viral V3 loop that disappears with the gradual erosion of the immune system. With the 
attenuation of this selection force the virus is apparently undergoing an unrestricted 
evolution on the V3 loop which traverses distant parts of sequence space. The existence 
of a similar selection mechanism has been suggested in other studies (Zhang, Diaz et al. 
1997). 
The nature of the selection pressure limiting the viral mutation in the early stage of 
infection is not clear. The observation that the development of a highly mutated X4 virus 
is associated with low CD4+ T cell numbers and therefore with the impairment of the 
immune system suggests an immunological component of this mechanism. There is 
some evidence for selective pressure against the emergence of X4 strains having an 
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immunological basis (van Rij, Hazenberg et al. 2003) and decrease of positive selection 
accompanying the drop in CD4+ T cell count. This supports the hypothesis that the 
emergence of mutated strains late in infection is related to the limitation in the 
suppressive capacity of the immune system. However, other studies (Shepherd, 
Jacobson et al. 2008) showed examples of patients infected with an X4 virus at relatively 
high CD4+ T cell counts. Such cases could be explained by a successful antiretroviral 
treatment, as viral tropism appears not to impact the response to the treatment in terms 
of CD4+ T cell count (Waters, Mandalia et al. 2008). In the datasets used for this study 
we find patients (mostly therapy-experienced) who exhibit an increase in sequence 
conservation with a reduction of the CD4+ T cell counts (example in Figure 3.12, top-
right). Other parameters may therefore influence the evolution of the viral V3 loop. 
Notably, high sequence conservation has been observed among patients under long-
term successful therapy (Chun, Nickle et al. 2005). 
This large-scale analysis of sequence space of the V3 loop provides a comprehensive 
description of R5 and X4 viral phenotypes. By characterizing X4 viruses as highly 
variable and dispersed in sequence space we provide further evidence for the fact that 
not only is this phenotypic change predictive of disease progression but also that it 
comes as a result of an extensive evolution of the V3 loop sequence and a decrease of 
the selective pressure on the viral envelope genome.  
3.3 Structural descriptor of V3 loop 
In the second study on the virus population scale, also described in Bozek, K., 
Lengauer, T., Sierra, S., Kaiser, R., Domingues, FS. Analysis of physicochemical and 
structural properties determining HIV-1 coreceptor usage. submitted, we constructed a 
structure-based predictor of the HIV coreceptor tropism. The predictor was designed 
such as to address the drawbacks of the existent structure-based methods (Sander, 
Sing et al. 2007; Dybowski, Heider et al. 2010), namely the interpretability of results and 
efficiency of prediction procedure. In this work, we performed a systematic approach to 
incorporating physicochemical and structure properties into the coreceptor usage 
prediction. We mapped 56 amino acid indices representing their physicochemical 
properties onto the V3 loop structure and used machine learning methods to extract the 
most informative for the coreceptor usage. The extracted set of amino acid and loop 
location features was strongly reduced as compared to the initial one and reached 
higher accuracy with decreased computational load. This structural descriptor offers a 
direct interpretation by pointing to two regions in the loop stem and their 
physicochemical properties that play crucial role in determining of the coreceptor usage. 
The method was developed on clonal data, however we also applied it to clinically 
derived data and tested its usability for prediction of the MVC therapy outcome. Finally 
we implemented the method as a server application available for public use. 
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3.3.1 Main dataset 
To construct the dataset on which the method was developed we searched the Los 
Alamos database (http://www.hiv.lanl.gov/) for all phenotyped V3 loop sequences. In 
order to avoid bias due to overrepresentation of a single patient data we filtered the 
dataset leaving one randomly chosen sequence per patient. This way obtained dataset 
contained 1186 sequences annotated with the coreceptor tropism, with 215 annotated 
as X4 viruses. This dataset was termed the main dataset. We aligned the dataset and 
the sequence of the crystallized loop using clustalw (Thompson, Higgins et al. 1994) 
obtaining an alignment of length 50. In this study the positions in the gp120 sequence 
are numbered relative to the reference as previously described (Korber, Foley et al. 
1998).  
3.3.2 Structural descriptor 
To represent the amino acids with their physichochemical properties rather than their 
one-letter code, we used the amino acid indices collected in the AAindex database 
(Kawashima, Ogata et al. 1999). In this database various physicochemical and 
biochemical properties of amino acids are stored in the form of numerical indices. Due to 
the high redundancy of over 500 indices in the database we used a representative and 
interpretable subset of 54 indices, selected using multivariate statistical analysis 
(Atchley, Zhao et al. 2005). Two of the selected indices – “Normalized frequency of beta-
turn” and “Free energy in beta-strand region” had double entries in the AAindex 
database (AAindex entries: CHOP780101/CHOP780203 and 
MUNV940104/MUNV940105 respectively) showing minor differences. In order to avoid 
an arbitrary decision between the double entries we used both of the ambiguous indices 
which resulted in a set of 56 indices selected for this study. 
Each amino acid of the V3 loop sequence was represented as a vector of the 56 
preselected amino acid indices. The structural information was integrated into the V3 
loop structural descriptor based on the published structure of the V3 loop with PDB 
(Berman, Westbrook et al. 2000) code 2B4C (Huang, Tang et al. 2005). To construct the 
structural descriptor for each V3 loop sequence we used spheres defining structural 
proximities on the loop within which the physicochemical properties of residues are 
averaged. The spheres are positioned along the reference loop backbone and centered 
on its residues. Positions of the residues were defined as the position of the 
representative atom of each residue of the structure – Cα atom for Glycine and Cβ for 
other amino acid types. Positions of insertions relative to the reference structure were 
inferred based on the positions of representative atoms of the residues at both ends of 
the insertions (flanking atoms). First, a line connecting the flanking atoms was 
calculated. Then the following insertion positions were placed along the line at 
equidistant spacing. This way calculated coordinates of the following positions of the V3 
loop sequence (residues and insertions) were used as centers of the spheres on the 
loop. In addition to the set of spheres corresponding to alignment positions additional 
spheres were positioned at the midpoints of lines connecting centers of each pair of 
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consecutive alignment spheres. This resulted in a set of 99 spheres – 50 corresponding 
to alignment positions and 49 positioned in-between consecutive alignment positions. 
Example spheres are illustrated in Figure 3.13. 
 
Figure 3.13 Schematic illustration of the structural proximities of the structural descriptor. Atoms of the 
2B4C V3 loop structure are represented by dots, representative atoms by larger dots. Black line 
connects representative atoms of the following loop residues. Atoms of each residue are colored 
according to the “Hydrophobicity factor” amino acid index as indicated in the legend. Sphere-shaped 
proximities were centered along the V3 loop backbone, three examples centered on representative 
atoms of residues 299, 317 and 322 are shown. The physicochemical features of residues within 
each sphere were summed and used as a part of the structural descriptor. 
The radius of the spheres was chosen such as to provide a balance between too small 
proximities that do not incorporate structural information and too large proximities that 
reduce spatial resolution. We investigated the number of residues included in each 
sphere as a function of the sphere radius and selected the radii of 8Å and 10Å for initial 
testing. We additionally tested other radii (3Å, 7Å, 15Å) to assess the performance of the 
chosen parameter values in a cross validation setting.  
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Each V3 sequence position was mapped to a sphere if the corresponding representative 
atom was located within the given sphere. Within each sphere the vectors of amino acid 
indices of the mapped residues were normalized using Gaussian smoothing. The vector 
of amino acid indices representing a mapped residue was multiplied by the value of a 
normalized Gaussian function applied to the distance between the representative atom 
of the residue and the sphere center. We inspected the cumulated contribution of each 
V3 residue to the descriptor as a function of the variance of the Gaussian function. We 
chose the variance equal to the sphere radius as resulting in the most uniform 
contribution of each atom and therefore not giving undue priority to any of the loop 
residues. We tested an additional set of variances (ratio 0.5 and 0.75 of the sphere 
radius) to assess the impact of this parameter on prediction performance. 
Figure 3.14 illustrates the rationale of the parameter choice. Black histograms represent 
the distribution of the number of residues included in proximities of a radius indicated on 
the corresponding plot on the left. Spheres of radius 6 include five residues on average 
with a 4.56 variance among spheres, which might be too small a number to represent a 
structural binding site. On the other hand, spheres with radius 12 contain 16 residues on 
average, which corresponds to almost half of the loop. Sphere radius 8 was chosen for 
further testing. Spheres of this radius contain 8.4 residues on average with a relatively 
small variability among spheres. Red histograms illustrate the sum of Gaussian 
normalizing factors per residue. This sum should be similar for each residue such that no 
individual residue is weighted markedly higher than others in the structural descriptor. 
The narrowest distribution was obtained if the variance equals the radius (R = 8, var = 
8). The chosen set of parameter values of the sphere radius and variance of the 
smoothing function was used in model testing, the final model parameters were selected 
as those showing the highest prediction accuracy on our dataset. 
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Figure 3.14 Choice of sphere radius and Gaussian smoothing parameters. Left diagrams show shapes of 
Gaussian function for the parameters indicated in the legend. Right diagrams contain histograms 
showing sum of normalizing factor per each residue (red) and number of residues in each sphere 
(black). Mean with variance in brackets of each distribution are indicated in legends.  
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After Gaussian smoothing the amino acid index vectors of the mapped residues were 
summed within each sphere. The sphere vectors were then concatenated into a single 
V3 loop vector and used as the V3 loop structural descriptor in the statistical model for 
coreceptor usage prediction. 
For comparison we implemented two sequence-based descriptors of the V3 loop. The 
indicator model represents each amino acid with a binary vector of size 20 in which the 
position of a one indicates the amino acid it encodes. The aaindex model encodes each 
amino acid as a 56-long vector of amino acid indices used in the structural descriptor. 
The structural descriptor-based model distinguishing between R5 and X4 viruses was 
constructed as an SVM (Boser, Guyon et al. 1992) implemented in the R package e1071 
(Dimitriadou, Hornik et al. 2005). In the model evaluation we used ROC curve illustrating 
the trade-off between specificity and sensitivity. The area under ROC curve was taken 
as a cutoff-independent class separation criterion. The specificity at the sensitivity of the 
11/25 rule was used as an additional measure of the model performance. We used the 
the R package ROCR (Sing, Sander et al. 2005) for visualization and evaluated the 
models with ten times ten-fold (10x10) cross-validation. Each descriptor feature was 
normalized to 0-1 within the training dataset. 
First, we tested the performance of the preselected parameter set on the main dataset. 
Apart from radii of 8Å and 10Å that were preselected based on the average number of 
residues included in each sphere, we also tested predictive performance of several other 
values (3Å, 7Å, 15Å) in a cross validation setting on the main dataset. Among these 
sphere radii the radius of 8Å showed the highest performance with AUC of 0.847 and 
sensitivity at the specificity of 11/25 rule of 0.587 (Figure 3.15 and Table 3.3). Much 
smaller and larger radii significantly reduced prediction performance (p < 0.001 for R=3Å 
and R=15Å, paired wilcoxon test). 
 Radius (Å) AUC sensitivity  
 3 0.833 0.548  
 7 0.847 0.572  
 15 0.789 0.470  
 8 0.847 0.587  
 10 0.814 0.483  
Table 3.3 Performance of models based on different radii tested on the full set of features. The radius 
selected for further analysis is marked in bold. The sensitivity is at the specificity of the 11/25. 
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Figure 3.15 ROCRs of models based on structural proximities of different radii. The selected radius of 8Å is 
traced with a black solid line. AUC and sensitivity at the specificity of 11/25 rule in brackets are 
indicated in the legend. 
 3.3.3 Feature selection 
In order to reduce the highly redundant feature vector of the structural descriptor and to 
investigate which features are informative for coreceptor usage we applied several 
feature selection procedures. We used two classification methods performing feature 
ranking: Random Forests (RF) (Breiman 2001) with the mean decrease in Gini index 
and linear SVM with its feature weights (Guyon, Weston et al. 2002). We also used 
Lasso regression (Tibshirani 1996) that performs feature selection by assigning zero to 
the less important feature parameters. In case of the methods producing feature ranking 
(RF and linear SVM) we tested two cut-offs for the selected features: top 1% and top 5% 
of a gamma distribution fitted to parameters of all the features using maximum likelihood. 
We used all features selected by the Lasso regression method. The feature ranking of 
the SVM and Lasso regression methods was obtained as an average of a 10x10 cross-
validation. The RF construction method performs internal randomization, its feature 
ranking was therefore inferred from a single run of the method. We tested the 
performance of models based on subsets of features selected by different methods and 
cut-offs separately and combined. Models based on subsets of selected features were 
named after the feature selection method with the percent cut-off indicated in 
parentheses (e.g. SVM(1)). Names of models based on combinations of feature sets 
selected using several feature selection methods were composed of the corresponding 
feature selection methods separated by a “_” (e.g. SVM(1)_Lasso). The best performing 
model constructed on the main dataset and based on the selected feature set was 
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termed the clonal model and used as the final structural descriptor model. As the 
analysis of the features selected for the clonal model was a goal of our study, feature 
selection was performed on the entire clonal dataset. To assess how the choice of the 
set of sequences on which the features are selected impacts the model’s prediction 
accuracy, we performed two different types of tests. In the first test, features of the 
model were reselected on the training set in each cross validation run on the clonal set. 
In the second test we applied the features of the clonal model on other sequence sets. 
The comparison of the performance of the structural descriptor based on the full set of 
features (full model) to the descriptor based on separate and combined subsets of 
features selected through three feature selection methods showed that overall, reducing 
the feature set results in an improvement in the prediction accuracy over the full set of 
features and over the indicator model (Table 3.4). The SVM(1) model based on the top 
1% ranking features performed better than the SVM(5) model based on a larger feature 
set of the top 5% ranked features. The Lasso model based on the most highly reduced 
feature set (102 featues) selected via Lasso regression resulted in the highest 
performance with AUC 0.893 and sensitivity 0.674 at the specificity of the 11/25 rule. 
Models based on features selected via RF ranking showed the poorest predictive 
performance of all models tested (Table 3.4). We performed the same feature selection 
procedures on models based on the structural descriptor with a sphere radius of 10Å. 
The results of models based on this radius showed analogous patterns of performance 
although with worse results (data not shown). In the rest of this study we therefore used 
models based on the 8Å radius.  
 
Figure 3.16 Correlation of features in the initial feature set. Histograms show distribution of the Pearson 
correlation of all features of the structural descriptor (left panel), of the features of the clonal model 
(middle panel) and of the features of the clonal model with the remaining features of the structural 
descriptor (right panel). Median, percentage of feature pair with correlation >0.5 and >0.75 are 
indicated in the legend. 
Features selected using the three methods showed a limited overlap ranging from ~1% 
between SVM and RF, 3.5% between SVM and Lasso and ~9% between RF and Lasso. 
This limited overlap might be due to correlation of features in the initial feature set, which 
was previously reported to additionally reduce the predictive accuracy of the underlying 
model (Tolosi and Lengauer 2011). Features of the initial structural descriptor showed 
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low correlation (median 0.03, see Figure 3.16) and models constructed on clustered 
features (Tolosi and Lengauer 2011) showed no improvement in accuracy compared to 
the models based on unclustered features. Therefore, we chose a more parsimonious 
approach of not involving feature clustering. 
 
Figure 3.17 ROCR of models based on features selected using RF, SVM and Lasso. Number of features, 
AUC and sensitivity at the specificity of 11/25 rule in brackets are indicated in the legend. Clonal 
model is represented by a black solid line, indicator by the red solid line. 
Next, we inspected the predictive performance of combined sets of features selected 
using different methods (Table 3.4). Based on the performance of the tested models we 
selected the SVM(1)_Lasso model combining the set of top 1% of the SVM-ranked 
features and Lasso-selected features as the result model termed the clonal model 
(Figure 3.16). The AUC and sensitivity at the specificity of 11/25 rule of this model 
showed a significant increase over the sequence-based indicator and aaindex models (p 
< 0.01, paired Wilcoxon test). Even though the performance of the clonal model is not 
significantly higher than that of the Lasso model that is based on a smaller set of 
features, we chose the SVM(1)_Lasso feature set offering higher sensitivity at the 
specificity of 11/25 rule. The AUC and sensitivity at the specificity of 11/25 rule of this 
model were significantly higher than those of the indicator and aaindex models (p < 0.01, 
paired Wilcoxon test). A test of reselecting the SVM(1)_Lasso features on the training 
set within each cross validation run resulted in a ~1.6% decrease of the AUC. We 
consider this difference as a potential uncertainty of the accuracy estimation inherent to 
the feature selection procedure. The accuracy within the indicated uncertainty is 
however significantly higher (p~0.003) than the accuracy of the sequence-based 
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prediction suggesting that the selected structural and physicochemical features are more 
informative of tropism than the sequence alone (Sing, Low et al. 2007). 
 Model # features AUC sensitivity  
 indicator 1000 0.860 0.616  
 aaindex 2800 0.829 0.565  
 full 5544 0.847 0.587  
 RF(1) 144 0.860 0.673  
 RF(5) 241 0.863 0.634  
 SVM(1) 123 0.889 0.706  
 SVM(5) 362 0.879 0.674  
 Lasso 102 0.893 0.674  
 RF(1)_SVM(1) 264 0.878 0.683  
 RF(5)_SVM(5) 588 0.875 0.668  
 RF(1)_Lasso 226 0.883 0.652  
 RF(5)_Lasso 315 0.874 0.639  
 SVM(1)_Lasso* 218 0.892 0.686  
 SVM(5)_Lasso 448 0.881 0.674  
 RF(1)_SVM(1)_Lasso 340 0.868 0.644  
 RF(5)_SVM(5)_Lasso 653 0.883 0.685  
Table 3.4 Performance of models based on feature sets and combination of feature sets selected using 
different feature selection methods. Models are named after the feature selection method with the 
number in parentheses indicating the percentage cutoff of the ranked features. Sensitivity shown is 
at specificity of 11/25 rule in the main dataset. The clonal model is indicated with an asterisk. 
3.3.4 Combining structure and sequence  
In order to test how much performance improvement can be gained from incorporation of 
another V3 loop structure, we repeated the same model construction and feature 
selection procedure using a more recently reported V3 loop structure (PDB ID 2QAD) 
(Huang, Lam et al. 2007). The descriptor vectors based on the two structures had a 
mean correlation of 0.71 (p < 0.01) for the V3s in the main dataset which reflected the 
similarity of the two descriptors. Moreover, models based on the 2QAD structure showed 
a similar performance to those based on the initially used 2B4C structure. The 2QAD-
based SVM(1)_Lasso model showed an AUC of 0.872 and sensitivity of 0.639 at the 
specificity of 11/25 rule. The selected features of models based on the two structures 
had an overlap of 5-8% in case of features selected through SVM and Lasso methods 
and 20-23% for the RF-selected features. 
We also tested the performance of combined structure and sequence descriptors. A 
combination of descriptors was obtained from concatenation of the vectors of respective 
descriptors structure- and/or sequence-based.  
As already indicated by the correlation of structural descriptors, the combination of two 
structures did not result in improvement of the prediction. The combination of the clonal 
models (SVM(1)_Lasso) based on two different structures obtained an AUC of 0.857 
and sensitivity of 0.625 at the specificity of 11/25 rule. Combining the indicator descriptor 
with the 2B4C-based structural descriptor or with the combined structural descriptors 
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reached in both cases an AUC of 0.875 and sensitivity of 0.630 at the specificity of 11/25 
rule. 
3.3.5 Other datasets 
In order to compare the performance of the proposed structural descriptor with other 
methods of coreceptor usage prediction, we tested the method on the datasets of the 
study of Sander et al. (Sander, Sing et al. 2007) (Sander dataset) and the study of 
Dybowski et al. (Dybowski, Heider et al. 2010) (Dybowski dataset). Summary statistics of 
all the tested datasets is presented in Table 3.5. 
 dataset # sequences X4 sequences R5 sequences  
 main 1188 215 973  
 Sander 1357 205 1152  
 Dybowski 515 151 364  
 HOMER 954 167 787  
 HOMER-filter 412 39 373  
 MVC 53 3 25  
Table 3.5 Summary statistic of the used datasets. Only a subset of the MVC dataset was phenotyped 
which is reflected by the number of X4 and R5 viruses that is lower than the total number of 
sequences in the dataset. 
In order to avoid overtraining and to test the performance of the model independent of 
the training dataset, we did not repeat the feature selection procedure on the new 
datasets but used the features of the clonal model. Structural descriptors of the Sander 
and Dybowski datasets were built and limited to the clonal model features and tested in 
a 10x10 cross-validation setting.  
The clonal model showed a slightly poorer performance than the original method on the 
Sander dataset with the AUC of 0.901 (0.923 reported by Sander et al.) and sensitivity of 
0.782 at the specificity of 11/25 rule on this dataset (0.774 reported by Sander et al.), 
see Table 3.6. The result of Sander et al. was obtained on a dataset with no insertions or 
deletions relative to the reference structure and involved costly side chain modeling 
steps. In contrast, clonal model was constructed based on a different dataset, prediction 
procedure did not involve any additional to V3 encoding and model training 
computational steps. On the Dybowski dataset the clonal model reached better 
performance as compared to the original method with AUC of 0.948 (0.937 reported by 
Dybowski et al.) and specificity of 0.838 at the sensitivity of 11/25 rule (0.810 reported by 
Dybowski et al.), see Table 3.6. Again, this result was obtained efficiently, without 
additional modeling steps employed by the original method. 
Both the Sander and Dybowski datasets were composed of clonal sequences from the 
Los Alamos database. Next, we tested the method on clinically derived patient data from 
the HOMER cohort (Brumme, Dong et al. 2004) (HOMER dataset). The dataset was 
filtered to contain one sequence per patient which resulted in a set of 954 sequences out 
of which 167 of X4 viruses. Each sequence in the clinical dataset represents a 
population of variants genotyped and phenotyped in bulk, an approach used in standard 
CHAPTER 3 – Virus population                                                                                                                      78 
 
clinical practice. Such sequences contain ambiguous positions with alternative amino 
acids corresponding to different variants in the population. Ambiguous positions were 
represented by an average of vectors of indices of all alternative amino acids on a given 
position. Due to these differences between the clinically and clonally derived data, we 
repeated the feature selection on this dataset and chose the best performing model 
(Lasso) as the clinical model. The clinical model showed AUC of 0.774 and sensitivity of 
0.463 at the specificity of 11/25 rule on this dataset, a result significantly higher (p < 
0.01, paired Wilcoxon test) than the one of the indicator method (Sing, Low et al. 2007) 
with AUC 0.743 and sensitivity of 0.451 (Table 3.6). Similar to the clonal model, the test 
of reselecting the Lasso features within the cross validation runs resulted in a ~1.8% 
decrease of performance scoring nevertheless significantly higher (p~0.002) above the 
indicator model. 
As previously shown (Sing, Low et al. 2007), genotypic methods of tropism prediction 
perform worse on clinically derived data. This performance decrease might be due to 
noise introduced by ambiguous positions and to the presence of minorities undetectable 
by bulk genotyping of viral populations. In order to test whether the proposed strategy of 
handling sequence ambiguities is a source of performance decrease we tested two 
sequence sets derived from the original dataset and not containing ambiguities. The 
HOMER-filter set was obtained from the HOMER set after removing all sequences 
containing ambiguous positions. It contains 412 sequences with 39 X4 virus sequences 
(Table 3.5). The HOMER-gap set was derived from the HOMER set by replacing all 
ambiguous positions with gaps. The same steps involving construction of structural 
descriptors, feature selection using Lasso and evaluation using cross validation were 
performed on the two datasets not containing ambiguous positions. Lower prediction 
performance was observed on both datasets (Table 3.6), suggesting that ambiguous 
positions carry information important for the tropism prediction and that the presence of 
undetectable minorities, rather than ambiguous positions, might be the reason for the 
low predictive performance of models applied to clinically derived data.  
As shown by Sing et al. (Sing, Low et al. 2007), the performance of coreceptor prediction 
methods on clinical data improves after enhancing the sequence information with clinical 
correlates, such as VL or CD4+ T cell counts. Accordingly, adding these clinical data as 
new features of the clinical model significantly improved the predictive performance (p < 
0.001, paired Wilcoxon test) over the clinical model to AUC 0.803 and sensitivity 0.474 
at specificity of the 11/25 rule (Table 3.6). This result was also significantly higher than 
the result of indicator method containing clinical correlates both in AUC and sensitivity at 
the 11/25 rule specificity (p < 0.001, paired Wilcoxon test), see Figure 3.18. This 
demonstrates the higher prediction accuracy of the proposed method based on 
preselected structural and physicochemical features of the V3 loop over the commonly 
used sequence-based methods (Sing, Low et al. 2007). 
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original method / 
geno2pheno  dataset model features used AUC sensitivity AUC sensitivity 
Sander clonal 218 0.901 0.782 0.923 0.774 
Dybowski clonal 218 0.948 0.838 0.937 0.810 
HOMER clinical 59 0.774 0.463 0.743 0.451 
HOMER-filter  95 0.657 0.313   
HOMER-gap  106 0.774 0.303   
HOMER clinical (CD4, VL) 61 0.803 0.474 0.781 0.442 
Table 3.6 Performance of the clonal and clinical models on different datasets. Clonal model performance on 
the datasets of clonal origins (Sander and Dybowski) is compared to the performance of the original 
methods developed on these datasets. Clinical model constructed on the HOMER dataset and with or 
without gaps is compared to the geno2pheno performance. Clinical (CD4, VL) is the clinical model of 
the HOMER dataset coupled with clinical correlates (CD4+ T cell counts and VL). 
As the last test set we used a clinical dataset of a German cohort undergoing MVC 
therapy (MVC dataset) and tested the capacity of the method to predict therapy outcome 
based on sequences obtained at the therapy start. In this dataset we identified 53 cases 
of patients under MVC whose therapy outcome could be assessed based on the VLs. 
Therapy success was defined as a 2 log decrease in VL with respect to the level at the 
therapy start or a VL drop below 50 copies/ml measured three months after the therapy 
start. We classified the virus sequences at the therapy start for their coreceptor tropism 
in order to investigate the capacity of the structural descriptor to predict the therapy 
outcome. Since the MVC dataset was derived through clinical bulk sequencing we used 
the clinical model to predict the phenotype of the sequences in this dataset. We used 
prediction score at the specificity of 11/25 rule which corresponds to a false positive rate 
(FPR) of 6.28%, in the HOMER dataset as a classification cut-off between the R5 and 
X4 viruses. The FPR is an estimation of the expected proportion of sequences 
incorrectly classified as X4 viruses with a given cutoff and is calculated as the ratio of R5 
viruses scored above the threshold to all viruses scores above the threshold in a 10x10 
cross-validation. As a measure of general prediction quality on the MVC dataset we 
used Matthews correlation coefficient (MCC) that expresses the correlation of the 
observed and predicted binary classification and is suited for a dataset with an 
unbalanced proportion of elements from two classes. 
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Figure 3.18 Performance of clinical (black) and indicator (red) models on the HOMER dataset without (solid 
line) and with patient clinical correlates (dashed lines). Number of features, AUC and sensitivity at 
the specificity of 11/25 rule (gray dashed line) in brackets are indicated in the legend. 
Out of 53 patient cases in the MVC dataset 5 experienced a therapy failure (Table 3.7). 
With the decision cutoff based on the 11/25 rule specificity (specificity 0.928, score 
0.097) two of the therapy failure sequences were predicted as X4 viruses. The other 
three cases of therapy failure were classified as R5 viruses with a high FPR (~80%). 
Notably both cases (32 and 34) were also phenotyped as R5 virus which suggest the 
presence of undetectable minorities as the reason for the classification error. 
The remaining 48 patients experienced therapy success. 41 of the cases were classified 
as R5 viruses by the clinical model with a median FPR ~55%. Seven cases were 
classified as X4 viruses with a median FPR of 3%. Three of these cases were 
phenotyped as R5 viruses, two as dual viruses. The therapy outcome prediction showed 
an overall accuracy of MCC=0.34. We also predicted tropism of the sequences in this 
dataset using the indicator method. We observed higher sensitivity of the proposed 
structure-based method in finding therapy failure cases with also a higher rate of falsely 
predicted therapy success cases compared to the indicator method trained on the same 
clinical data. The indicator method reported correctly only two therapy failure cases 
however showed a lower number of incorrectly predicted therapy success cases (four). 
Given the imbalance between the numbers of therapy success and failure cases 
indicator method showed a generally lower accuracy compared to clinical model with 
MCC=0.29. 
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Both clonal model and indicator method trained on clonal data showed a generally lower 
capacity of detecting therapy outcome. Both models predicted correctly only one therapy 
failure case. Partial results of the MVC dataset analysis are provided in Table 3.7. 
case therapy outcome phenotype score FPR (%) 
predicted 
phenotype 
33 -  0.731 0.4 X4 
46 -  0.187 2.9 X4 
58 - R5X4 0.176 3.0 X4 
32 - R5 -0.013 79.6 R5 
34 - R5 -0.015 81.1 R5 
52 +  0.672 0.6 
17 + R5 0.553 0.9 
44 + R5X4 0.228 2.2 
24 +  0.195 2.8 
15 + R5X4 0.175 3.0 
2 + R5 0.139 4.4 
36 + R5 0.100 7.1 
X4 
1 +  0.083 9.3 
29 + R5 0.075 10.6 
30 +  0.075 10.6 
45 +  0.0.73 11.1 
… + … … … 
R5 
Table 3.7 Patient cases in the MVC dataset. First five rows of the table show patient cases that 
experienced therapy failure (-) three of which were correctly predicted by the clinical model. 
First eleven cases of the remaining 48 cases that experienced therapy success are presented 
in a decreasing order of the prediction score. Seven cases show score above the selected 
cutoff and are hence predicted as X4 viruses. Two of the seven cases (44, 15) are classified 
as R5X4 viruses despite the therapy success. Remaining therapy success cases are correctly 
predicted with a median FPR ~55%. 
3.3.6 Feature analysis 
In order to facilitate the interpretation of the large number of selected features we 
clustered the 56 amino acid indices into similarity groups. As a similarity score among 
the properties we used the absolute value of their correlation. Thus indices that express 
the same distances among amino acids are considered similar. We performed 
hierarchical clustering of the 56 amino acid indices and computed silhouette values 
(Rousseeuw 1987) in order to select the best set of clusters. The highest silhouette 
value was obtained for a partitioning of indices into 12 clusters. The highest silhouette 
value assigned to partitioning into less than 12 clusters was obtained for four clusters. 
We selected this number of clusters for further analysis as it contained a small number 
of interpretable attribute groups that are relatively well separated as inferred from the 
silhouette value. The selected clustering is presented in Figure 3.19. 
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Figure 3.19 Hierarchical clustering of the amino acid indices. Vertical line indicates the separation of the 
tree into clusters. Labels of the tree are colored according to the clusters – cluster 1 in green, 2 in 
red, 3 in blue, 4 in orange. 
Cluster 1 is composed of two types of indices – related to residue size and volume and 
to residue occurrence in proteins. Cluster 2 contains the smallest number of indices and 
is composed of indices related to residue charge. Indices of cluster 3 are related to 
secondary and tertiary structure of proteins. Cluster 4 contains indices related to 
different structural properties e.g. residue occurrence in β-sheet, solvent accessibility, 
amino acid polarity or hydrophobicity. 
By combining amino acid indices with specific positions in the V3 loop the proposed 
features provide description of physicochemical properties along the structure of the 
loop. Since features selected for the clonal model are the most informative for the 
prediction of coreceptor usage, their analysis can provide insights into the 
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physicochemical and structural determinants of virus tropism. Features of the clonal 
model were selected based on two different feature selection methods – Lasso and SVM 
methods. Among 218 features in this model seven were selected by both methods. 
Three of the features describe electrical charge along positions 319-322. Two of the 
features are structure-related (“Free energy in β-strand region”, “Normalized frequency 
of turn”) and describe positions 304 and 305. The remaining two features selected by 
both methods are based on amino acid indices “Number of codons” at position 297 and 
“Relative mutability” at position 307. 
Both feature selection methods allow for feature ranking based on the feature 
coefficients in the respective linear models. We inspected the top-scoring features in 
both rankings (Figure 3.20). SVM scoring follows a gamma distribution with a shape 
parameter of 2.2. The selected features follow a close to uniform distribution in the range 
of values above the chosen cutoff. Feature scores based on Lasso selection are 
distributed over a wider range of values and contain several high-scoring outliers. 
 
Figure 3.20 Distribution of scores of features selected using SVM (left panel) and Lasso (right panel) 
methods. On the left panel the vertical line indicates the cutoff for features selected for the clonal 
model. The scores of the top-scoring features are listed. On the right panel top-scoring features in 
the distribution are indicated. Positions of the features mapped on the V3 loop structure are indicated 
in brackets, labels are colored according to their clusters as in Figure 3.19. 
Among the top-scoring features selected by both methods we found “Positive charge” at 
the stem position 322 corresponding to the position 25 in the consensus sequence. 
Highly ranked features in the SVM scoring include also “Positive charge” at the position 
321. Additionally SVM scoring pointed to secondary structure propensities and mutability 
at the loop stem (“Normalized frequency of coil”, “Normalized frequency of β-sheet 
unweighted”, “Normalized relative frequency of bend” at positions 307, 319-320 and 
324). 
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Among the high-ranking features in the Lasso scoring we found mostly charge indices at 
the loop stem (“Positive charge”, “Isoelectric point” and “Net charge” at positions 307, 
316, 322-323) and at the loop base (“Net charge” at position 300). Additionally we found 
“Hydrophobicity factor” at the loop base positions 302-303. Two structure-related 
features based on “Normalized frequency of turn” and “Normalized frequency of β-turn” 
amino acid indices at the base position 305 were also scored high by the Lasso method. 
 
Figure 3.21 Overrepresentation of features of different amino acid index clusters among features selected 
for the clonal model. On the upper plot positions of the proximities of features of the clonal model 
were mapped on the positions on the reference sequence. Numbers of selected features on the 
following sequence positions were summed and averaged over a window of three neighboring 
sequence positions. This way obtained distribution of all features is represented by the black line, 
distributions of features of four clusters are represented by lines in colors as in Figure 3.19. Bottom 
histogram shows the number of features related to amino acid indices among features selected for 
the clonal model. Bars are colored according to the amino acid index cluster. Significantly 
overrepresented amino acid indices are indicated with an asterisk. 
Next, we inspected the distribution of selected features of the clonal model along the V3 
loop and the amino acid indices most often appearing among the selected features 
(Figure 3.21). The selected features appear to group around two regions in the 
sequence: between positions 303-312 and even more strongly between positions 318-
324. These regions correspond to two strands of the V3 stem. In the first region (303-
312) the selected features are based mostly on indices from clusters 1 and 3. In the 
second region (318-324) there is also a high number of features based on indices from 
cluster 2 which are predominantly associated with residue charge. Among individual 
amino acid indices we found six that are significantly enriched among selected features: 
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“Positive charge”, “Isoelectric point”, “Hydrophobicity factor”, “Number of codons”, 
“Relative mutability” and “Normalized frequency of extended structure” (Figure 3.21, 
bottom panel). Notably all of the significantly overrepresented indices belong to clusters 
1 or 2. 
The location of the features in the V3 structure is illustrated in Figure 3.22. Most selected 
features describe positions in two regions on both sides of the loop stem located in 
proximity of positions 304, 307 and 319-321, respectively (Figure 3.22A). We labelled 
these regions core sites (CSs) 1 and 2. In the bound conformation of the loop (PDB code 
2QAD) CS1 and CS2 are located closer to each other than in the open conformation 
(Figure 3.22B). We investigated the interactions of the residues of the two sites (Word, 
Lovell et al. 1999) and found that in the bound conformation residues of CS1 and CS2 
form interacting pairs between two sides of the central loop stem. In particular residues 
304 and 307, which are located in one side of the loop stem, form van der Waals 
interactions with residues 319 and 320, which are located on the other strand of the 
stem. In the open conformation CS1 and CS2 are more widely separated and the 
interactions between two sides of the loop are not observed. Position 324 is also 
associated with a high number of selected features and is located on the loop stem 
however does not interact with CSs in either of the conformations. 
The analysis of the location in the loop structure of the features based on significantly 
overrepresented indices confirmed the importance of CS1 and CS2 in determining 
coreceptor usage. These overrepresented indices are related to residue charge and 
hydrophobicity (e.g. “Positive charge”, “Isoelectric point”, “Hydrophobicity factor”), 
secondary structure (e.g. “Normalized frequency of β-turn”, “Normalized frequency of 
coil”) or mutability (e.g. “Number of codons”, “Relative mutability”), and are all found in 
CS1 or CS2 as well as residue 324 (Figure 3.22).  
We also investigated which clusters of indices were significantly overrepresented among 
selected features. The only cluster significantly overrepresented among the selected 
features was cluster 2 (p < 0.05). Three out of five features of this cluster are also 
overrepresented individually in the full set of selected features – “Positive charge” (22 
features), “Isoelectric point” (14 features) and “Normalized frequency of extended 
structure” (9 features). Most of the selected features from this cluster describe residues 
of CS1 and CS2, in particular positions 319-320 and position 324 (Figure 3.22). 
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Figure 3.22 Important V3 positions and amino acid indices in the V3 structure. (A) 2B4C V3 structure used 
in this study. Cα atoms are marked with small black spheres in the loop backbone in gray. 
Representative atoms are represented by gray spheres with the size proportional to the number of 
selected features mapped on the respective V3 position. Positions showing largest number of 
selected features are numbered. (B) V3 structure in a bound conformation (2QAD) (Huang, Lam et 
al. 2007) with the same sphere representation as the structure in panel (A). Positions important for 
the tropism come close to each other in this conformation. (C, D) Structure representation of V3 as in 
panel (A) with positions of the loop colored according to the ratio of selected features related to 
“Positive charge” (C) and “Hydrophobicity factor” (D) to the overall number of the selected features 
present on the respective V3 position with red indicating high proportion of given features and gray 
none. 
3.3.7 Discussion 
Physicochemical and structural properties of proteins determine their binding affinities. 
Prediction methods of HIV-1 coreceptor usage based uniquely on V3 sequence do not 
account for this type of properties nor provide the information about loop features that 
are crucial for the interaction. Here we present a predictive model of HIV coreceptor 
usage based on V3 sequence and structure (Huang, Tang et al. 2005). The method is 
constructed upon a set of features that was selected from a large initial feature set. This 
way reduced model shows better performance than the one based on the initial feature 
set, both in terms of prediction accuracy and computational efficiency. Moreover, the 
model affords an interpretable set of physicochemical properties pertaining to two 
regions of the loop structure that play crucial role in determining viral tropism. This study 
reaches beyond the classical prediction methods by providing additional insights into the 
determinants of viral tropism. 
The initial set of features is large and highly redundant which is reflected by the small 
overlap of features selected by different feature selection methods. The proposed 
structural descriptor appears to encode both structure and sequence information as 
adding the sequence binary encoding to the descriptor does not improve its 
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performance. In contrast, the distance-based descriptor of Sander et al. (Sander, Sing et 
al. 2007) is complementary to the sequence which is demonstrated by the improved 
performance of the descriptor combined with the sequence. 
The prediction performance of the proposed method is significantly higher than that 
based on sequence only (Sing, Low et al. 2007) both on the clonal and clinical datasets 
with and without patient clinical markers. It shows also a higher or similar prediction 
performance to that of other structure-based methods (Sander, Sing et al. 2007; 
Dybowski, Heider et al. 2010) without modeling steps that increase the computational 
cost of the prediction. Therefore both the accuracy and efficacy of our approach allow for 
its usage as a server application. 
We assessed the capacity of our method to predict therapy outcome of a patient cohort 
treated with MVC. This analysis is limited due to the small number of cases in this 
dataset and the lack of a comparable study. With increasing use of entry inhibitors, 
therapy outcome data are expected to become more abundant and the capacity to train 
models predicting therapy outcome will improve. The higher performance of the clinical 
over the clonal model in predicting therapy outcome suggests that targeted datasets can 
produce more reliable models. 
The analysis of features important for the coreceptor tropism points to two critical sites in 
the loop stem, consisting of residues 304, 307 and 319-322, respectively and to position 
324 located closer to the base of the stem. Residues on both sides of the stem form 
interactions in the bound conformation of the loop probably contributing to the rigid form 
of the loop upon binding. Predominantly charge- and hydrophobicity-related indices in 
the CS1 and CS2 around positions 307 and 319-322 respectively, and secondary 
structure of 304 in CS1 and of residue 324 appear to be important for coreceptor usage 
The results of other studies of structural features related to the tropism are in general 
accordance to our results. A recently published method (Masso and Vaisman 2010) 
predicts coreceptor usage based on a perturbation vector reflecting relative change in 
compatibility of a given V3 the sequence and structure with the reference structure 
(Vranken, Budesinsky et al. 1995). The ten most important positions for the coreceptor 
usage, according to this study are positions 302-304, 306-307, 309, 312, 322, 324-325. 
No additional interpretation of the characteristics of these positions is however provided. 
Sander et al. (Sander, Sing et al. 2007) rank high the distances from residues 298, 302, 
306, 308, 315, 317, 319, 321, 322 and 328. The regions found in my analysis are close 
or in-between the positions listed by Sander et al. However the ranking of Sander et al. 
is based on the importance of distances among functional atom types of the V3 residues 
which is not equivalent to the importance of the residue itself. Dybowski et al. (Dybowski, 
Heider et al. 2010), point to electrostatics hulls that are of highest importance for the 
classification: around positions 306, 321 and 322, and between position 301 and 326. 
Additionally, hydrophobicity of residues 303 and 307 appears to be important for the 
virus tropism based on Dybowski et al. analysis. Notably, the feature selection methods 
used in this study applied on Dybowski dataset, showed a strong overrepresentation of 
CHAPTER 3 – Virus population                                                                                                                      88 
 
“Hydrophobicity factor” amino acid index (over 2-fold higher than any other) among 
selected features in this dataset. 
Given the considerable structural flexibility and sequence variability of the V3 loop, 
individual features of this region distinguishing between two virus phenotypes are hard to 
define. We performed a comprehensive analysis of a large number of physicochemical 
residue characteristics in various locations on the loop and pointed to those that are the 
most informative of the tropism. The resulting method offers better performance over 
sequence-based method with a comparable efficiency and a direct interpretation of 
structural and physicochemical determinants of tropism. The method was implemented 
as a server application. 
3.4 Conclusions 
Variability of HIV underscores the importance of population scale studies comprising 
comprehensive sets of viral variants. V3 loop is an example of a particularly highly 
variable part of the virus genome. Its evolution is accelerated by evasion of the host 
immune recognition, constrained by the need of host receptor binding and subject to drift 
due to the lack of other functional restrictions. The multiplicity of forces influencing V3 
composition is reflected in the complex evolutionary trajectories of sequences in 
sequence space where a clear pattern of X4 virus evolution is difficult to discern. V3 loop 
appears to be highly flexible, both in sequence and structure, which contributes to the 
limited accuracy of the coreceptor usage prediction methods. 
The two studies presented in this chapter were performed on sequence data on the virus 
population level. The analyses extend beyond the classical coreceptor tropism 
classification methods based on sequence and/or structural information. Consequently 
they offer biological and evolutionary insights into the virus coreceptor tropism. Even 
such in-depth analyses fail however to explain all virus variants. One potential reason for 
this might be the incompleteness of the sequence data. Another reason might lie in other 
host and environmental factors impacting HIV tropism in addition to the viral V3 loop and 
not being accounted for in the classification models. 
The first reason is well demonstrated by the inaccuracy of coreceptor prediction on the 
clinically derived data as compared with the clonal data. Clonal data represent 
individually cloned and tested virus strains, the sequences are therefore unambiguous 
and their phenotypes reliably tested. Clinically derived data represent entire virus 
populations sampled from patient plasma, the sequences and phenotypes represent 
therefore a consensus picture of the dominant circulating virus. Such simplified and often 
incomplete view of a virus population derived through bulk virus sequencing and 
phenotyping results in an important decrease in the accuracy of coreceptor prediction 
methods. With the development of the next generation sequencing (Metzker 2010) virus 
studies on the population scale enter currently a new stage. Next-generation or deep 
sequencing platforms can read millions of base pairs in a more cost-effective and faster 
way than traditional Sanger sequencing. This technology has already been used to 
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address such questions as resistance mutations in minority populations (Hoffmann, 
Minkah et al. 2007; Wang, Mitsuya et al. 2007; Johnson, Li et al. 2008; Simen, Simons 
et al. 2009), evolution of virus populations (Poon, Swenson et al. 2009) or coreceptor 
usage characterization of entire within patient populations (Archer, Braverman et al. 
2009). The increased use of the next generation sequencing technologies will allow to 
resolve virus populations more accurately and overcome the drawbacks of using the 
consensus sequence representation.  
The second potential reason for the incapacity of population-based models to correctly 
classify all virus variants is the lack of host and environmental factors in the analysis. 
Even though studies of massive amounts of virus population data generated by next 
generation sequencing can provide a picture of the evolution of virus populations to an 
unprecedented level of detail, without accounting for other environmental and host 
factors affecting virus tropism, these analyses cannot explain the biological mechanisms 
of the coreceptor switch. Factors that trigger the virus tropism switch in the later stages 
of infection are still unclear. However studies of virus population sequences independent 
of their level of detail do not afford causal information of the biological reasons for this 
switch. Virus evolves in response to specific conditions in its environment such as host 
immune system, availability of specific host cells or the presence of drugs. Expanding 
the virus population studies to include host and environmental parameters would provide 
a more comprehensive picture of the virus evolution with a potential of explaining the 
basis of the coreceptor switch. 
An additional drawback of virus population-based methods aimed at predicting the virus 
coreceptor tropism is their limited capacity to predict therapy outcome. Certain patients 
analyzed using structural descriptor described in this chapter experienced therapy 
outcome unexpected from the virus phenotype. This indicates that therapy outcome 
might be affected by other than V3 loop environmental and patient factors. General virus 
fitness or availability of receptors on the surfaces of host cells are other examples of 
factors that might influence response to treatment. With the increasing use of MVC 
therapy, it is important to develop more comprehensive models of virus phenotype 
comprising not only V3 sequence but also virus fitness, drug response and coreceptor 
dependencies. Data required for such models should involve experimental testing 
beyond phenotypical coreceptor usage however they will allow for predicting the therapy 
outcome with a higher accuracy as compared to current coreceptor usage prediction 
methods.  
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CHAPTER 4 – Single cell scale  
                         host and drug factors affecting viral cell entry in 
                         addition to the virus genome 
 
The V3 loop of the gp120 protein is recognized as the major determinant of the HIV 
coreceptor tropism. Population scale studies of viral V3 sequences such as described in 
the previous chapter provide classification methods that support the clinicians in the 
patient treatment with therapies based on entry inhibitors. The accessibility of 
bioinformatical prediction methods and the low cost of genotyping are among the major 
advantages of using sequence-based computational approaches for predicting 
coreceptor usage. While being an invaluable support in the clinics, the genotype-based 
methods are subject to two major limitations. Firstly, binary classification of virus tropism 
provides a simplified picture of the virus phenotype and limited insights into the biological 
determinants of the coreceptor tropism. Secondly, sequence-based statistical models 
are based on observed or functionally tested cases are therefore prone to bias inherent 
to the data and, more importantly, are unable to provide reliable predictions of cases 
unobserved in the past and unenclosed in the train dataset. The latter limitation 
becomes important in the view of changing therapies and fast evolving virus.  
The limitations of sequence-based prediction methods call for development of improved 
models providing biological description of the phenotype, capable of characterizing 
cases unobserved in the data and this way of discovering new undescribed cases and 
producing testable hypotheses about them. Development of such models requires 
expanding of the binary sequence and phenotype data with information regarding the 
mechanism of the interaction and a broader spectrum of phenotypes. The enhanced 
models would result in a comprehensive picture of the biology of virus tropism allowing 
for characterizing of viruses and hence for deriving personalized treatment strategies.  
In this chapter we present an analysis of the HIV-host interaction at the scale of single 
cell. In this project several virus V3 loop variants were examined with respect to the 
efficiency of their entry into host cells in the presence of entry inhibitors of different types 
and in varying concentrations. The data from a high-throughput single cell assay was 
collected, processed and used for building models of virus cell entry efficiency. The 
models reflect virus phenotype involving host and drug parameters and, in this way, 
extend the classical coreceptor tropism classification based on genotype. 
This project was performed in collaboration with the lab of Prof. Dr. Hans-Georg 
Kräusslich and Dr. Barbara Müller at the Department of Virology, Heidelberg University 
and the virology group of Dr. Rolf Kaiser, Institute of Virology, University of Cologne. The 
wet-lab experiments were performed by Dr. Manon Eckhart in the Heidelberg lab, 
phenotyped patient viral samples were provided by the Cologne lab. The manuscript 
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describing our results is currently in preparation: Bozek, K., Eckhardt, M., Sierra, S., 
Kaiser, R., Müller, B., Kräusslich, HG., Lengauer, T. A comprehensive model of HIV cell 
entry phenotype based on multi-parameter single cell data. 
4.1 Background 
Several factors affect HIV cell entry. In addition to the composition of V3 region of the 
virus gp120 protein, analyzed in the previous chapter, factors such as coreceptors on 
the host cell and entry inhibitors play a role in virus cell entry. 
In addition to the primary cellular receptor used by HIV, CD4 (Maddon, Dalgleish et al. 
1986), two major coreceptors, the cytokines CCR5 and CXCR4, condition successful 
virus cell entry. Although CCR5 and CXCR4 share little sequence homology (Doms and 
Moore 1997), they can be used interchangeably by certain HIV strains. Both coreceptors 
are expressed on the surface of primary T cells and macrophages (Douek, Picker et al. 
2003), CXCR4 can also be found on other types of human cells. Only a small 
percentage of CD4+ T cells express CCR5 while CXCR4 is present on 80-90% of 
circulating naïve CD4+ T cells (Nicholson, Browning et al. 2001). The Δ32 mutation in the 
CCR5 coreceptor is a naturally occurring genetic variation in the human population 
(Samson, Libert et al. 1996) that emerged as a result of ancient selection pressures. 1% 
of the European Caucasian population is homozygous and 15% heterozygous for the 
CCR5Δ32 mutation, which however appears not to have an effect on the life expectancy 
or health of the affected individuals (Liu, Paxton et al. 1996). This mutation prevents 
functional expression of the CCR5 chemokine receptor, resulting in resistance to HIV 
infection (Liu, Paxton et al. 1996) which underscores the relevance of cell surface 
receptor and coreceptor expression for the infection.  
Blocking HIV cell entry represents a potential therapeutic strategy for HIV treatment. All 
steps of virus entry have been regarded as potential targets for anti-HIV intervention 
(Este 2003) with cell membrane fusion and coreceptor binding among them. Enfuvirtide 
is a fusion inhibitor (also known as Fuzeon, T-20, or ENF) that was approved as the first 
HIV entry inhibitor for use in patients (Fletcher 2003). It inhibits fusion of the virus with 
the host cell by binding to gp41 and preventing the creation of an entry pore for the 
capsid of the virus and this way keeping it out of the cell. Another class of entry inhibitors 
target cellular coreceptors. AMD-3100, a drug blocking CXCR4, is the first coreceptor 
antagonist described (De Clercq, Yamamoto et al. 1992). However, due to the severe 
side effects it was never approved for clinical use (Dai, Dou et al. 2005).   
Blocking the CCR5 coreceptor is a more promising strategy for HIV entry inhibition 
based on the observation that host defects in CCR5 expression severely reduce acute 
HIV infection without impacting health or life span of an individual (Liu, Paxton et al. 
1996). Several CCR5 antagonists have entered clinical trials (Este and Telenti 2007), 
however only MVC has been approved for patient treatment so far (Westby and van der 
Ryst 2005). This drug was shown to be active against a broad spectrum of R5 strains in 
vitro and in vivo with no observable adverse effects in patients (Fatkenheuer, Nelson et 
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al. 2008). The majority of patients experiencing unsuccessful MVC treatment show a 
switch of viral coreceptor usage towards CXCR4 which is not affected by the drug. 
These X4 viruses might emerge from reservoirs in the patient present at undetectable 
levels before the start of the treatment (Westby, Lewis et al. 2006). However mutations 
conferring resistance to MVC were also reported in the V3 loop (Trkola, Kuhmann et al. 
2002; Westby, Smith-Burchnell et al. 2007) enabling the virus to use the drug-bound 
coreceptor and thus obviating the need of tropism switch. This underscores that 
monitoring of coreceptor usage might be insufficient for accurate prognosis of therapy 
outcome. With the increasing number of patients under MVC treatment a better 
understanding of viral drug resistance as well as the development of algorithms 
predicting the efficacy of entry inhibitors are both timely and important. 
In this project we developed models of the dependence of HIV entry efficiency on the 
following host and drug parameters: host cell receptor and coreceptor expression level, 
presence of entry inhibitors of different types in varying concentrations, and viral V3 loop 
variant. Models were based on single-cell level data generated in high-throughput 
experimental assays. The models provide a comprehensive description of virus 
phenotype that expands beyond the classical classification of coreceptor usage based 
on virus genotype only by including other host and environmental factors that affect HIV 
cell entry. The resulting picture of virus phenotype contributes to our understanding of 
the determinants of virus tropism, offers an improved capacity of identifying X4 viruses 
and allows to infer the phenotype from V3 sequence – a feature that is essential for the 
practical use of this method in patient treatment.  
4.2 Clone selection 
As the first step of this study we selected viral samples for experimental testing using the 
sequence space and coreceptor prediction methods described in the previous chapter. 
94 sequences of phenotyped virus isolates derived from therapy-experienced patients 
were provided by the Cologne lab. We analyzed the sequences with respect to their 
position in sequence space (Figure 4.1) and reported and predicted phenotype. In order 
to locate the provided sequences in sequence space the R5/X4 we used the dataset 
from the sequence space analysis in chapter 3. Each clone was described by the mean 
distance of its sequence to all R5 and X4 sequences in the R5/X4 dataset and by the 
step of the clustering procedure in which its sequence joins a cluster as described in 
chapter 3. Small distances and cluster steps are typical for R5, large for X4 viruses. 
Three different prediction methods (geno2pheno (Sing, Low et al. 2007), WebPSSM 
(Jensen and van 't Wout 2003) and 11/25 rule (Fouchier, Groenink et al. 1992; Shioda, 
Levy et al. 1992)) were additionally used to predict the tropism of each clone.  
For the initial testing eight samples were selected: two clearly R5, three clearly X4 and 
three of questionable tropism where the predicted and tested tropism as well as the 
position in sequence space were contradictory or close to the decision boundary. The 
following rounds of experiments were aimed at populating the sequence and phenotype 
space with X4 viruses and viruses of questionable tropism. In these experiments nine 
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clones were selected of clearly X4 (252, 381, 391, 420, 719, 309, 315, 376, 631) and 
five of dubious (239, 334, 446, 468, 541) tropism. Out of the initially selected clones 
seven in the first round of experiments (220, 286, 651, 685, 822, 838, 924) and nine in 
the following experiments (252, 381, 391, 309, 315, 376, 631, 468, 541) (Table 4.1) 
showed entry efficiency on the level of 20-30%, a sufficient level for data analysis and 
modeling. Remaining clones showed entry efficiency below 5% and were therefore 
excluded from this study. Additionally, five lab-adapted clones of known characteristics 
(JRFL, SF162, HxB2, BaL, YU-2) and two reference clones (NL4-3 and NL4-3 R5) were 
added to the clone pool resulting in a set of 23 clones tested and characterized in our 
experimental and computational pipeline.  
 
Figure 4.1 Sequence space analysis of the clones provided for experimental testing. The clones selected for 
the first set of experiments are located on a splitstree (Huson 1998) together with 25 X4 (red dots) 
and 25 R5 viruses (blue dots) from the dataset used in the sequence space analysis presented in 
chapter 3. Three of the selected clones (220, 286, 685) were phenotyped as X4 viruses and were 
found in locations typical for X4 viruses in sequence space which is characterized by long branches 
separate from R5 virus clades in the tree. Two selected clones (822, 838) were phenotyped as R5 
viruses and clustered with R5 viruses in sequence space. Three remaining clones were phenotyped 
as either X4 (409, 651) or R5 (924) viruses but appeared in unexpected parts of sequence space – 
close to R5 viruses or on the boundaries between the phenotypes. These viruses were selected for 
experimental testing as viruses of dubious tropism. 
Figure 4.2 shows another visualization of the proximities of the tested clones in V3 loop 
sequence space. The sequences of the Bonn cohort patient samples and the used lab-
adapted clones were incorporated into the R5/X4 dataset used in the sequence space 
analysis presented in chapter 3. The dataset was hierarchically clustered and an optimal 
CHAPTER 4 – Single cell                                                                                                                              94 
 
clustering of the sequences into 70 clusters was chosen based on the silhouette value 
(Rousseeuw 1987). 11 of the clusters contained clones tested in this study. Three 
sequences from these 11 cluster were sampled randomly. The sampled sequences 
together with the sequences of the selected clones are plotted in Figure 4.2. Clones 
selected as R5 (822, 838) as well as clone 924 and R5-tropic lab-adapted clones (JRFL, 
YU-2, BaL, SF162) are located in the part of the tree containing predominantly R5 
sequences showing close similarity as reflected by short branch lengths. X4 clones 
(NL4-3, 286, HxB2) are located in clades occupied by predominantly X4 sequences and 
showing longer branch legths. Notably, HxB2 and NL4-3 show high similarity. Among the 
remaining clones, clones 252, 381, 315 and 376 form a closely related group seemingly 
dual-tropic. Other clones are located in parts of the tree occupied by both R5 and X4 
sequences and showing intermediate branch lengths. 
clone phenotype R5 distance 
clustering 
step 
geno2pheno 
score 
(prediction) 
WebPSSM 
score 
(prediction) 
11/25 
positions 
(prediction) 
220 X4 0.354 0.153 0.700 (X4) -2.87 (X4) GK (X4) 
286 X4 0.400 0.280 0.973 (X4) 2.63 (X4) RG (X4) 
651 X4 0.346 0.153 0.170 (R5) -2.80 (X4)  SD (R5) 
685 X4 0.344 0.142 0.983 (X4) 0.74 (X4) RK (X4) 
822 R5 0.261 0.056 0.055 (R5) -10.64 (R5) SQ (R5) 
838 R5 0.227 0.027 0.082 (R5) -12.71 (R5) SE (R5) 
924 R5 0.275 0.074 0.120 (R5) -8.25 (R5) GE (R5) 
252 X4 0.276 0.102 0.970 (X4) -2.58 (X4) RD (X4) 
381 X4 0.276 0.102 0.950 (X4) -2.66 (X4) RQ (X4) 
391 X4 0.372 0.280 0.990 (X4) -1.01 (X4) RR (X4) 
468 X4 0.368 0.280 0.658 (X4) -6.82 (R5) SQ (R5) 
541 X4 0.301 0.010 0.856 (X4) -6.92 (R5) GR (X4) 
308 X4 0.328 0.108 0.658 (X4) 0.50 (X4) SK (X4) 
315 X4 0.302 0.102 0.983 (X4) -3.93 (X4) RQ (X4) 
376 X4 0.277 0.102 0.910 (X4) -5.32 (X4) RQ (X4) 
631 X4 0.317 0.142 0.960 (X4) -1.49 (X4) RT (X4) 
NL4-3 X4 0.359 0.153 0.928 (X4) 0.50 (X4) SK (X4) 
NL4-3 R5 R5 0.230 0.052 0.090 (R5) -12.17 (R5) GE (R5) 
Table 4.1 Selected clones for the initial (upper part of the table, above the double line) and the following 
rounds (bottom part, below the double line) of testing and the two reference clones (NL4-3, NL4-3 
R5). Viruses were phenotyped by the Cologne lab. In order to locate the provided sequences in 
sequence space the R5/X4 dataset from the sequence space analysis in chapter 3 was used. Column 
“R5 distance” indicates the mean distances of a clone sequence to all R5 and X4 sequences in the 
R5/X4 dataset, “clustering step” indicates the step of the clustering procedure in which a sequence 
joins a cluster (see chapter 3). Three remaining columns indicate the score and phenotype predicted 
by three different prediction methods (geno2pheno (Sing, Low et al. 2007), WebPSSM (Jensen and 
van 't Wout 2003) and 11/25 rule (Fouchier, Groenink et al. 1992; Shioda, Levy et al. 1992)). The 
color indicates the type of clone: blue – clearly R5, red – clearly X4, magenta – dubious. 
The selected V3 loop sequences were inserted into the genetic backbone of an X4 
reference virus NL4-3 that is a standard laboratory virus (Adachi, Gendelman et al. 
1986). This X4 reference virus, as well as R5 reference virus NL4-3 R5, were used as 
control X4 and R5 viruses respectively. 
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Figure 4.2 Dendrogram of the tested clones and several V3 sequences hierarchically clustered as described 
in the text. R5 sequences are colored in blue, X4 in red, dual-tropic in magenta. Clones are indicated 
with arrows. Those tested in the first set of experiments are colored in black, those tested in the 
second set of experiments in orange, lab-adapted clones in dark red.  
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4.3 Experimental assays 
In the Heidelberg lab two experimental assays for high-throughput data measurement at 
the single cell level were established – based on fluorescence microscopy and on 
quantitative flow cytometry. In each of the assays a different cell line and different 
cellular markers of virus cell entry were used. Due to the higher biological relevance of 
the cell line used in quantitative flow cytometry assay and to its higher measurement 
capacity, the second round of experiments and the modeling were based on this assay 
only. Fluorescence microscopy was used in the initial set of experiments for the purpose 
of additional validation and for characterization of the tested clones. 
4.3.1 Fluorescence microscopy 
In the fluorescence microscopy assay a lab-derived cell line was used called Affinofile 
cells (Johnston, Lobritz et al. 2009). This cell line offers the possibility of artificially 
inducing CD4 and CCR5 expression to different levels and independently of each other 
(Figure 4.3) and thus for obtaining broader ranges of CD4 and CCR5 expression levels 
for further modeling. 
Surface expression of CD4 and CCR5 in the Affinofile cell line is induced by Tetracycline 
(Tet) and Ponasterone A (Pon), respectively. Amounts of Pon in concentrations from 0 to 
1µM, induce the expression of CCR5 in Affinofile cells in a range from ~600 to ~7000 
molecules/cell. Higher concentration of Pon leads to saturation of the CCR5 expression. 
Concentrations of Tet between 0 and 10ng/ml show a linear dependence with the CD4 
expression ranging from ~1200 to ~37000 molecules/cell (Table 4.2). CXCR4 is 
expressed at low levels in this cell lines and cannot be artificially induced. 
Expression of CCR5 and CD4 in this cell line was measured using immunostaining. 
Mouse antibodies raised against CCR5 and CD4 were bound to molecules emitting light 
in different spectra: Alexa 568 for CCR5 and Alexa 647 for CD4. Emission of light by the 
coupled antibodies reflects the surface expression of the corresponding protein. Another 
stain Hoechst was used to mark cell nuclei and derive cell positions on microscope 
images. 
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Figure 4.3 Induction of expression of CD4 and CCR5 in the Affinofile cells. 2D density plots of cell surface 
expression of CD4 and CCR5 are shown for three different concentrations of Pon and Tet and their 
combinations. Amounts of Pon are given in µM, of Tet in ng. 
Green fluorescent protein (GFP) was used as a marker for measuring the presence of 
virus in a cell in this cell line. Into each viral particle a self inactivating (SIN) vector 
encoding GFP (Zufferey, Dull et al. 1998) was incorporated and viral entry could be 
detected by the green fluorescence of target cells after the virus transduction. 
Cells stained for CD4 and CCR5 expression were seeded on a plate composed of 96 
wells. Each well was filled with the required concentrations of Pon and Tet and then 
transduced with GFP-labeled viruses with varying V3 sequences. Next, cell data within 
each well was measured using automated fluorescence microscopy. Data acquisition 
and preprocessing was done in the lab of Fred Hamprecht, Heidelberg Collaboratory for 
Image Processing (HCI), Interdisciplinary Center for Scientific Computing (IWR), 
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University of Heidelberg. The high-throughput image was obtained using an 
epifluorescence ScanR screening microscope equipped with the ScanR acquisition 
software (Olympus Biosystems GmbH, Münster, Germany). The surface of each well 
was covered by 16 images in four different channels filtering for stained nuclei, infected 
cells, CCR5 and CD4 immunostains. Microscope images were processed in two steps. 
First, cells were segmented based on the cell nuclei and antibody stains (Borner, Hermle 
et al. 2010). Then, within each segment the strength of CD4 and CCR5 stains and GFP 
was quantified (Figure 4.4). 
 
Figure 4.4 Intermediate steps of the microscope image analysis. A and B show the images of CCR5 and 
CD4 expression respectively. C shows an overlay of pictures taken in the channels for the nuclei 
stain (blue), GFP (green) and the maximum of CD4 and CCR5 stains (red). D shows the 
segmentation of the image into cells (yellow lines) based on the respective staining.  
On average ~800 cells were measured on each image. As a result of the image 
analysis, the levels of CD4 and CCR5 expression and the virus presence in a cell were 
quantified for each cell based on the signal strength in the respective channel. 
4.3.2 Quantitative flow cytometry 
In the flow cytometry assay human T cells were used – C8166 and C8166-R5 for 
development of data processing methods and SupT1-R5 cells for the quantitative 
measurements. Both cell types originate from the human immune system, express 
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receptors and coreceptors used by HIV in sufficient amounts (Table 4.2) and are 
therefore appropriate for HIV cell entry testing. 
cell line CD4 CCR5 CXCR4 
Affinofile (no induction)     1 241.7    547.1      950.8 
Affinofile (1µM PonA)     1 151.3 7 298.3   1 128.8 
Affinofile 10ng/ml Tet   36 722.6    577.2   1 056.6 
SupT1-R5   38 212.7 2 323.1 22 411.6 
C1866 195 278.6    318.6 10 833.5 
C1866-R5   23 112.5 1 761.9 22 883.6 
Table 4.2 Surface expression of measured receptor and coreceptors on the cell lines tested. Values are 
displayed in molecules per cell. 
As a marker of virus presence in a cell in this data acquisition system a virion fusion 
assay termed β-Lactamase (BlaM) assay was used (Cavrois, De Noronha et al. 2002). 
This assay is well established in the HIV research and is based on the bacterial β-
Lactamase enzyme which is incorporated into the virus and delivered to the target cell 
after virus and cellular membranes fusion. Target cells are loaded with a cleavable 
fluorescent substrate (CCF2) that emits green light in its uncleaved state and blue light 
once it has been cleaved with β-Lactamase. Emission of blue light in a cell is a marker of 
a cell being infected. 
Cells exposed to BlaM-carrying virus were additionally stained with labeled antibodies 
attaching to CD4 receptor, CCR5 and CXCR4 coreceptors. This way treated cells were 
next scanned using the fluorescence activated cell sorting (FACS) machine. In the 
machine, cells are suspended in a liquid that separates them from each other and are 
pumped through a flow chamber at a speed of ~500 cells per second (Figure 4.5). Laser 
beams hit the cells as they pass through the flow chamber and their reflection angle 
provides the information on the physical characteristics of each cell. Light reflected at 
small angles is termed forward scatter (FSC), light reflected in other directions is termed 
side scatter (SSC). Forward scatter provides a measure of cell size, side scatter of its 
granularity. Different cell types in a cell population can be characterized in terms of 
separate clusters of unique combinations of these two parameters. In addition to the 
physical characteristics of the cells, their biological and chemical properties can be 
measured by color detectors detecting light emitted by biological markers attached to or 
incorporated into each cell. In our assay, β-Lactamase, each receptor and coreceptor-
specific antibodies emit light of a different color. Therefore, the intensity of the light 
signal at the respective frequency quantifies the cell surface expression of CD4, CCR5 
and CXCR4 as well as the virus presence in a cell. 
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Figure 4.5 Schematic depiction of the FACS machine. Beam scatter provides information on the physical 
properties of each cell (inserted image, bottom-left). Light detectors allow to measure light intensity of light 
in different spectra emitted by the cells. (From http://en.wikipedia.org/wiki/Fluorescence-
activated_cell_sorting). 
FACS output files contain information on the forward and side scatter, green and blue 
light emission of the BlaM assay, CD4, CCR5 and CXCR4 staining signal for each of the 
cells scanned in a high-throughput manner. Numbers of cells captured in individual 
FACS machine measurements are listed in Table 4.4 in section 4.5.2. 
4.3.3 Comparison of experimental assays 
Overall, both fluorescence microscopy and flow cytometry offer efficient methods of 
acquiring high-throughput data at the single cell level. Technical limitations of the 
fluorescence microscopy include the lack of an additional light channel to measure the 
expression of CXCR4 coreceptor and the low expression level of this coreceptor in 
Affinofile cells. The possibility of inducing higher levels of CD4 and CCR5 expression 
presents an efficient way to extend the range of measured parameter values that allows 
for construction of more general models. However artificially high levels of surface CD4 
and CCR5 expression do not occur in vivo, moreover, the lack of CXCR4 expression on 
the Affinofile cells limits the relevance of this assay for the true environmental settings of 
an HIV infection. 
Cells of the T cell family used in the fluorescence microscopy assay are not adapted for 
capturing in the microscope and do not offer the possibility of enhancing receptor and 
coreceptor expression. However natural variability of the receptor and coreceptors 
expression, sufficient levels of CXCR4 expression and the immune system origin of 
these cells present more physiologically relevant conditions for testing of the HIV cell 
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entry. In addition, FACS machine offers a sufficient number of measurable light spectra 
to capture all parameters that are relevant for this study. It is not charged with image 
acquisition and processing errors and offers higher throughput measurements at a lower 
cost. 
4.4 Data preprocessing 
In order to analyze data at the single cell level we developed methods that allow for 
automated processing of data measured in both high-throughput single cell data 
acquisition systems. Instead of a classical approach of averaging measurements of 
entire cell populations (Johnston, Lobritz et al. 2009), we developed methods that allow 
for accessing the data at the single cell level and using their natural variability for 
generation of models of HIV cell entry. Models based on single-cell level data offer 
higher accuracy by accounting for the variation of individual cells and this way allow for 
deriving more detailed information based on individual experiments as compared to the 
averaging approach. 
4.4.1 Fluorescence microscopy 
As a first step of the analysis of fluorescence microscopy data we inspected the 
distribution of cells, of the GFP and other light signals on the plates. Figure 4.6 shows 
the distribution of cells (upper panels) and the GFP signal (bottom panels) on a 
microscope plate. The wells of the two rightmost columns on the plate contain control 
measurements: in column 11 a virus with no envelope gene (Env(-)) is titrated, column 
12 contains cells without any virus (no virus). GFP signal in those two columns is 
expected to be at a constant background level. Microscope pictures that show a higher, 
above the background, level of GFP might therefore contain errors that change the 
average level of the signal of the controls. Since the control measurements are used to 
establish a cutoff for classification of cells into infected and not infected, control images 
with unexpectedly high signal levels were removed before further classification as they 
might introduce an overestimation of the background entry efficiency levels. 
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Figure 4.6 Example distributions of number of cells (upper panels) and the GFP signal (bottom panels) on a 
microscope plate. Colors of the heat maps indicate the number of cells (upper panels) and the 
strength of the GFP signal (bottom panels) with red representing higher and yellow lower values. 
White squares indicate missing images. Plots on the right hand side represent 3D visualizations of 
the corresponding heat maps on the left hand side and are colored according to the type of virus 
titrated in each column of the plate with red representing X4 viruses, blue R5 viruses, magenta 
dubious viruses and gray control measurements – Env(-) and no virus. In each column of the plate a 
different clone was tested, the following rows of this plate were titrated with an increasing amount of 
Tet which resulted in increased entry efficiency of R5 viruses. 
In addition to the noise in the control measurements certain plates showed an uneven 
distribution of cells among wells. On the plate shown in Figure 4.7, row G contains up to 
twice as many cells as row C. On the same plate a negative correlation between the 
number of cells in a well and the strength of the staining signal could be observed 
(Figure 4.6, bottom panels). Rows containing lower numbers of cells showed an 
increased signal of CCR5 expression at a constant Tet induction and the same amount 
of the antibody titration on the entire plate. This negative correlation might be due to the 
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higher amounts of antibody per cell in the wells where the number of cells is lower. 
However this hypothesis was not tested experimentally. 
 
Figure 4.7 Example distribution of cells (upper panels) and the corresponding CCR5 stain signal (bottom 
panels). The coloring scheme is in accordance with Figure 4.5. Lower amounts of cells in the bottom 
rows of this plate correspond to higher signal of the CCR5 expression. 
With the lack of experimental measurements allowing for correction of the biased stain 
signal values, we introduced a computational correction procedure. In this procedure we 
fitted a linear function expressing the dependence of the average stain value on the 
number of cells in each well of a plate. Next, individual values of a stain intensity  of 
the cells were corrected based on the fitted function and the number of cells  in the 
corresponding well of a given cell according to the formula: 
 
where  is the parameter of the fitted linear function and its offset and  is the 
middle value of the stain value of all the wells on a given plate. Intuitively, the stain 
values in wells are pivoted around a central stain value by an angle dictated by the 
strength of correlation. This operation produces uncorrelated values of stain and cell 
numbers (Figure 4.8). 
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Figure 4.8 Negative correlation of the number of cells in a well with the CCR5 (upper panels) and CD4 stain 
(bottom panels) on the plate shown in Figure 4.6. The correlation is indicated in the upper right 
corner of each diagram. The black line represents a linear function derived based on the least-
squares fit. The right-hand panels show the corresponding data after the correction. 
After the two correction steps – removal of flawed control images and correction of stain 
signal, cells were classified into infected and not infected based on the GFP signal 
intensity. Classification cutoff was established for each plate based on the distribution of 
the GFP signal in the control measurements of Env(-) and no virus. First, gamma 
distribution was fitted to the GFP values of all cells in the control measurement. Gamma 
distribution offers the largest variation of shapes and is therefore appropriate for fitting to 
data with unknown distribution. Next, a cutoff was chosen at the value which is 
exceeded by a fraction of 0.0001 of the distribution (Figure 4.9). The cutoff was 
established based on control measurements (Env(-) and no virus) on each plate, cells in 
other parts of the same plate were classified accordingly. 
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Figure 4.9 Classification of cells into infected and not infected based on the GFP signal. Gamma distribution 
is fitted to the control measurements, the cutoff is defined at the 0.0001 upper fraction of the fitted 
distribution (left panel). Middle panel shows the cumulative distribution of the GFP signals in cells 
titrated with each of the tested clones. The curves are colored according to the clone phenotype as 
indicated in the legend. Proportion of cells infected with each of the clones according to the 
established cutoff is shown on the right panel.  
Classification of cells allowed for assessment of the experimental setup and preliminary 
inspection of virus entry efficiencies (Figure 4.10). Specifically, Pon and Tet induction 
showed a pronounced effect on the entry efficiency of the R5 viruses and less of the X4 
viruses (Figure 4.10, upper panels). X4 viruses showed a generally lower entry efficiency 
in this cell type possibly due to the low levels of CXCR4 expression.  
The analysis of the fluorescence microscopy data at the single cell level offered a 
detailed picture of the dependencies of virus entry efficiency (Figure 4.10, bottom 
panels). The discussion of the results follows in section 4.5. 
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Figure 4.10 Entry efficiency of two example clones 685 and 822 tested in the fluorescence microscopy 
assay. Upper panels show an increase in the entry efficiency of the clones with the induction of 
CCR5 and CD4 expression using Pon and Tet, respectively. Entry efficiency here is represented by 
an averaged ratio of infected cells for each Pon and Tet induction level. Bottom panels show the 
same experimental data with the clone entry efficiency plotted as a function of the CCR5 and CD4 
stain signal. These plots were generated based on the single cell data, the ratio of infected cells was 
averaged within 30 ranges of stain values spanning over the full range of stain values obtained in this 
experiment. The color scheme of the plots are detailed in section 4.4.3. 
4.4.2 Flow cytometry 
Similar to the fluorescence microscopy, single cell data measured with the flow 
cytometry assay was filtered and classified before further analysis. As the initial step of 
data preprocessing, cell populations were filtered according to the FSC and SSC 
parameters, an operation termed gating. The distribution of the combination of these two 
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parameter values was analyzed in order to identify the major cell population and filter out 
cells not belonging to the major population as they might be defunct or be of a different 
cell type. A classical way to perform gating consists of manually defining the gate, i.e. 
the contour surrounding the major population based on subjective visual inspection 
(Figure 4.11). Although this approach is predominant in the FACS community, it is not an 
objective or systematic procedure. Therefore the results of manual gating can be 
questionable and hard to reproduce. 
 
Figure 4.11 Examples of manually gated cell populations. 
In order to address the shortcomings of manual gating, we developed a computational 
method for gating of cell populations as follows. Cell populations are commonly plotted 
on 2D scatter plots with FSC on the x-axis and SSC on the y-axis. In the proposed 
automated gating procedure cells are first filtered through a user-defined square window 
defined on the FSC and SSC values. In the case of SupT1-R5 cells we used a filter of 
300 < FCS < 1200 and 0 < SSC < 900. Next, a grid of FSC and SSC values is defined 
and the numbers of cells in each bin of this two-dimensional grid are calculated, which 
can be presented in form of a heat map (Figure 4.12). Each bin of the grid is of width 
and height 5, a value that was chosen among several others based on its optimal gating 
agreement with the manual method. Next, for following values  on the x-axis (FSC) a 
grid bin is found with position that contains the maximum number of cells among all bins 
at the given . For each such bin position  minimum distance  is found such 
that no cells are found in the bins at equidistant positions  or . The 
positions  and  are termed surrounding points. 
The y-coordinates of the surrounding points are next averaged:  is replaced by a 
mean value of itself and two neighboring surrounding points , where . 
This averaging results in a smooth gating line. The same search for surrounding points 
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and averaging procedure is repeated along the y-axis. A gate is defined as the minimal 
contiguous area on the FSC-SSC grid encircled by the line connecting surrounding 
points. Example results of the automated gating procedure are shown in Figure 4.12. 
The no virus measurement was used as the control for establishing the gate. All 
measurements in the same experiment were gated accordingly. For reading the FACS 
files R package prada was used, a part of Bioconductor (Gentleman, Carey et al. 2004).  
 
Figure 4.12 Automated gating of FACS data. Top-left panel shows a heat map of the cell density showing 
specific FCS and SSC values before gating. Calculated gate is traced with a black line. Heat map of 
the gated cell population is shown on the top-right panel. Bottom panels show 3D views 
corresponding to the heat maps above. Cell population with a small FSC and high SSC values as 
compared to the major population is removed in this example.  
After gating of the cell populations, cells were classified into infected and not infected 
based on the BlaM marker. Each cell in the FACS assay carries a green dye that turns 
into blue after cleavage with the β-Lactamase enzyme incorporated into the virus. A shift 
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from green to blue light is therefore indicative of a cell being infected. Similar to gating, a 
common approach to classification of the BlaM-stained cells entails a manually 
established decision boundary based on the control measurement not containing the 
virus. The decision boundary is defined on the plot of blue against green light signal of 
the cells in the control measurement. It delineates the region of uninfected as a minimal 
region cells such that  and a proportion of ~0.01% of the control cells are located 
outside of this region. Measurements of cells titrated with viruses are classified 
according to such a control-based decision boundary. 
In order to efficiently classify a large number of FACS measurements and to obtain 
objective and reproducible results we established an automated method of BlaM assay 
classification. The steps of the classification procedure are illustrated in Figure 4.13. 
Cells showing specific values of the green and blue light are depicted as points in a 
scatter plot with blue light intensities on the x-axis and green on the y-axis (Figure 4.13, 
panel 6). A corresponding heatmap representation (Figure 4.13, panel 1) illustrates the 
density of thousands of cells that appear as overlapping dots on the scatter plot. First, a 
linear function  is fitted to the points representing the cells of two control 
measurements – not containing the virus and unstained (Figure 4.13, panel 1). For each 
point on the fitted line , where  and , the data points 
 on the scatter plot are found lying on the line perpendicular to the fitted line 
and intersecting it at : , where , such that are the most 
distant from the point  and  (Figure 4.13, panel 2). These points 
represent cells showing the highest shift in the blue light relative to the green light in the 
control. The distances of these points from the fitted line (Figure 4.13, panel 3) are next 
smoothed in a sliding window approach by averaging the values within each window and 
adding of one standard deviation of the values within that window (Figure 4.13, panel 4). 
The added standard deviation produces a margin beyond the control cells that ensures a 
required low proportion of false positives in the control measurement (~0.01%). Window 
size of 30 was selected as the size resulting in the best performance. The smoothed 
points projected back onto the plot of green and blue light signals define the cutoff 
decision line (Figure 4.13, panel 5) – cells represented by data points located in the part 
of the plot below the decision line are classified as infected, those located above the line 
are classified as not infected. The method design and the choice of parameters were 
dictated by the comparison with manual classification and the best performance on a 
large number of measurements. The classification based on this procedure assigns a 
binary value to each cell, 0 representing not infected and 1 infected cells and was 
termed binary classification.
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Figure 4.13 Following steps of the classification method for the BlaM assay. (1) Heat map of the density of 
cells of the control measurement showing given combinations of blue and green light signals. The 
line represents the linear function fitted to the values of the blue and green light signal. (2) Most 
distant points from the fitted line are found showing the highest blue-to-green light ratio. (3) Distances 
of these points are measured and smoothed (4) in a sliding window approach. (5) Smoothed points 
mapped back onto the blue-green light heatmap define the classification curve. (6) Plot of blue and 
green light values of the cells of the control measurement with no virus. The classification curve 
estimated in the previous steps is shown in black, the number of cells and the percentage of control 
cells outside the classification curve are indicated in the legend.  
Two examples of classification of virus measurements using the classification curve 
depicted in Figure 4.13 are shown in Figure 4.14.  
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Figure 4.14 Classification of two virus measurements based on the classification curve depicted in Figure 
4.13. Cells classified as infected are represented by blue dots, uninfected cells by green dots. 
Percentage of the infected cells (positive) is indicated in the legend. 
Comparison of the automated method with manual classification indicated a lower 
agreement between the manual and the automatic method for samples with high cell 
concentration close to the decision line. In order to account for potential errors of the 
automated method for these cells, we developed a second classification method that 
instead of a cutoff curve calculates a region delimited by two parallel margins 
surrounding the decision curve of the binary method (Figure 4.15). Cells located within 
the region delineated by these two curves are assigned a value between 0 (not infected) 
and 1 (infected) that estimates the probability that a given cell is infected. The probability 
estimate is calculated as proportional to the distance of a cell from the upper boundary 
of the region (lower blue-to-green ratio) with probability 0 at this boundary and 1 at the 
bottom boundary (higher blue-to-green ratio). We selected 5 as the optimal width on the 
region that compensates the difference in the classification results between the binary 
automated method and manual classification. This approach was termed margin 
classification. 
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Figure 4.15 Classification of two example viruses shown also in Figure 4.14, using the margin method. Two 
black lines trace the margin between not infected (green) and infected (blue) cells. Cells located 
within the margin are colored according to the assigned probability with a green shade representing 
values closer to 0 and blue closer to 1. 
4.4.3 Visualization methods 
As the next step of the study we developed visualization methods that allowed for 
preliminary inspection of the tested clones with respect to their overall entry efficiency in 
dependence on the measured parameters. This initial inspection was informative for 
further model development. Throughout the next section we visualize the experimental 
results using 3D plots of virus entry efficiency in relation to two chosen parameters. 
Colors of the plots are dictated by virus phenotype – red for X4 viruses, blue for R5, 
magenta for dubious. Individual cells of a microscope or FACS measurement are 
localized in a 30x30 grid of values spanning the range of values of the two parameters. 
Virus entry efficiency is calculated as the mean classification value (assigned using 
GFP-based, binary or margin classification) of cells within each bin of the grid. Prior to 
plotting, the grid is smoothed by averaging values from neighboring bins of the grid. In 
order to account for the differing numbers of cells that show a given combination of 
parameter values, parts of the grid that contain less than a selected minimum number of 
cells are colored in gray. The selected minimum number of cells is 10% of the expected 
number of cells if the cells were evenly distributed over the grid. 
4.5 Data analysis 
4.5.1 Fluorescence microscopy 
In the fluorescence microscopy assay four experiments were performed (Table 4.3). As 
an experiment we define a set of measurements in which certain parameter or 
combination of parameters is varied. Table 4.3 shows the average number of cells 
measured per each parameter value combination in the performed experiments. This 
number is both a measure of how high-throughput the assay is and an indicator of how 
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much information is processed in the analysis at the single cell level. In the fluorescence 
microscopy assay only the first set of 8 selected clones was tested. The results were 
used for the clone characterization, however due to the limitations of this assay 
(described in subsection 4.3.3), the modeling and following experiments of this study 
were done using only the flow cytometry assay. 
experiment plates parameters varied 
parameter 
values 
cells per 
measurement 
Pon-Tet 2 Pon, Tet 16 5 379 
C46 1 C46 2 30 223 
AMD 1 AMD 2 47 835 
MVC 2 MVC 5 41 607 
AMD-MVC 8 AMD, MVC 16 16 543 
Table 4.3 List of measurements performed using fluorescence microscopy. Parameters varied in each 
experiment are indicated in the “parameters varied” column. The column “cells per measurement” 
shows the number of cells captured for each clone and individual level of drug or Pon/Tet 
induction, which represents the efficiency of this experimental assay. 
Example figures of the Pon-Tet experiment were shown in the previous section (Figure 
4.10). Induced expression of CD4 and CCR5 increased the entry efficiency of the R5 
viruses substantially to high levels close to 100%, levels that do not occur in vivo and do 
not provide sufficient output variability for modeling. Since the induction did not increase 
the entry efficiency of X4 viruses and R5 viruses showed sufficient efficiency at the 
natural expression levels of Afinofile cells, the induction was reduced to a low constant 
level of 2.5 ng/ml of Tet and 250 nM of Pon in the following experiments. 
 
Figure 4.16 Effect of three types of entry inhibitors on the entry efficiency of the tested clones. Line colors 
correspond to the virus type: blue - R5 viruses, red - X4 and magenta - dubious. 
Next, three experiments were performed testing three different entry inhibitors: fusion 
inhibitor C46 (Fletcher 2003), CXCR4 blocker AMD (De Clercq, Yamamoto et al. 1992) 
and CCR5 blocker MVC (Westby and van der Ryst 2005). Only a single high 
concentration of C46 and AMD was tested, MVC was tested at several levels of 
concentration (Figure 4.16). As expected, all viruses were blocked by C46. AMD 
restricted only two X4 viruses that showed low overall entry efficiency in Affinofile cells: 
the reference virus NL4-3 and clone 286. The remaining R5 and dubious clones were 
efficiently restricted by MVC (Figure 4.16, right panel) with R5 clones showing generally 
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higher entry efficiency and a weaker response to the drug at low concentrations as 
compared to dubious clones. 
Inspection of entry efficiency dependencies of different clones at the single cell level 
showed a strong relationship between the level of CCR5 expression and entry efficiency 
of all viruses blocked by MVC (Figure 4.17). 
 
Figure 4.17 Entry efficiency of clones 651 (upper panels) and 822 (bottom panels) in relation to CD4 and 
CCR5 expression without drugs (left panels) and in the presence of MVC at a concentration of 4nM 
(right panels). Both clones show a positive relation of CCR5 expression to entry efficiency and a 
strong drug response. 
The last experiment in this assay tested virus responses to combinations of MVC and 
AMD on different levels (Figure 4.18). As expected, based on the results of previous 
experiments, all except two viruses (NL4-3 and 286) showed a strong response uniquely 
to MVC.  
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Figure 4.18 Response of clones 286 (left), 651 (middle) and 822 (right) to combination of different 
concentrations of MVC and AMD. AMD concentrations are in ng/ml, MVC in nM. Plots are colored 
according to the clone phenotype (see section 4.4.3). 
Overall, these results indicate that only two of the tested viruses are purely X4. Clones 
selected as X4 viruses show overall low entry efficiency suggesting their dependence on 
the CXCR4 that is expressed only at low levels in Affinofile cells. Two of the X4 clones 
showed a decrease of the entry efficiency in the presence of CCR5 blocker suggesting 
their misclassification. R5 viruses showed high entry efficiency and a strong response to 
MVC. Dubious clones showed medium-level entry efficiency and a strong response to 
MVC already at low concentrations.  
These results indicate that two of the viruses selected as X4 (220 and 685) do not 
exclusively use CXCR4 but also show the capacity to bind to the CCR5 coreceptor. This 
binding might be less efficient in case of these viruses which is demonstrated by their 
overall low entry efficiency. Viruses selected as dubious show binding affinity to CCR5 
that is weaker than binding of R5 viruses and stronger than the binding of X4 viruses.  
Differences in the overall entry efficiency of different types of viruses can be explained 
by the insufficient CXCR4 expression in this cell line. The overall entry efficiency 
appeared to be a discriminatory feature between the R5 and X4 clones. Since the 
models were aimed to capture the dependence of virus entry efficiency on other 
parameters there should be no variance on the overall entry efficiency among the 
clones. In order to avoid this problem in the further experiments, virus input levels were 
adjusted for each clone to reach similar general entry efficiency in the flow cytometry 
assay. 
4.5.2 Flow cytometry 
The data measured using the flow cytometry assay was used to generate models of 
entry efficiency. In this assay two rounds of experiments were performed. In the first 
round the first set of 8 selected clones was tested (Table 4.1) on which initial models 
were developed. In the second round of experiments a new set of clones was tested that 
was used for model validation and assessment of their capacity to distinguish virus 
phenotypes. 
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Table 4.4 lists example experiments performed in this assay – from the initial and 
following rounds of experiments. In the first measurement of all clones (e.g. experiment 
100720) different levels of input virus are tested to establish the input levels of each 
clone that was maintained constant in the following experiments. Next, repeated 
measurements of virus response to different levels of individual drugs and drugs in 
combinations were performed. The SupT1-R5 cell line used in this assay does not offer 
the possibility to induce receptor and coreceptor expression. Models were therefore 
based on the natural variation of protein expression measured by antibody staining. 
experiment parameters varied 
parameter 
values 
cells per 
measurement 
100720 input virus 8 35 719  
100817 MVC 8 53 111 
100824 AMD 8 77 443 
100827 AMD 7 74 084 
100831 AMD 7 74 805 
100831 MVC 8 75 495 
100903 MVC 8 74 407 
100910 MVC, AMD 15 21 266 
101013 MVC, AMD 11 47 639 
101020 MVC, AMD 14 38 424 
101021 MVC, AMD 15 39 313 
101027 MVC, AMD 15 42 944 
Table 4.4 Example measurements performed using flow cytometry. “Experiment” and “cells per 
measurement” are defined in the previous section (Table 4.3). The column “parameter values” 
indicates the number of values or combinations of values of the parameters varied in the 
respective experiment. The upper part of the table (above the double line) contains the first set of 
experiments used for model development; the bottom part contains example experiments used 
for validation and evaluation of the modeling approach. 
In the 100720 experiment, different levels of input virus were tested (Figure 4.19). 30% 
was chosen as the optimal entry efficiency of a virus in the absence of drugs. This 
proportion of infected cells offers sufficient variation in the response variable for 
modeling while minimizing the probability of saturation by several virus particles infecting 
the same cell. The horizontal line in Figure 4.19 indicates the input virus levels chosen 
for each of the tested clones that were fixed in the following experiments.  
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Figure 4.19 Entry efficiency of tested clones depending on the virus input levels. Optimal entry efficiency 
was established at the level of 30%. Points of intersection of the horizontal line with the curves 
representing each clone define virus input levels selected for each clone for the further experiments. 
We analyzed the dependence of the entry efficiency of each clone on the measured 
parameters. First, we inspected the variation induced by different expression levels of 
the two coreceptors – CCR5 and CXCR4 in the absence of drugs. The relevant 
dependency plots (Figure 4.20) point to differences among the clones of R5 and X4 
viruses. Clone 286 selected as an X4 virus, showed a dependence uniquely on the 
expression level of CXCR4 (Figure 4.20, left panel). Clone 838 being an R5 virus 
showed a notable dependence on the expression level of CCR5 (Figure 4.20, middle 
panel), 685 selected as an X4 virus showed a strong dependence on the expression 
level of both coreceptors (Figure 4.20, right panel). 
In three experiments virus response to different levels of AMD was tested. Similar to the 
fluorescence microscopy results, only clone 286 and the NL4-3 reference virus showed 
response to this drug (Figure 4.21, left panel). 286 virus showed a weaker response to 
the drug than the reference virus with about ~5% infected cells at the highest drug 
concentration (1000 ng/ml). Clone 220 showed an unexpected increase in entry 
efficiency with higher drug concentration that was attributed to an unknown error in the 
assay.  
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Figure 4.20 Dependence of the entry efficiency of the clones 286, 838 and 685 on the expression levels of 
two coreceptors – CCR5 and CXCR4. Plots are based on the data illustrated in Figure 4.21 not 
containing drugs. Clone 286 (left panel) responding to AMD showed dependence on the expression 
level of CXCR4 for its cell entry efficiency, clone 838 (middle panel) blocked by MVC showed 
dependence on the expression level of CCR5, clone 685 (right panel) responding only to the 
combination of drugs showed dependence on the expression of both coreceptors. 
Three more experiments tested virus response to different concentrations of MVC. Here 
in addition to X4 viruses 286 and NL4-3, clone 685 showed no response to the drug 
(Figure 4.21, right panel). Noteworthy, this virus was not responsive to the AMD drug 
either, suggesting a dual-tropic nature of this virus – its capacity to alternate the use of 
two coreceptors. Other R5 and dubious viruses showed responses to MVC of similar 
strength. 
  
Figure 4.21 Effect of AMD (left panel) and MVC (right panel) on the average entry efficiency of the tested 
clones in the FACS assay. Curves show averaged entry efficiency of each clone based on three 
experiments testing AMD response and three experiments testing MVC. 
Next, several combinations of AMD and MVC drug concentrations were tested. In 
contrast to the microscopy assay where rows and columns of a plate are measured 
simultaneously, FACS measurements are done sequentially. While the microscope plate 
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provides a natural layout for testing combinations of two parameter values, FACS is a 
more time-consuming method. The number of combinations of drug concentration was 
therefore reduced from a full grid (30 measurements) to 15 measurements with a full 
range of MVC concentrations at a low (100 ng/ml) and a high (800 ng/ml) AMD 
concentration and four measurement of medium levels of concentrations of both drugs 
(Figure 4.22). 
 
Figure 4.22 Entry efficiency of three example clones in the presence of two drugs at different 
concentrations. Planes traced with dashed lines are fitted using linear regression and indicate the 
direction of the decrease of the entry efficiency with the increase of each drug concentration. Virus 
286 (left panel) shows response uniquely to AMD, 838 (middle panel) uniquely to MVC, 685 (right 
panel) to both drugs. 
This combination test showed that the blocking is independent of the concentration of a 
second drug for the clones responding to a specific drug individually. Viruses that 
responded to AMD (286, NL4-3) showed the same relationship between AMD 
concentration and entry efficiency also in the presence of MVC (Figure 4.22, left panel). 
All viruses blocked by MVC showed response uniquely to this drug in the presence of 
AMD (Figure 4.22, right panel). Clone 685 that did not respond to AMD or MVC in the 
previous tests, was efficiently blocked by drug combinations even at low concentrations 
(Figure 4.22, right panel). 
4.5.3 Observations 
Observations collected in the tests of the initial set of viruses directed the development 
of models of virus entry efficiency. Experiments showed the predominance of R5 viruses 
in this clone set. Only one of the selected clones (286) showed a purely X4 phenotype 
with strong CXCR4 dependency and response to AMD. Clones selected as R5 viruses 
showed CCR5 dependency and response to MVC. All clones selected as dubious (651, 
924) and one selected as X4 virus (220) showed a phenotype of an R5 virus however 
with a generally lower entry efficiency and a stronger response to MVC even at low drug 
concentrations. This points to a weaker binding affinity of these viruses to the CCR5 
coreceptor as compared to R5 viruses. The fact that these viruses were not clearly 
classified as R5 viruses suggests a potential error of phenotypic assays on viruses with 
low CCR5 binding affinity.  
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One of the tested clones (685) showed no response to an individual coreceptor blocker 
and dependence of the entry efficiency on both of the coreceptors. However, 
combination of coreceptor blockers even at low concentrations was efficiently blocking 
the virus. This indicates the dual-tropic nature of this virus demonstrated by its capacity 
to shift its coreceptor use in the presence of coreceptor blockers. 
Overall, the picture of virus phenotype emerging from the described experiments does 
not convey a clear distinction between X4 and R5 viruses. Viruses of the same tropism 
showed differences in general entry efficiency, strength of drug response and 
dependencies on coreceptor expression. This variety of profiles of virus entry efficiency 
calls for more elaborate models of virus phenotype extending beyond the mere tropism 
classification. 
4.6 Models 
Based on the above observations, we developed models of the dependence of the virus 
entry efficiency on the measured parameters. The models were aimed at distinguishing 
among the variety of virus phenotypes that are only partially captured by the tropism 
classification. They were based on the data generated by the flow cytometry assay, the 
initial set of viruses was used for training, remaining viruses for the validation and testing 
the models in their capacity to describe virus phenotypes. 
Models were developed based on multivariate regression and on several quality 
measures for selecting the best model. The measured parameters were used as input 
variables, the entry efficiency as the response variable. Models were first trained and 
tested on the NL4-3 (X4 model) and NL4-3 R5 (R5 model) reference virus data. Based 
on these data the best model was determined according to predefined model selection 
criteria. Next, the selected model was trained on the cell entry data of each of the clones 
separately. The vector of input variable coefficients of the trained model of each virus 
was used as a multidimensional descriptor of the virus phenotype. This descriptor 
expresses virus entry dependency on each of the measured parameters in the form of 
the magnitude and sign of the respective coefficient. Coefficient vectors were next 
compared with the coefficient vectors of the reference viruses (X4 and R5 models) and 
plotted on 2D phenotype maps that illustrate similarity of virus phenotypes to the 
reference R5 and X4 phenotypes. Finally, based on the limited number of tested clones 
we developed a procedure for predicting phenotype vectors based on sequence. Such 
model for predicting virus phenotype without experimental testing is the eventual goal of 
this study. Details of the successive steps of the modeling procedure are described in 
the following sections. 
4.6.1 Data preparation 
Classification methods described in the section 4.4.2 assign to each cell either a binary 
value (binary classification) or a value in the range [0,1] (margin classification) that 
estimates the probability of a cell being infected. To reduce the number of highly 
redundant data points and to compensate for the potential noise in the measurement at 
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the single cell level, the data was aggregated into a multidimensional grid defined on 
aggregated receptor and coreceptor parameter values – CD4, CCR5 and CXC4 and on 
all measured drug concentration levels. CD4, CCR5 and CXCR4 expression levels were 
first scaled to standard normal distribution, top and bottom 2.5% outliers were removed. 
Next a five-dimensional grid was defined – spanning over all tested concentration levels 
of AMD and MVC and over a predefined number of values of the CD4, CCR5 and 
CXCR4 expression levels dividing their range of expression into bins of equal size. We 
tested four numbers of bins – 5, 10, 20, 50 – for the quality of the resulting models. 
Classification values assigned to individual cells were averaged in each grid bin. 
4.6.2 Model selection criteria 
The best model was selected according to two criteria: accuracy of model fit to the data 
and separation of the X4 and R5 models.  
The first criterion – accuracy of model fit to the data – was based on R2 measure 
estimated as: 
, 
where 
 
is the sum of squared residuals with  being observed and  estimated output, and 
 
is the total sum of squares proportional to the sample variance with  being 
the sample mean. R2 was used as a measure of agreement between the observed and 
modeled values with higher values representing a better agreement. Models of cell entry 
efficiency were used as a description of a virus phenotype rather than for predicting the 
virus entry efficiency for a specific input. For this reason, model agreement with training 
data rather than its predictive power in a cross validation setting was used to evaluate 
the model. 
The second criterion – separation of the R5 and X4 models – was used in order to obtain 
models capable of distinguishing between the two contrasting phenotypes. To measure 
the separation of the R5 and X4 models we used two measures of similarity of 
coefficient vectors: Pearson correlation and Euclidian vector distance. The two 
measures are related, R5 and X4 models are chosen such as to show the lowest 
possible correlation and the highest distance from each other. Models were tested on 
the merged data of all experiments performed on the first set of viruses (Table 4.4). 
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Additionally, the significance of model variable coefficients was inspected. Models 
showing insignificant coefficients were reduced by removing the respective input 
variables and recalculated. We used the analysis of variance (ANOVA) method on 
nested models excluding each of the input variables separately. F-test was used to 
assess the significance of a coefficient in the not reduced model as compared to the 
respective nested model. 
4.6.3 Tested models 
There is a large number of possible models that can be defined on the basis of five 
parameters. Here, we limited the tested models to those varying in six different respects. 
The corresponding model properties and their possible variations are listed in Table 4.5, 
numbered from 1 to 6 and discussed below. 
 model property values tested  
1 aggregation level 5 / 10 / 20 / 50  
2 response variable binary / margin   
3 underrepresented grid cells  0 / 10 / 20  
4 drug concentration scale linear / logarithmic  
5 drug-coreceptor combination yes / no  
6 drug-drug combination yes / no  
Table 4.5 Varying elements of the tested models. 
The aggregation level (1) corresponds to the number of bins into which the coreceptor 
and receptor expression levels are separated to produce data grid, as explained in the 
data preparation section 4.6.1. The tested bin numbers are 5, 10, 20 and 50. The 
response variable (2) is based on the classification method – binary or margin. The 
“underrepresented grid cells” property (3) defines the filter cutoff for the parts of the data 
grid that contain numbers of single cell measurements below a given value. The basis 
for introducing this filter is the observation that the distribution of residuals of the models 
showed a tail of high residual values supposedly due to the high variance of entry 
efficiencies estimated from a low number of single cell measurements. Elimination of 
parts of the data grid with a low number of cells resulted in a normal distribution of 
residuals. “Drug concentration scale” (4) involves two scales of the drug concentration 
parameter – linear and logarithmic. As more measurements were done for low drug 
concentrations the logarithmic scale produced a more balanced coverage of the range of 
the MVC and AMD variables’ values, which might result in a better model fit. The 
properties “drug-coreceptor combination” (5) and “drug-drug combination” (6) describe 
models in which in addition to the individual effects of the coreceptor expression levels 
and drug concentrations on the response, their combined effect is also tested. These 
models include the effect of all combinations of values of a coreceptor expression level 
and the corresponding drug concentration i.e. combinations of MVC concentration with 
CCR5 expression and AMD concentration with CXCR4 expression, as well as of the 
combinations of values of the two drugs. The coefficient values of the combined input 
variables are more difficult to interpret, however, they might contribute to a better model 
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fit and R5-X4 models separation. The combination of the varied model properties 
resulted in 192 models tested, 48 for each aggregation level. 
Models including insignificant (p > 0.05) variable coefficients were reduced accordingly. 
Strong data aggregation resulted in a higher number of reduced models – among 
models based on data aggregated to 5 bins 64.6% were reduced, among those based 
on data aggregated to 50 bins 25.0% were reduced (Table 4.6). Notably only the 
coefficients of combined variables were insignificant, coefficients of coreceptor and 
receptor expression levels as well as drug concentrations were significant in all tested 
models. Table 4.6 lists the quality of models based on different levels of aggregation. It 
appears that aggregation 50 results in models of a markedly lower fit to the data (R2 ~ 
0.10 on average) as compared to stronger data aggregations 5, 10 and 20 (R2 ~ 0.47 on 
average). In the following analysis only models based on the aggregations 5, 10 and 20 
were considered. 
max R2 (mean) aggre-
gation 
reduced 
models [%] R5 model X4 model 
min R5-X4 
correlation 
(mean) 
max R5-X4 
distance 
(mean) 
5 64.6 0.726 (0.516) 0.622 (0.521) 0.161 (0.224) 1.715 (1.585) 
10 58.3 0.711 (0.467) 0.632 (0.474) 0.135 (0.222) 1.781 (1.594) 
20 33.3 0.676 (0.406) 0.615 (0.426) 0.045 (0.202) 1.943 (1.623) 
50 25.0 0.131 (0.102) 0.126 (0.108) 0.128 (0.200) 1.805 (1.636) 
Table 4.6 Quality of models based on different levels of data aggregation. “Reduced models” indicates the 
percentage of models that were reduced by removing of the the variables showing insignificant 
coefficients. Model quality is based on the model fit to the data (R2) and separation of the R5 and X4 
models (R5-X4 correlation and distance).  
Table 4.7 lists the quality of models grouped according to the five remaining model 
properties. Among them, filtering of the underrepresented data grid cells (3) showed the 
strongest pattern of increase in the model fit and R5-X4 model separation with the 
stringency of the filter. Filtering of the grid bins that contain below 20 data points resulted 
in mean R2 ~ 0.57 and mean R5-X4 model correlation ~0.18 as compared to the mean 
R2 ~ 0.30 and the mean R5-X4 model correlation ~0.26 of the models based on data 
where only grid bins containing below 5 data points were filtered. In the data aggregation 
to 5, 10 and 20 bins the filters removed <1%, 2-6.5% and 25-50% single cell 
measurements respectively. Also the logarithmic drug concentration scale (4) resulted in 
models of a higher fit to the data (mean R2 ~ 0.54) as compared to the linear scale 
(mean R2 ~ 0.39). Among the remaining model properties (2, 5, 6) a clear pattern of 
model fit and the R5-X4 model separation for models of various features was not 
observed.  
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max R2 (mean)    
R5 model X4 model 
min R5-X4 
correlation 
(mean) 
max R5-X4 
distance 
(mean) 
binary 0.716 (0.456) 
0.652 
(0.464) 
0.045 
(0.211) 
1.943 
(1.614) 2 response 
margin 0.726 (0.469) 
0.662 
(0.484) 
0.064 
(0.222) 
1.904 
(1.587) 
5 0.468 (0.281) 
0.491 
(0.320) 
0.211 
(0.259) 
1.655 
(1.519) 
10 0.690 (0.530) 
0.643 
(0.527) 
0.088 
(0.205) 
1.655 
(1.519) 3 
under-
represented 
grid cells  
20 0.726 (0.577) 
0.662 
(0.574) 
0.045 
(0.185) 
1.943 
(1.659) 
linear 0.480 (0.369) 
0.563 
(0.425) 
0.045 
(0.201) 
1.943 
(1.660) 4 
drug 
concent-
ration scale logarithmic 0.726 (0.557) 
0.662 
(0.523) 
0.131 
(0.231) 
1.737 
(1.541) 
no 0.722 (0.462) 
0.661 
(0.473) 
0.045 
(0.210) 
1.943 
(1.621) 5 
drug-
coreceptor 
combination yes 0.726 (0.463) 
0.662 
(0.475) 
0.135 
(0.223) 
1.781 
(1.580) 
no 0.723 (0.462) 
0.662 
(0.473) 
0.078 
(0.229) 
1.885 
(1.579) 6 drug-drug combination yes 0.726 (0.463) 
0.662 
(0.475) 
0.045 
(0.204) 
1.943 
(1.622) 
Table 4.7 Quality of models varying in the five model properties (2-6). Models are based on the data 
aggregation to 5, 10 and 20 segments and those not satisfying the parameter coefficient criterion are 
reduced accordingly. Maximum and mean model fit to the data (“R2”) and the best and mean 
separation of the R5 and X4 models (R5-X4 correlation and distance) are shown for models grouped 
according to each of the properties. 
Due to the lack of clear best model properties, we inspected the distribution of the model 
features among models of different fit to the data and R5-X4 model separation (Figure 
4.23). We selected two models for further inspection – one offering the best R5-X4 
model separation and another one showing a lower separation and a better model fit. 
The models are indicated with arrows in Figure 4.23 and differ in model property “drug 
concentration scale” (4) with the logarithmic scale showing a better model fit (R2 ~ 0.62 
vs 0.49) and linear scale a better model separation (R5-X4 model correlation of ~ 0.05 
vs 0.13). We termed these models logarithmic model and linear model respectively. 
Remaining properties are shared by both models and involve: 
1. aggregation level: 20 
2. response variable: binary method 
3. underrepresented data grid cells: 20 
5. drug-coreceptor combination: yes 
6. drug-coreceptor combination: yes 
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Figure 4.23 Fit of the R5 and X4 models vs their separation. Dots represent the tested models. Left hand 
side panels show R5 and right hand side X4 models. Color shades correspond to values of two 
properties of the models: underrepresented grid cells (3, upper panels) and drug-drug combination 
(6, bottom panels). Optimal model is the one offering low correlation and high fit to the data – models 
located in the bottom right corners of the plots. The property “underrepresented grid cells” (upper 
panels) shows a clear pattern of a better model fit with a higher filter value while the property “drug-
drug combination” (bottom panel) is more evenly distributed among models of different fit and 
separation. Selected models – logarithmic (better fit) and linear (better separation) – are indicated 
with arrows.  
Figure 4.24 shows the parameter coefficient estimation of the reference R5 and X4 
logarithmic (upper panels) and linear (bottom panels) models. Logarithmic and linear 
drug concentration scales result in different magnitudes of coefficients however the 
relative values of the coefficients are similar between the scales. R5 reference clone is 
characterized by inhibition by MVC and dependence on CCR5, which is reflected by 
negative MVC and positive CCR5 coefficients. Conversely, X4 reference clone is 
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characterized by inhibition by AMD and dependence on CXCR4, which is reflected by 
negative AMD and positive CXCR4 coefficients. This way, the coefficients represent a 
multivariate phenotype description of the V3 loop variants. 
   
Figure 4.24 Parameter coefficient estimation of R5 and X4 selected models with the logarithmic (upper 
panels) and linear (bottom panels) scales of drug concentration. Boxplots show parameter coefficient 
variation in a bootstrapping test of 100 times sampling of 75% data points and model estimation. 
4.6.4 Phenotype map 
Models selected in the previous step of this analysis were next trained on the entry 
efficiency measurements of each of the clones separately. This resulted in a parameter 
coefficient vector representation of each clone. The coefficient vector reflects the 
dependence of the entry efficiency of a virus on the measured parameters and is termed 
here phenotype vector. The phenotype vectors of the reference viruses – NL4-3 R5 and 
NL4-3 – represent reference R5 and X4 phenotypes respectively. Correlation and 
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distance between the phenotype vectors of tested clones and the two reference 
phenotypes were used as measures of clone similarity to both reference phenotypes. 
Each clone was next represented by two numbers expressing its similarity to the R5 and 
X4 phenotypes. This representation allows for visualizing clone phenotype on 
convenient 2D plots termed here phenotype maps. The linear model produced a 
stronger separation of the reference models, for convenience in the following part of this 
section phenotype maps based on the linear model are presented. 
 
Figure 4.25 Phenotype map of the first set of data based on correlation (left panel) and distance (right 
panel) with R5 and X4 reference models. Reference phenotypes are marked with colored dots, red 
for X4 and blue for R5 phenotype. Clones are represented by black dots and labeled. 
Figure 4.25 shows phenotype maps of the initial set of clones. Most of the clones 
showed a phenotype typical for R5 viruses which is reflected by their high correlation 
with and a small distance to the R5 reference virus. Only one clone in this dataset, clone 
286, showed X4 phenotype which is reflected by its position close to the X4 reference 
phenotype on the map. Clone 685 showed the phenotype of a dual-tropic virus, 
responding only to the coreceptor blockers in combination. This clone appears in 
between two phenotypes on the map closer however to the X4 phenotype.  
4.7 Prediction of phenotype vectors 
The analysis of the first set of clones showed the capacity of our experimental and 
computational pipeline of distinguishing between R5, X4 and dual-tropic viruses. Virus 
position on a phenotype map indicates its entry dependence on coreceptors and 
susceptibility to inhibition by each of the drugs. Phenotype maps can be therefore used 
for visual display of the boundary between clones sensitive and non-sensitive to MVC 
treatment. Since experimental testing of an individual clone is a costly process, 
circumventing the testing by prediction of the phenotype vector based on the V3 loop 
sequence is essential for the practical use of our method for patient treatment. In this 
section we present a prediction model of virus phenotype based on sequence. Only few 
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clones were phenotypically tested in this study so far, we therefore first address the 
problem of high dimensionality of the data with a low number of observations. Next, we 
estimate the number of clones necessary for obtaining satisfactory prediction accuracy. 
4.7.1 Populating of the phenotype map 
In order to gain insight into a potential separation of the phenotypes on the map, 
additional phenotype vectors of the clones tested in the following rounds of experiments 
were used to populate the phenotype map. The experimental measurements of the 
clones were subject to data processing pipeline described above. The selected models 
were next trained on the data of each clone and the resulting phenotype vectors were 
plotted on the phenotype map of the clones tested in the first round of experiments 
(Figure 4.26). 
 
Figure 4.26 Phenotype map of the first set of data (Figure 4.25) enriched with clones (orange) and lab-
adapted viruses (dark red) tested in the following rounds of experiments. Reference phenotypes are 
marked with larger red and blue dots. 
All the clones in the second dataset, except the lab-adapted clones, were selected as X4 
viruses. Based on visual inspection of the clone tested in our assay, four of the clones 
showed X4 (308, 315, 391 and 468), three R5 (376, 381 and 541) and two dual-tropic 
phenotype (252 and 631). The dual-tropic clones were not inhibited or only partially 
inhibited by individual drugs however showed a strong response to drugs in combination. 
Figure 4.27 illustrates the strength of the inhibition by MVC and AMD of the clones on 
the phenotype map. The dots on both panels are colored in a range of colors between 
red and blue. On the left plot blue dots represent clones susceptible to MVC, red – non-
susceptible. On the right panel red dots represent clones susceptible to AMD, blue – 
non-susceptible. Two groups of clones can be distinguished on the map, responsive to 
MVC and responsive to AMD (colored in different shades of blue and red respectively). 
Coloring of clones 685, 631 and 252 suggests either an attenuated response to both 
drugs (685 and 631) or no response to any of the drugs (252). These clones are also 
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positioned between the two groups of R5 and X4 viruses on the map, clones 252 and 
631 closer to R5 clones, clone 685 closer to X4 clones. This illustrates the way clone 
position on the map provides information on its susceptibility to drugs and where a 
potential boundary between phenotypes can be situated. 
 
Figure 4.27 Phenotype map based on distances to the reference models colored according to the MVC (left 
panel) and AMD (right panel) coefficients. On the left panel gradient of color between blue and red 
indicates MVC coefficient with low coefficient indicating susceptibility to MVC colored in blue. On the 
right panel gradient of color between red and blue indicates AMD coefficient with low coefficient 
indicating susceptibility to AMD colored in red. 
4.7.2 Phenotype prediction 
Given the essential information for patient treatment that can be derived from the 
phenotype map and the cost of phenotypic testing of an individual virus variant, a 
computational method for phenotype prediction based on V3 loop sequence is important 
for the practical use of our approach. Since the variability of V3 loop, and in particular of 
X4 strains, is high, clones tested within this part of the study might be insufficient for 
accurate prediction of the phenotype. To address this problem the predictive model 
developed here is based on shrinkage methods that allow for reducing the high number 
of dimensions of the sequence data compared to the low number of measured clones. 
Throughout this section the phenotype vectors estimated using linear model are used. 
The binary sequence encoding of the V3 loops of the 23 tested clones includes 88 
positions that show variation among the clones. Since the number of clones (23) is lower 
than the length of the sequence vector, the problem of phenotype prediction is 
underdetermined and cannot be solved by least square approach. Instead of classical 
regression we used two methods that involve regularization procedures: Ridge 
regression (Tychonoff 1943) and Lasso (Tibshirani 1996). These methods were trained 
on the binary sequence encoding of the clones with the respective phenotype vectors as 
the output variables. For each position of the phenotype vector the penalty parameter  
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resulting in minimal prediction error in leave-one-out cross validation (LOOCV) was 
chosen from a sequence of 100 values. The chosen s were used in further phenotype 
prediction.  
In addition to Ridge and Lasso, we tested the performance of linear regression based on 
a reduced number of input variables. The input variables were reduced to those showing 
significant (p < 0.01) pearson correlation with any of the output variables. Significance 
was calculated in 1000 permutation tests. The reduction procedure resulted in 26 and 17 
input variables in the logarithmic and linear models of phenotype vectors respectively. 
 
Figure 4.28 Error of the predicted phenotype vectors of three models – Ridge (left panel), Lasso (middle 
panel) and reduced linear model (right panel). Predictions are calculated in LOOCV setting, error is 
estimated as Euclidian distance between the predicted and observed phenotype vectors. Bar colors 
represent clone groups: black bars depict clones tested in the first, orange in the following rounds of 
experiments, dark red bars depict lab-adapted clones, blue and red bars depict R5 and red X4 
reference clones respectively. 
Figure 4.28 shows prediction errors of the three models on the tested clones. The 
reduced linear model showed the lowest accuracy, presumably due to the number of 
input variables exceeding the number of observations in this model. Among three 
prediction models similar relative prediction errors among clones were observed. Low 
prediction error was obtained for clones phylogenetically close to any other clones in this 
test set or being situated in uniform R5 clusters as pictured in Figure 4.2. Three clones 
showing a markedly elevated prediction error are clones 220, 651 and 308. Notably 
these clones were phenotyped and classified as X4 viruses however two of them, 220 
and 651, showed R5 phenotype in our assay. In sequence space these clones are 
located in a sparse cluster occupied by both R5 and X4 viruses (Figure 4.2) suggesting 
the sequences of these viruses represent boundary cases whose minor changes might 
result in tropism switch. These cases should be analyzed in detail for further 
characterization of the changes determining their tropism. A training set of clones 
covering the boundary parts of V3 sequence space is therefore critical for obtaining an 
accurate prediction method. Model based on Lasso shrinkage showed the highest 
accuracy in the linear and logarithmic models and was used in the following steps of this 
analysis. 
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In this study phenotype map is used for visualizing and approximating virus phenotype. 
Next, we inspected how a clone position on the phenotype map differs between the 
observed and predicted phenotype vectors. Figure 4.29 shows phenotype maps with 
three examples of predicted phenotypes indicated with arrows. Predicted phenotypes of 
the clones 838 and 685 show a relatively small change of position on the phenotype 
map, which does not result in the misclassification of virus tropism. The prediction error 
of clone 286 is higher – the location of the predicted phenotype on the map suggests it is 
dual-tropic contrary to the observed virus X4 phenotype. 
 
Figure 4.29 Position of predicted phenotypes of three clones 838, 685 and 286 on phenotype map. The 
arrows connect the positions of the observed with predicted phenotypes labeled with respective 
clone name and an asterisk. 
4.7.3 Improving phenotype prediction 
Finally, in order to test the feasibility of an accurate sequence-based phenotype 
prediction method, we approached the question of the relationship of the size of the 
training with the accuracy of prediction. In order to define an accurate prediction, we 
introduced the notion of borderline phenotype. A borderline phenotype is derived from 
the observed clone phenotype by reducing the coefficients characterizing given 
phenotype to zero. For an R5 virus these coefficients are CCR5 and MVC, for an X4 
virus CXCR4 and AMD, for a dual-tropic virus MVC and AMD. This way derived 
borderline phenotypes are located in the region between R5 and X4 viruses on the 
phenotype map (Figure 4.30) and represent the minimal change in a virus phenotype 
vector that leads to virus tropism misclassification. 
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Figure 4.30 Positions of borderline phenotypes on the phenotype map. Arrows connect the observed 
clones’ phenotypes with the respective borderline phenotypes. 
Next, we investigated the relationship between the size of the training set and the 
prediction accuracy. We devised a procedure of predicting each clone’s phenotype 
based on a sampled training set of an increasing size between 2 and 22. Training sets of 
each size were sampled multiple times; the prediction error of each clone was averaged 
for each size of the training set. A polynomial function  was next fitted to the 
relationship between the size of the training set and the prediction error. In Figure 4.31 
three examples of fitted functions are shown showing different gradients of the error 
decrease with the increasing train set size.  
Three of the tested clones – 220, 651 and 308 – showed an increasing error function 
with suggesting that an accurate prediction of their phenotype is not possible 
based on the current train set. Notably these three clones are located on a clade of the 
tree presented in Figure 4.2 occupied by both X4 and R5 viruses and showing relatively 
long branches. Virus 308 shows X4 phenotype, viruses 220 and 651 an R5 phenotype 
despite being classified as X4 viruses based on sequence. This indicates that there is a 
lack of clones of sufficient sequence similarity to the clones 220, 651 and 308 to obtain 
their accurate phenotype predictions. Shrinkage methods failed to select features 
predictive of the phenotype of these clones as they represent outliers in the sequence-
phenotype pairing. These cases were excluded from further error estimation it should be 
however considered that the averaged error and train set size might be underestimated 
due to the exclusion of these cases. 
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Figure 4.31 Fitted function of the prediction error against the size of training set for three example clones 
286 (left panel), 685 (middle panel) and 838 (right panel). Dots represent averaged prediction error 
obtained for sampled training sets of respective sizes. Black lines represent the fitted function plotted 
in the range (0, 75] of the train set sizes. 
The  parameter of the functions of the remaining clones was located in the range         
(-0.454, -0.059) with a mean of -0.244. The mean was similar for the R5 and X4 clones 
(-0.256 and -0.261, respectively) even though R5 clones showed a lower prediction error 
on average in the LOOCV setting, which suggests that with a representative train set 
covering large parts of sequence space an accurate prediction of the X4 phenotype is 
possible. 
The fitted functions were next used to approximate the prediction error of models 
constructed on training sets of sizes exceeding 23. Figure 4.32 shows averaged fitted 
functions of all (thick black line) of R5 (dashed blue line) and of X4 (dashed red line) 
clones plotted in the range (0, 1250]. As previously described, borderline phenotypes 
represent the minimal change in a virus phenotype vector that results in virus tropism 
misclassification. Vector distance between the observed and respective borderline 
phenotypes was therefore used to define a cutoff for prediction accuracy. We defined 
two cutoffs: the minimal error of clones with an X4 or R5 phenotype (R5/X4 cutoff) and 
the minimal error of dual-tropic clones (dual-tropic cutoff). Dual-tropic clones are situated 
between the R5 and X4 phenotypes on the map, the difference between their observed 
and borderline phenotypes is therefore small and represents a conservative criterion for 
prediction accuracy. R5 and X4 clones show greater differences with borderline 
phenotypes and the error margin allowing for their correct tropism prediction is larger. 
R5/X4 cutoff is therefore less stringent than the dual-tropic cutoff however might result in 
misprediction of the dual-tropic clones. R5/X4 and dual-tropic cutoffs are represented by 
dashed horizontal lines colored in black and magenta respectively in Figure 4.32. The 
averaged function reaches the R5/X4 cutoff at the train set size of 50 and the dual-tropic 
cutoff at the train set size of 360. The upper quantile of the fitted functions (black thin 
line) intersects the R5/X4 cutoff at the train set size 290. These results were obtained for 
linear models of the clone entry efficiency. Logarithmic models showed train set sizes of 
110 and 530 for R5/X4 and dual-tropic cutoffs respectively. These results indicate that in 
order to obtain satisfactory prediction accuracy on average a training set of ~100 clones 
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is required. However a reliable prediction of the X4 and dual-tropic phenotype can only 
be achieved by augmenting the training set to the size of ~400-500 clones. 
 
Figure 4.32 Estimation of the prediction error with an increasing number of clones. Thick black line 
represents the average of fitted functions of all tested clones, thin black lines their quantiles. Two 
vertical gray lines show the distance between the quantiles. Dashed red and blue lines represent the 
average of fitted functions to the X4 and R5 clones respectively. Dashed horizontal lines represent 
R5/X4 (black) and dual-tropic (magenta) cutoffs. Train set size of the averaged function at two cutoffs 
are pointed by arrows and indicated in the legend.  
As the last step of this study, we elaborated a quantitative description of the clones 
whose phenotype is difficult to predict based on current set of tested clones. The goal of 
this analysis was to characterize clones such as 220, 651 and 308 that show a lack of 
relation between the accuracy of their phenotype prediction and the size of the 
underlying train set which suggests that the sequences in the current train set provide 
insufficient information for the accurate phenotype prediction of these three clones. We 
based the analysis on two factors that might affect the accuracy of a clone phenotype 
prediction: presence of a genetically similar clone in the train set, and the position of the 
clone in V3 sequence space. Genetically similar clones in the train set might provide 
information on the sequence features that are determinant for the phenotype of a given 
clone. Location of a clone sequence in V3 sequence space reflects either its close 
affinity to sequences of a particular tropism or its location on the tropism boundaries in 
which case distinguishing sequence features proper to a specific phenotype is more 
difficult. 
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cluster clone closest clone (distance) 
distance to 
cluster center nb score R5s X4s 
838 
JRFL 
SF162 
BaL 
YU-2 
NL4-3 R5 
JRFL (0.19) 
838 (0.19) 
JRFL (0.25) 
JRFL (0.14) 
BaL (0.17) 
JRFL (0.13) 
0.44 
0.32 
0.40 
0.56 
0.84 
0.48 
1 0.95 96 1 
822 JRFL (0.19) 0.63 2 0.93 139 1 
924 NL4-3 R5 (0.22) 0.69 3 0.92 44 0 
631 685 (0.48) 0.80 4 0.63 11 1 
541 NL4-3 R5 (0.31) 0.14 5 -0.13 9 12 
220 
651 
376 (0.48) 
SF162 (0.54) 
0.53 
0.67 6 -0.10 7 9 
252 
315 
376 
381 
381 (0.18) 
376 (0.22) 
315 (0.22) 
252 (0.18) 
0.26 
0.91 
0.74 
0 
7 -0.36 1 5 
391 
468 
685 
685 (0.42) 
631 (0.59) 
391 (0.42) 
0.51 
0.81 
0 
8 -0.17 4 6 
308 BaL (0.47) 1.00 9 0.79 12 1 
HxB2 
NL4-3 
NL4-3 (0.14) 
HxB2 (0.14) 
0 
1.00 10 -1.00 0 2 
286 685 (0.47) 0 11 -0.75 0 3 
Table 4.8 Characterization of clones in V3 loop sequence space. Clones are grouped according to the 
cluster they belong to as described in section 4.2 of this chapter. Closest clone among the tested 
clones is indicated in column “closest clone” with the distance normalized to [0,1] in the V3 sequence 
dataset. Distance to the cluster center and cluster score are measured as described in the text 
above. Cluster number, amounts of R5 and X4 sequences are indicated in respective columns. 
Table 4.8 lists characteristics of the sequences of the tested clones. Clones are grouped 
according to the cluster they belong to as described in the clustering procedure in 
section 4.2 of this chapter. Column “closest clone” indicates the genetically closest clone 
among the tested clones and its distance normalized to [0,1] interval among all distances 
in V3 sequence space. Following columns depict the clusters that the clones belong to 
and the clone position in the clusters. Column “distance to cluster center” lists the 
distances of clone sequences to the respective cluster center relative to the cluster 
radius. Cluster center is defined here as the sequence of a minimal mean distance to 
other sequences within the cluster. Cluster radius is defined as the maximal distance of 
a cluster sequence to the cluster center. Distance 0 in the column “distance to cluster 
center” indicates cluster center, distance 1 indicates the most distant sequence of a 
cluster, lying on the cluster boundary. To depict the composition of a cluster we 
introduced cluster score as:  
, 
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where 
€ 
r5i,x4 i,r5x4 iare the numbers of R5, X4 and dual-tropic sequences respectively 
in cluster 
€ 
i . Cluster score close to 0 is characteristic of mixed and dual-tropic clusters, 
close to -1 of predominantly X4 clusters, close to 1 of predominantly R5 clusters. 
Clusters 1-4, 7, 9-11 represent relatively uniform X4 or R5 clusters as reflected by the 
value of the cluster score clearly distinct from 0. It can be assumed that sequence space 
location of the clones that pertain to these clusters provides information for their 
phenotype prediction. Clone 308 belonging to cluster 9 represents the most distant 
sequence from the cluster center lying on the cluster boundaries (distance = 1). This 
cluster is predominantly R5, however the closest neighbor of 308 in this cluster is the 
only X4 sequence in this cluster suggesting the boundary location of this clone (Figure 
4.33, middle panel). In cluster 10, clone HxB2 is also located on the cluster boundaries, 
however, unlike clone 308, this clone is closely related to another clone in this cluster 
(NL4-3) that provides information for its phenotype prediction. 
Among the remaining clusters, cluster 6 shows the score closest to 0 (score = -0.1) 
among the analyzed cluster, suggesting its mixed composition. This cluster is also 
sparse as reflected by long branches of the respective tree (Figure 4.33, left panel). Two 
clones contained in this cluster – 220 and 651 – are in addition relatively distant from 
other clones (distance >= 0.48) which underlies the difficulty of their phenotype 
prediction. Clone 541 belongs to another mixed cluster 5. However this clone is closely 
located to clone NL4-3 R5 in sequence space which provides information for its 
phenotype prediction. Similarly, clones contained in cluster 8 that is also relatively mixed 
(score = -0.17) are each other’s closest neighbors among the tested clones which might 
contribute to the accurate prediction of their phenotypes. 
 
Figure 4.33 Dendrograms of three example clusters from the clustering described in section 4.2 of this 
chapter. Cluster 6 (left panel) is a mixed and sparse cluster as reflected by the equal proportion of R5 
and X4 sequences and long tree branches. Cluster 9 (middle panel) is a uniform R5 cluster with 
clone 308 located on its boundaries. Prediction error of the clones 220, 651 and 308 does not 
improve with the increasing size of the train set in this study. Cluster 7 (right panel) is predominantly 
X4 and contains four closely related clones from the train set. Phenotypes of the clones in this cluster 
are predicted more accurately with the increasing size of the train set.  
Overall, this analysis shows that sequence location on a tropism boundary (clone 308) or 
a location in a mixed cluster with no close neighbors among the tested clones (clones 
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220, 651) contribute to the difficulties in the phenotype prediction. With more sequences 
tested that would populate a larger number of clusters, a systematic approach to 
establishing a confidence score for the phenotype prediction will be possible. Based on 
the current clone set two rules for recognizing clones of high prediction error can be 
derived: 
- sequences located on the boundaries of clusters not containing other clones 
from the train set, or 
- sequences belonging to mixed clusters (absolute cluter score < 0.15) and far 
from other tested clones (distance > 0.45). 
These two rules characterize clones 308, 220 and 651 in our dataset and 68 out of 880 
sequences in the V3 sequence dataset used for this analysis. Testing of these 
sequences is of high interest for further development of the proposed approach.  
4.8 Discussion 
The difficulty of predicting MVC therapy outcome (Trkola, Kuhmann et al. 2002; Westby, 
Lewis et al. 2006; Westby, Smith-Burchnell et al. 2007), the flexibility of the virus to use 
other receptors (Turville, Cameron et al. 2002) and high variability of V3 loop suggest 
that the virus cell entry phenotype is more complex than the CCR5/CXCR4 coreceptor 
tropism. The study presented in this chapter is an attempt to address the shortcomings 
of sequence-based HIV tropism classification, the need of more accurate recognition of 
X4 viruses and better virus characterization for the effective use of coreceptor blockers. 
The study is based on high-throughput data on the single cell level. The analysis on the 
single cell level affords higher accuracy as compared to the approach based on 
averaged measurements of entire cell populations and provides additional cellular 
information used for the construction of the expanded picture of virus phenotype. Novel 
methods were developed for data analysis, visualization and modeling of virus cell entry 
phenotypes. The major result is the virus phenotype representation in the form of a 
multivariate phenotype vector expressing the determinants of virus cell entry efficiency. 
The multivariate phenotype vector and its position on the phenotype map provide a 
comprehensive picture of virus phenotype reaching beyond tropism classification and 
distinguishing among a spectrum of virus phenotypes. Tests of predicting phenotype 
vector based on sequence show that with an enhanced dataset of experimentally tested 
clones this approach affords practical application in predicting virus response to 
coreceptor blockers. A method of predicting virus phenotype vector from V3 sequence is 
of high interest for effective patient treatment as viruses of similar locations on the 
phenotype map represent also potentially similar treatment targets. 
Among the tested clones we found scarcity of strictly X4 viruses. Clones selected as 
dubious showed an R5 phenotype, several clones selected as X4 viruses showed R5 or 
dual-tropic characteristics. A potential explanation for this observation is the fitness cost 
coming with maintaining of the X4 phenotype and its high sequence diversity. It is 
therefore likely that in the evolutionary process in which the X4 viruses emerge from R5 
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viruses, the capacity of using CCR5 is often not entirely lost. The exclusive use of CCR5 
is more common among the tested clones, majority of the R5 clones show also relatively 
high sequence conservation. This suggests the existence of a conserved part of the 
phenotype map occupied by R5 viruses that are uniform in sequence and show fitness 
advantage over highly variable X4 viruses occupying other parts of the map. 
The presented approach of phenotype inference based on sequence suggests that with 
more data points on the phenotype map a systematic method of clone phenotype 
prediction based on sequence can be developed. Approach presented in this chapter is 
based on shrinkage methods that allow for reducing the data dimensionality with a 
limited number of observations. With a larger training set, more accurate and customized 
models can be developed, for example targeted at characterization of dual-topic viruses 
representing the boundary between X4 and R5 phenotypes. Detailed description of 
boundary phenotypes would allow for delineation of viruses susceptible to either CCR5 
or CXCR4 blockers and would be therefore of high interest for effective patient treatment 
with entry inhibitors. 
4.9 Conclusions 
The study presented in this chapter analyzes virus V3 loop interaction with a host 
coreceptor on a single cell level. The experimental and computational pipeline 
developed for this analysis is laborious however results in an insightful view of the virus 
phenotype involving several determinants of virus cell entry and expanding beyond the 
binary coreceptor tropism classification.  
As opposed to high-throughput data based on recently developed deep sequencing 
technology, here we examine data obtained from a long-time established technology but 
the study relies on novel methods of information classification, visualization and 
analysis. The advantage of the single cell data over sequence data is the insight it offers 
into the host molecular and environmental parameters conditioning virus cell entry in 
addition to the virus sequence variability. This kind of data allows for construction of a 
comprehensive picture of the virus phenotype describing virus cell entry dependence on 
the expression of cell surface proteins and on the presence of blocking them molecules. 
The cost of testing of a single virus variant presents a limitation to the developed 
approach. Given the variability of V3 loop a complete phenotype map of virus variants is 
hard to obtain, nevertheless, with an increased number of tested clones and the 
knowledge on the possible phenotypes and their relation to the sequence, a more 
targeted selection of viruses for testing can be employed that might result in a 
representative phenotype map without the need of analyzing a large set of clones. Such 
selection should aim at covering different clades of the V3 phylogenetic tree (Figure 4.2), 
obtaining a large variability of X4 clones and obtaining clones from sequence cluster 
boundaries as described in the last part of this study. 
Similar to the sequence space analysis presented in the previous chapter, this study of 
cell entry efficiency points to the predominant proportion of R5 virus phenotypes – 
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several viruses predicted as X4 showed R5 or dual-tropic characteristics in our assay, 
while the opposite situation was never observed. This suggests a fitness advantage of 
the R5 phenotype over other types of viruses which results in higher preservation of this 
phenotype. When a yet unknown mechanism triggers change of a virus coreceptor 
tropism from the CCR5 usage it evolves into highly variable variants in the process 
involving certain fitness loss. The fact that only few of the tested clones showed a purely 
X4 phenotype suggests that due to the fitness advantage of using the CCR5 coreceptor 
the capacity of using this coreceptor is rarely completely lost in the evolutionary process 
of the coreceptor switch. This way the analysis of virus phenotypes on the single cell 
level complements the sequence study on the level of virus population. Phenotypic 
testing of additional virus variants characterized by sequence space location should 
further expand our knowledge on the potential relationship between sequence and 
phenotype. 
This study represents a step towards building virtual phenotype – a computational model 
of virus biology incorporating comprehensive biological information. Virtual phenotype of 
the virus cell entry described in this chapter contributes to our understanding of virus 
tropism and to predicting of a variety of virus phenotypes reaching beyond binary 
tropism classification. Given the limitations of sequence-based methods of virus tropism 
classification, expanding models with other than sequence molecular information 
represents a potentially promising avenue for improving our understanding of the 
phenotype and its prediction. 
The studies presented in this chapter and chapter 3 analyze a specific host-virus 
interaction on a population and single-cell levels. In spite of the high relevance of the 
interaction between the V3 loop and host coreceptors for the disease development and 
of its importance in the MVC patient treatment, this interaction represents a limited 
fraction of the highly complex host-virus interaction network. The short genome of 
retroviruses encodes only a small number of essential proteins, the virus relies strongly 
on the host molecular machinery for its successful replication and spread. Throughout its 
lifecycle HIV is involved in a multitude of molecular interactions with the host, certain of 
which are a part of the virus replication process, others involve host immune recognition 
that might counteract the infection. The molecular host-virus interactions present 
therefore evolutionary constrains and pressures on the virus that shape its genetic 
constitution, lifecycle and infection strategies. Knowledge of other host-virus interactions 
beyond the ones presented in the previous chapters is therefore crucial for better 
understanding of the virus biology, its mechanisms of infection and pathogenicity.
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In the previous chapter we presented a study of a specific host-virus interaction that 
comprised host, virus and environmental parameters. This thorough analysis of a 
specific interaction produced a detailed picture of virus phenotype that is of high interest 
for the application of therapies based on entry inhibitors. The current success of MVC-
based treatment creates a good prognosis for a new generation of HIV treatment that 
instead of virus proteins would be targeted at host factors involved in crucial interactions 
for the HIV life cycle. Such type of treatment that efficiently blocks crucial host factors 
might prove more efficient and long-term effective since it would require the virus to 
evolve a new biological function instead of simply mutating the drug binding site.  
HIV is involved in a multitude of molecular interactions with different host proteins 
throughout its life cycle. Starting from binding to the host receptors through replication to 
budding, the virus subjugates and exploits host cellular machinery in order to propagate. 
Knowledge of the mechanisms of all HIV-host interactions is of great not only scientific 
but also therapeutical interest. In this chapter we present a study of host-virus 
interactions on the broadest, genomic scale. We perform a comparative genomics 
analysis of all reported HIV-host interactions and point to individual ones that are 
potentially interesting for further study. We additionally correlate the amounts of genetic 
change between the interacting host and virus genes and point to the parts of host-
pathogen biology that undergo accelerated evolution as opposed to those that are 
relatively conserved. The results of this study are published in: Bozek, K., Lengauer, T. 
Positive selection of HIV host factors and the evolution of lentivirus genes. BMC Evol 
Biol. 2010 Jun 18;10:186. 
5.1 Background 
Phylogenetic studies have shown that HIV emerged in humans through at least eleven 
cross-species transmission events of simian immunodeficiency virus (SIV) from non-
human African primates. Three transmissions of chimpanzee SIV (SIVcpz) from the 
central African chimpanzee subspecies (Pan troglodytes troglodytes) gave rise to the 
HIV-1 groups M, N and O (Gao, Bailes et al. 1999), with the group M causing the AIDS 
pandemic. Other transmissions of sooty mangabey (Cercocebus torquatus atys) SIV 
(SIVsmm) gave rise to HIV-2 groups A-H (Hirsch, Olmsted et al. 1989 ; Gao, Yue et al. 
1992) (Figure 5.1). 
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Figure 5.1 Phylogenetic tree of different SIV and HIV lineages based on neighbor joining analysis of partial 
pol sequences. The scale bar indicates 0.1 substitutions per site, asterisks indicate bootstrap support 
of >85%. The positions of different HIV-1 and HIV-2 lineages (marked in bold) interspersed with the 
SIVcpz/SIVgor and SIVsmm lineages respectively, indicate the origins of the human viruses. From 
(Van Heuverswyn and Peeters 2007). 
SIV infection of African non-human primate host species (including sooty mangabeys, 
African green monkeys, mandrills, and several others) is non-pathogenic despite high 
levels of viremia (Silvestri 2005; Silvestri, Paiardini et al. 2007; Pandrea, Sodora et al. 
2008). Different levels of pathogenicity of immunodeficiency viruses in their host species 
(Pandrea, Sodora et al. 2008; Keele, Jones et al. 2009) as well as the lack of adaptation 
to their non-natural species (Bogerd, Doehle et al. 2004; Jia, Serra-Moreno et al. 2009) 
show how interspecies differences can impact viral infectivity and drive adaptation. Host 
genetic differences between individuals also affect the dynamics of disease progression 
(Heeney, Dalgleish et al. 2006; Fellay, Ge et al. 2009). There is a growing list of genes 
and alleles for which there is evidence of a positive or negative effect on infection and 
disease progression. Among them, several host factors block or restrict retroviral 
infections in primates (see chapter 2): TRIM5α (Stremlau, Owens et al. 2004); 
APOBEC3G (Sheehy, Gaddis et al. 2002) and tetherin (BST-2, CD317) (Neil, Zang et al. 
2008). These restriction factors constitute defense mechanisms of the host acting in a 
species-specific manner (Bogerd, Doehle et al. 2004; Jia, Serra-Moreno et al. 2009) 
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blocking the viruses from replication in their non-natural host species and thus being 
potential agents of anti-HIV defense. 
A feature of pathogenic HIV-1 infection that distinguishes it from non-pathogenic SIV 
infections is the high level of chronic immune activation associated with accelerated T 
cell turnover rates and apoptosis (Silvestri 2005). The basis for this difference in 
pathogenicity is not understood, however deciphering which viral and host factors are 
responsible for the nonpathogenic course of natural SIV infections could prove useful in 
developing more effective treatments and prevention strategies for AIDS. 
Positive selection, demonstrated in part by the rapidly evolving immune system genes 
(Endo, Ikeo et al. 1996), reflects the evolution of the host defense against various 
infections. Several HIV restriction factors have been shown to be under positive 
selection throughout primate evolution (Sawyer, Emerman et al. 2004; Zhang and Webb 
2004; Sawyer, Wu et al. 2005; McNatt, Zang et al. 2009). Due to the relatively long 
generation times of primate species with slow rate of genetic evolution in contrast to the 
short generation times of viruses with high rates of genetic evolution and the potentially 
recent introduction of SIV into primates (Wertheim and Worobey 2009), the impact of the 
selection pressures solely from SIV on the host species is likely to be negligible. 
However, genetic polymorphisms in genes interacting with the virus can influence traits 
relevant for the susceptibility to lentiviral infection and point to a potential role of a gene 
in infection and its contribution to disease. Comparative genomics can offer insights into 
disease mechanisms by correlating molecular differences that arose during primate 
evolution with the variation in disease susceptibility. 
There is ample scientific knowledge on HIV-1 human protein interactions. The HIV-1 
Human Protein Interaction Database is a catalogue of over 1400 human proteins that 
participate in approximately 3000 unique HIV-1-to-human protein interactions reported in 
peer reviewed scientific literature (Fu, Sanders-Beer et al. 2009). The size and scope of 
this database allows for large-scale analyses of HIV-host molecular interactions. 
Together with several fully sequenced primate genomes it allows for a systematic search 
for host factors under positive selection that might be relevant for infection and merit 
further investigation. Previous studies of positive selection in the HIV host factors 
focused on individual examples (Sawyer, Emerman et al. 2004; Zhang and Webb 2004; 
Sawyer, Wu et al. 2005; McNatt, Zang et al. 2009), as well as on a set of 140 proteins 
compiled from the literature (Ortiz, Guex et al. 2009). Here we analyze all 1439 genes 
available in the HIV-1 Human Protein Interaction Database. 
In this study we explore genetic differences of HIV-interacting genes among primates. 
We perform a comparative genomics analysis of the HIV-interacting proteins in search of 
positively selected genes in four different primate species. The positively selected genes 
are next characterized by their biological function, role in the protein-protein interaction 
networks and interactions with the virus. We also analyze the relationship between the 
strength of positive selection in the host proteins with the evolutionary rates of the 
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interacting proteins of five immunodeficiency viruses in search of patterns in the 
evolution of host-pathogen interactions. 
5.2 Primate sequence analysis 
In the first part of this study we analyzed HIV-interacting host genes. We extracted and 
aligned sequences of all genes reported to interact with the virus from four primate 
species genomes. Positive selection in the sequences of the four primates and human 
genes separately is next estimated. Genes under positive selection were next analyzed 
in terms of their interactions with the virus, functionality and role in the protein-protein 
interaction network. 
5.2.1 Sequences 
From the University of California, Santa Cruz (UCSC) Genome Browser Database 
(GBD) (Karolchik, Kuhn et al. 2008) we extracted the gene sequences of human proteins 
reported in the HIV-1 Human Interaction Database (Fu, Sanders-Beer et al. 2009) to 
interact with HIV-1 as well as of the respective homologs in three non-human primate 
species: chimpanzee (Pan troglodytes), orangutan (Pongo pygmaeus abelii) and rhesus 
macaque (Macaca mulatta). We used all available primate species for which genome 
sequences were publicly available and at least partially annotated. Homologous 
sequences were aligned using Threaded Blockset Aligner (TBA) (Blanchette, Kent et al. 
2004) with the human sequence as the reference and trimmed to their coding parts 
based on the human gene annotation. We excluded sequences of genes not identified in 
the human genome or in more than one non-human primate species. We also excluded 
sequences composed of > 50% gaps as compared to the human sequence. This filter 
helped to ensure that the results of the analysis are not influenced by the lack of proper 
homolog identification. The information on the alignment quality is provided in Table 5.1. 
Of the 1439 human proteins and 3643 unique interactions in the interaction database, 
1182 proteins involved in 2596 unique interactions fulfilled these alignment criteria. 
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 all chimp orangutan macaque 
removed gene 
sequences [%] 18.1 7.8 14.8 14.2 
mean gap ratio 0.0183 0.0234 0.0241 0.0284 
sliding window 
score - gap ratio 
correlation 
0.0101(0.293) 0.0021(0.473) -0.0196(0.829) 0.0292(0.07) 
site-based score 
- gap ratio 
correlation 
-0.0977(0.962) -0.1123(0.984) -0.1402(0.999) 0.0107(0.406) 
Table 5.1 Alignment quality and independence of the positive selection score from the number of gaps in a 
sequence. Genes with no sequence found in the human genome were excluded from the analysis as 
were genes with more than one unidentified homolog among the three non-human primate species. 
Alignment of homologous sequences containing more than 50% gaps as compared to the human 
gene sequence were also excluded from the tests for positive selection. The first row of the table lists 
the percentage of the sequences excluded according to these criteria. The second row shows the 
quality of the alignment of the remaining sequences in terms of the mean ratio of the number of gaps 
over the length of a gene sequence. The last two rows show the correlation between the quality of 
alignment and the result of the positive selection tests. It appears that high scores of positive 
selection are not correlated with poor sequence alignment. P-values are given in parentheses. 
5.2.2 Positive selection in primate species  
Next, we performed the search of the host factors under positive selection among the 
1439 host factors reported in the HIV-1-Human Protein Interaction Database. We used 
Bayes Empirical Bayes (BEB) approach for inference of amino acids under positive 
selection (Yang, Wong et al. 2005) implemented in the PAML package (Yang 2007). 
This approach uses a statistical distribution to describe the variation of the dN/dS ratio 
(non-synonymous to synonymous nucleotide substitution ratio) among sites and a 
likelihood ratio test (LRT) to compare two distributions: a distribution that allows a subset 
of sites to have dN/dS  > 1 and a null model that does not. If the result of the LRT is 
statistically significant then one can infer a gene to be under positive selection. An 
empirical Bayes test is then used to calculate the probability that a site belongs to the 
class of sites whose dN/dS ratio is larger than 1. We applied two LRTs implemented in 
the PAML package: M1a (NearlyNeutral) to M2a (PositiveSelection) comparison and M7 
(beta) to M8 (beta&ω) comparison retaining the results of the higher LRT. The first LRT 
compares the NearlyNeutral null model which assumes two site classes one with 0 < 
dN/dS < 1 and one with dN/dS = 1 to the alternative model PositiveSelection which adds 
a site class of dN/dS > 1. The second LRT compares the beta null model which assumes 
a beta distribution for dN/dS in the interval (0,1) to the alternative model beta&ω which 
adds a site class with dN/dS > 1. In order to assess the amount of positive selection in 
the HIV-interacting genes and to rank the genes accordingly, we established a site-
based score. This score is based on the weighted sum of sites with dN/dS > 1 
normalized by the sequence length. The sites are weighted according to the calculated 
probability P of a site being under positive selection: by a factor of 3 for the sites with P > 
0.99, a factor of 2 for the sites with P > 0.95, other sites by a factor of 1. 
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In order to assess the robustness of, and provide additional support for, the site-based 
score we compared it with a sliding window score. The sliding window score was based 
on the dN/dS ratio averaged over each sliding window across the protein gene 
sequence. We used the method of estimating the dN/dS substitution rates of entire 
sequences by Yang and Nielsen (Yang and Nielsen 2000) also from the PAML package 
(Yang 2007). The calculation of the dN/dS ratio was done in windows of 150 base-pair 
length (50 amino acids) slid along the sequence by a step of 30 base-pairs (10 amino 
acids). This test facilitates the localization of regions with a high dN/dS ratio in gene 
sequences rather than specific sites returned by the BEB approach. 
While there are potential false positives associated with the LRT some genes might be 
missed by the sliding window approach due to a small number of positively selected 
sites. We considered the LRT approach to be more relevant for long and highly 
conserved primate sequences and therefore used the more stringent LRT significance 
as the indicator of positive selection, the sliding window measure was used as a 
supporting score. We used both tests to search for positive selection in all four primate 
species and subsequently in the human and chimpanzee gene sequences separately.  
The site-based search for genes under positive selection returned 152 genes having 
sites under positive selection among all four primate species and in 97 genes having 
sites under positive selection in the human-chimp comparison with an overlap of 49 
genes. The genes were next ranked according to their site-based and sliding window 
scores. The ranks of genes obtained with the sliding window score correlate with the 
site-based score ranks with a correlation coefficient of 0.65 in all species and 0.52 in the 
human-chimp comparison (p < 0.01). This positive correlation of ranks obtained with two 
different methods, together with the high scores assigned to proteins reported to be 
under positive selection in other studies (APOBEC3G (Sawyer, Emerman et al. 2004; 
Zhang and Webb 2004), TRIM5α (Sawyer, Wu et al. 2005) – Figure 5.2, left panel) 
suggests that the ranks used in further analyses are robust with respect to the scoring 
method. 
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Figure 5.2 Distribution of the site-based score in the genes of four primate species. Left panel shows the 
distribution of all gene scores. Positions of important host factors are indicated. Colors indicate the 
functional group to which the factors belong: blue - membrane-related proteins, red – innate immune 
response proteins, magenta – both, black – none of the groups. Right panel shows median values of 
site-based scores in the interaction grouping. Shown are groups of the size > 2% of all interactions. 
Bar colors indicate the percentage of the genes under positive selection in each group as inferred by 
LRT (listed in Table 5.2). CA protein (not shown on the figure) has less that 1% interactions reported 
in the dataset showing a high median of 1.3. 
The recently identified host restriction factor tetherin (BST-2, CD317) (Neil, Zang et al. 
2008) was not included in the HIV-1 Human Interaction Database. We separately 
extracted, aligned and performed the positive selection tests on the tetherin sequences 
of the four primate species. Even though positive selection in the primate tetherins has 
been reported before (McNatt, Zang et al. 2009), the site-based approach did not result 
in significant LRT. However the sliding window test showed this protein to be under 
positive selection with a rank of 62 among the full list of 1182 genes (APOBEC3G rank 
6, TRIM5α - 38). 
In order to inspect the distribution of positive selection scores in subsets of the HIV-
interacting genes we established an interaction grouping based on with which viral 
protein the host proteins interact. The interaction grouping showed variation in the 
distributions of site-based scores as well as in the ratio of positively selected host 
proteins among groups (Figure 5.2, right panel). Permutation tests revealed a 
significantly lower mean of the ranks based on site-based scores of host genes 
interacting with gag protein and a comparatively higher mean for integrase (IN), protease 
(PR), vpr and rev proteins (Table 5.2). The ranks based on sliding window scores were 
additionally significantly lower for the Env-, gp120-, gp41- and CA-interacting genes and 
higher for Vif- matrix (MA)- and nucleocapsid (NC)-interacting genes. The site-based 
ranking was limited to the 152 genes under positive selection. The discrepancies of the 
significance of mean ranks of gene groups between the two scorings were due to the 
differing numbers of genes included in both rankings. The mean group ranks in both 
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scorings are positively correlated with r = 0.52 (p ≈ 0.07). If only the 152 genes under 
positive selection are considered the correlation increases substantially to r = 0.92 (p < 
0.05). 
virus 
gene rank 
interacting 
genes 
% genes under 
pos. sel. 
mean site-
based rank 
mean sliding 
window rank 
gp120 1 434 12.9 70.11 489.1 
Vpu 2 22 18.2 45.75 529.2 
Env 3 145 15.9 69.52 505.7 
p6 4 12 16.7 40.50 692.8 
Rev 5 59 6.8 113.75 770.1 
gp41 6 123 16.3 66.40 496.3 
Nef 7 168 12.5 67.14 534.4 
Gag 8 45 13.3 17.00 625.0 
Vif 9 55 16.4 54.56 670.1 
Tat 10 636 11.0 80.81 616.0 
MA 11 69 7.2 84.00 754.0 
NC 12 19 15.8 64.67 772.0 
Vpr 13 152 11.2 100.06 624.4 
RT 14 33 9.1 93.67 631.6 
Pol 15 1 100.0 30.00 96.0 
CA 16 21 28.6 37.00 379.2 
PR 17 71 21.1 109.47 639.8 
IN 18 66 7.6 112.60 738.9 
Table 5.2 Ranking of viral proteins and characterization of interacting host genes. Positively selected host 
genes are inferred from the significance of the LRT. Colors indicate significantly high (red) and low 
(blue) mean ranks or ratios of interacting genes under positive selection. 
5.2.3 Positive selection in humans  
In order to additionally estimate positive selection that acted along the more recent 
timescale after the primate interspecies split we searched for single nucleotide 
polymorphisms (SNPs) in the human gene sequences. We used the haplotype map 
HapMap Phase II (Sabeti, Varilly et al. 2007) to search for the SNPs located in the gene 
regions (both introns and exons) of the analyzed HIV-interacting human proteins (Fu, 
Sanders-Beer et al. 2009). We then used the integrated haplotype score (iHS) 
introduced by Voight et al. (Voight, Kudaravalli et al. 2006) to identify those SNPs that 
might have emerged as a result of positive selection. The iHS score is based on the idea 
that a favored allele increases its frequency in a population fast and therefore tends to 
be located in unusually long haplotypes of low diversity in contrast to the more variable 
haplotypes of the unselected background. Therefore the decay of identity of a haplotype 
as a function of distance from a given allele reflects the strength of positive selection 
acting on the allele. High levels of haplotype homozygocity extending much farther than 
expected under neutral model are an evidence for selection acting at or near the SNPs 
in the allele. The cutoff of |iHS| ≥ 2 was used to choose SNPs under positive selection.  
Out of 1335 SNPs in the analyzed genes 88 showed |iHS| ≥ 2, slightly more (6.6%) than 
expected from the standard normal distribution of the iHS. For each gene we calculated 
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the number of positively selected SNPs, and used their presence as evidence of positive 
selection acting on a gene in the human lineage. We found 61 genes containing 
positively selected SNPs with a maximum number of 5 SNPs in a gene (BRCA1) and the 
majority of genes having only one positively selected SNP (43 out of 61). Among genes 
found to be under positive selection using site-based method in the four primates and in 
the human-chimp comparison, 10 and 4 genes, respectively, were found to contain 
positively selected SNPs. We found no significant correlation between the presence of 
SNPs and positive selection in primates. 
5.2.4 Gene Ontology  
Subsequently, we searched for Gene Ontology (GO) (Ashburner, Ball et al. 2000) terms 
enriched among the positively selected HIV-interacting genes. GO separates biological 
roles performed by genes of different organisms into three separate ontologies: 
biological process, molecular function and cellular component, each organized in a 
hierarchical manner with more general terms preceding more specific terms in the GO 
graph. We used the R package topGO (Alexa, Rahnenführer et al. 2006) to score GO 
terms by their overrepresentation in groups of genes. The method makes use of the 
hierarchical structure of the GO by first grouping genes related to each of the terms in 
the GO graph and then processing the nodes bottom-up. Iteratively genes annotated to 
significant GO terms are removed from more general parent terms to test how enriched 
a node is if the genes from its children nodes are not considered. We applied two 
statistical tests, Fisher’s exact test (FET) and Kolmogorov-Smirnov test (KS), to test for 
the overrepresentation of terms in the three groups of positively selected genes: in all 
four primates, in human-chimp comparison and human only as inferred from the SNPs 
analysis resulting in six enrichment tests in total. The FET and KS test for two different 
aspects of enrichment – enrichment of genes under positive selection and enrichment 
among high-ranking genes based on a positive selection score. The GO annotation of 
the genes from the HIV-1-Human Protein Interaction Database has been previously 
reported (Ptak, Fu et al. 2008), the goal of this analysis was to find which terms were 
specific for the three groups of genes being under positive selection as compared to the 
full set of HIV-interacting genes. We therefore assessed term enrichment among genes 
under positive selection using the full set of HIV-interacting genes as a control. This 
helps to ensure that the significance of a term is not due to the general abundance of 
genes assigned to this term in the full set of HIV-interacting genes. Here we discuss 
selected terms that were significantly enriched (p < 0.05) in at least three out of the six 
tests.  
In the biological process ontology several terms related to immune response were found 
to be enriched among the positively selected genes (e.g. “antigen processing and 
presentation”, “immune response” – Figure 5.3, left panel) and several immune response 
terms were enriched among the high-ranking genes in all three groups of genes (e.g. 
“innate immune response” and “defense response to virus”).  
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Among the terms of the cellular component ontology we found evidence of genes related 
to the cellular membrane being under positive selection. Eight out of 14 terms of this 
ontology that were overrepresented in at least four out of six enrichment tests were 
associated with the cellular membrane (Figure 5.3, right panel). The MHC protein 
complex group of terms in this gene ontology also appeared to be enriched among 
positively selected HIV-interacting genes. 
 
Figure 5.3 GO graphs of terms of the biological process (left) and cellular component (right) gene ontologies 
enriched among the positively selected HIV-interacting genes. Brightness of the nodes indicates the 
number of enrichment tests in which a term was found to be overrepresented (p < 0.05), ranging from 
three (light nodes) to five (darkest nodes) significant results out of six enrichment tests. The red node 
represents the innate immune response term, blue nodes represent membrane-related terms that are 
discussed in detail in the text. 
In the molecular function ontology the terms enriched among the positively selected 
genes are predominantly related to receptor or signaling activity, e.g. “receptor activity”, 
“MHC class I and II activity”, “transmembrane receptor activity”, “signal transducer 
activity”. 
Given the high enrichment of the terms “membrane” and “innate immune response” we 
further analyzed genes in those two functional groups. To identify the first group we 
extracted all genes annotated with the GO term GO:0016020 (“membrane” from the 
cellular component ontology) and its subterms. To identify the innate immune response 
genes we performed a two-step procedure. First, we extracted all genes annotated with 
the GO term GO:0045087 (“innate immune response” from the biological process 
ontology) and its subterms and then we searched the dataset for all proteins known to 
participate in the innate immune response (Katze, Fornek et al. 2008; Sadler and 
Williams 2008). 
We found the membrane-related proteins to be overrepresented among the positively 
selected genes in all four primates (chi-square test p < 0.05) and innate immune 
response to be overrepresented in all three groups of positively selected genes (chi-
square test p <0.001). 
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5.2.5 Protein-protein interaction networks  
To characterize the importance of the HIV-interacting proteins for the host and those 
among them being under positive selection, we analyzed their position in the network of 
human protein-protein interactions (PPIs) and human-pathogen PPIs, based on the 
analysis of human-pathogen interactions for 190 pathogens, both bacterial and viral, 
merged into 54 pathogen groups based on taxonomic similarity (Dyer, Murali et al. 
2008). Dyer et al. reported that both viral and bacterial proteins preferentially interact 
with human proteins that are either hubs – i.e., those involved in many interactions, or 
bottlenecks – i.e., those central to many human PPI network pathways suggesting that 
pathogens may have evolved to interact with proteins controlling critical processes in the 
host cell as a mechanism of disrupting the key elements of the host cellular machinery. 
We inspected the distribution of the local connectivity, centrality, number of interacting 
pathogens, and number of pathogen groups for the host proteins in the interaction 
grouping. Local connectivity of a protein is defined as the number of human PPIs in 
which it participates; centrality is the fraction of shortest paths in human PPI network 
between all protein pairs that pass through the given protein. High centrality is 
characteristic of a bottleneck in an interaction network, high connectivity – of a hub.  
 group proteins local connectivity centrality pathogens 
pathogen 
groups 
PR 27 <0.01 <0.01 - - 
RT 20 0.01 <0.01 - - Po
l-
en
co
d
ed
 
IN 49 <0.01 - - <0.01 
 Nef 97 - 0.03 - - 
 Rev 42 <0.01 0.01 <0.01 <0.01 
 Tat 455 - - - 0.01 
 Vif 45 <0.01 - - <0.01 
 Vpr 98 <0.01 0.03 0.03 0.01 
 Vpu 20 - <0.01 0.02 0.01 
MA 54 - - - <0.01 
CA 18 0.03 - - - 
NC 16 - - <0.01 - 
p6 8 0.01 <0.01 <0.01 <0.01 G
ag
-
en
co
de
d 
Gag 26 0.01 - 0.01 <0.01 
gp120 175 - - - - 
gp41 61 <0.01 - 0.01 <0.01 En
v-
en
co
d
ed
 
Env 57 0.04 - - - 
Table 5.3 Interaction specificities of HIV-related host factors in the interaction grouping. Significant p-values 
for local connectivity, centrality, number of interacting pathogens and pathogen groups are shown in 
red for high values and in blue for low values. 
We found that IN, p6, PR, Rev, reverse transcriptase (RT), Vif, Vpr interact with host 
proteins of a significantly high local connectivity. p6 and Rev interact with proteins that 
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are also highly central (Table 5.3). In contrast, gp41, Env, CA and Gag seem to interact 
with host proteins of a significantly lower local connectivity. 
Given the low local connectivity of envelope-interacting host proteins, we investigated 
the distributions of the local connectivity, centrality, number of interacting pathogens and 
pathogen groups of the HIV-interacting proteins annotated with membrane-related GO 
terms. These proteins were of 0.73-fold lower degree (p < 0.01), interact with 0.69-fold 
lower number of pathogens (p < 0.01) and 0.93-fold lower number pathogen groups (p < 
0.03). 
All of the positively selected genes in the four primates tend to be less connected (0.76-
fold difference, p ≈ 0.05) and less centrally located (0.74-fold difference, not significant, p 
≈ 0.16) in the human PPI than the genes that show no positive selection. No clear 
patterns were observed in the number of interacting pathogens and pathogen groups or 
in the positively selected genes in the human-chimp comparison. 
5.3 Virus sequence analysis 
In order to further characterize the host proteins interacting with the virus, we analyzed 
the evolution of corresponding virus genes of several virus species. We aligned 175 
genomes of five species of HIVs and SIVs and the genomes of the HIV-1 and SIVcpz 
only. Viral gene sequences extracted from the alignments were ranked according to their 
relative evolutionary rates, a measure of genetic variability in the genes based on their 
phylogenetic distances corresponding to the positive selection measure in the primate 
genes. 
5.3.1 Viral sequences  
We searched the Los Alamos HIV sequence database (http://www.hiv.lanl.gov/) for 
complete genomes of the following viral species: HIV-1 and HIV-2, SIVcpz, rhesus 
macaque SIV (SIVmac) and SIVsmm. Since our primary interest was in estimating 
general patterns in large data sets rather than in the analysis of individual genomes, we 
excluded SIV species for which less than five genomes were available. In order to 
minimize the bias associated with the overrepresentation in the public databases of the 
HIVs and to obtain the highest variability of the HIV-1 genomes with approximately equal 
distribution among groups, we additionally filtered the HIV-1 group M genomes by 
retaining only therapy-naïve patient sequences, only one sequence annotated with both 
the same country and year and only one sequence per patient. In case of several 
sequences of the same year-country or patient category the longest genome sequence 
was selected. This filter was applied only to the HIV-1 group M sequences. All available 
HIV-1 group N and O complete genome sequences were kept as well as the reference 
HIV-1 sequence HXB2-LAI-HXB2R (accession number NC_001802). We additionally 
included one available Colobus guereza SIV (SIVcol) genome in the dataset (GenBank 
AF301156) as an outgroup genome for further analyses. From the complete genomes 
we extracted individual protein sequences according to the original genome annotation. 
We aligned these gene sequences using MUSCLE (Edgar 2004) and removed those 
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that contained more than 50% insertions or deletions as compared to the reference virus 
HXB2-LAI-HXB2R gene sequence. We refer to the alignment of all viruses the full 
alignment. We computed an additional alignment of the HIV-1 and SIVcpz viruses only 
(HIV-1/SIVcpz alignment). The compiled dataset contained 76 HIV-1 genomes out of 
which 54 were M, 16 of type O and 6 of type N, 30 HIV-2, 19 SIVcpz, 36 SIVmac and 14 
SIVsmm genomes. The filter applied to the HIV-1 group M genomes resulted in a 
representative diversity of the subtypes, with 35% subtype B sequences, 17% C, 8% A, 
one sequence of the D, E, F subtypes and 33% circulating recombinant forms of 
subtypes A to G. After gene extraction, alignment and filtering there were, on average, 
160 sequences of each protein in the full alignment (90 in the HIV-1/SIVcpz alignment) 
approximately 45% of which are HIV-1 sequences (80% in the HIV-1/SIVcpz alignment). 
5.3.2 Evolutionary rates  
Unlike primate gene sequences, lentiviral genomes are highly variable, relatively short 
and contain overlapping reading frames, e.g Tat protein has overlapping coding regions 
in different frames. Calculation of its dN/dS substitution rates can be therefore strongly 
biased.  
Different methods of estimating divergence in HIV genes have been previously applied. 
Several studies used the dN/dS ratio estimates within different HIV genes in order to 
quantify the positive selection related to the virus immune evasion (Simmonds, Balfe et 
al. 1990). Interpretation of the averaged values of dN/dS over gene regions is 
complicated as positive selection can be limited to narrow immunogenic domains within 
proteins, and average values of these ratios for full genes can be misleading. Many 
forces concurrently influence the evolutionary pattern of the virus in vivo, such as 
counterbalancing influences of retention of protein structure and function. Hence, other  
approaches estimating these parameters for each site were also used (Zanotto, Kallas et 
al. 1999; Yamaguchi-Kabata and Gojobori 2000; Yang and Nielsen 2000). 
Given the difficulty of estimating precise selection pressures acting on highly variable 
lentivirus genomes exposed to complex evolutionary pressures, instead of using 
classical methods of estimating positive selection we developed a surrogate measure of 
relative evolutionary rate. The aim of this measure was to quantify the relative 
accumulation of genetic change of each virus gene without indicating specific sites or 
evolutionary forces that might have acted on each of the gene. 
Across all host species, each protein of the immunodeficiency virus has the same 
specific biological role in the viral life cycle and host species adaptation – a role that 
necessitates interaction with a set of host proteins. These roles and the resulting 
interactions present specific constraints and selection pressures on viral genes that 
contribute to the accumulation of genetic change with a rate characteristic to each viral 
protein. Even though the date of the introduction of the viral species into its respective 
host species and the duration of the infections in each host individual are unknown, the 
common functionality of a viral protein in different host species determines its ability to 
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evolve at a specific rate. Therefore, we assumed that the genetic change in the viral 
gene relative to the genetic change in a reference gene in the same viral genome is 
similar among different viruses (Muller-Trutwin, Corbet et al. 1996). Due to its role each 
protein shows itself specific patterns and rates of evolution. Using this assumption we 
introduced the relative evolutionary rate measure and used it to assess the rate of 
accumulation of genetic change in different viral protein sequences independently of the 
host species and the time of infection. This measure affords ranking viral genes 
according to the amount of genetic change accumulated among viral species. 
We based the measure of relative evolutionary rate on maximum likelihood (ML) trees of 
nucleotide sequences estimated using the dnaml program (Felsenstein and Churchill 
1996), part of the PHYLIP package (Felsenstein 2005). Due to the potential errors in 
dating of the SIV sequences and the difficulty of estimating evolutionary parameters with 
incomplete data from highly variable viral populations (Muller-Trutwin, Corbet et al. 1996; 
Rey-Cuille, Berthier et al. 1998), more advanced phylogenetic methods (Drummond and 
Rambaut 2007) were not applied. The trees constructed using the dnaml program 
(Felsenstein and Churchill 1996) are based on a Hidden Markov Model (HMM) inferring 
different rates of evolution at each alignment site. We used the gamma distribution for 
approximating the distribution of evolutionary change at different sites with shape 
parameter 1 and nine rate categories. These settings were selected because they 
resulted in the trees with the highest likelihood in several tests over a range of 
parameters on different viral genes. 
We inferred a phylogenetic tree for each viral gene separately. Corresponding genes of 
the SIVcol genome were used as an outgroup in each of the trees. The distance 
between two gene sequences was defined as the sum of branch lengths between the 
nodes representing those sequences in the ML tree. Branches with low significance (p > 
0.05) were excluded; pairs of sequences having such a branch between them were 
excluded from the calculation. Since the dataset of viral sequences was based on 
complete viral genomes, each of the gene trees contained corresponding sequences for 
each virus. Next, we calculated the relative evolutionary rate of each single sequence 
pair by dividing the distance between the two sequences of a viral gene by the distance 
between the reference gene sequences for the same pair of viruses. IN was chosen as 
the reference gene because its phylogenetic tree had the shortest branches on average 
resulting in mean relative evolutionary rates > 1 for all other genes. 
To account for the differing numbers of sequences of each viral species in the dataset 
we introduced a weighting scheme for the sequence distances to reduce the bias in the 
mean evolutionary rate due to the overrepresentation of the HIV-1 sequences. The 
weighting resulted in only minor changes in the viral gene ranking that did not influence 
the overall results. Thus, we chose the more parsimonious approach of not weighting. 
We first inspected the capacity of the relative evolutionary rate measure to quantify the 
amounts of genetic change within among different virus genes. We defined diversity and 
divergence as the within and between species variation respectively. Diversity and 
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divergence of a gene is based the distances between all pairs of sequences of the same 
and different viral species respectively. Examples of diversity and divergence values 
distributions are shown in Figure 5.4.  
Divergence distributions of three example proteins gp120, Nef and PR picture the 
differences among the divergence of a fast, medium and slow evolving proteins (Figure 
5.4, upper panel). Gp120 shows the highest average divergence among virus species, 
about four times higher than the reference IN gene. Protease (PR) gene shows lower 
and less widely distributed divergence values. Notably, PR is an essential protein for the 
HIV lifecycle – it cleaves newly synthesized polyproteins to create the mature protein 
components of an infectious HIV virion (Kräusslich, Ingraham et al. 1989). Nef is an 
accessory protein, known to modulate virus pathogenicity (Kirchhoff 2009) and shows 
intermediate divergence between PR and gp120.  
 
Figure 5.4 Relative evolutionary rates of virus genes. Top panel shows the density estimation of the 
divergence values of three example proteins in the full alignment. Bottom panel shows the density 
estimation of diversity values of the envelope gene in three example virus species. Densities are 
estimated using Gaussian kernel.  
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Diversity values distribution affords means of distinguishing different levels of gene 
variability among virus species (Figure 5.4, bottom panel). These differences are 
however harder to interpret and might be biased by a limited number of sequences of 
certain virus species. 
The final viral gene ranking is based on the average of the relative evolutionary rates 
over all pairs of sequences (Table 5.2). In order to determine how this ranking depends 
on the distance measure, we recalculated the relative evolutionary rates based on 
Hamming distances. The ranks based on distances inferred from phylogenetic trees 
correlated with the rates based on Hamming distance (r = 0.93, p < 0.001 in the 
alignment of all viruses and r = 0.94, p < 0.001 in the HIV-1/SIVcpz alignment). The main 
goal of the ranking was to compare the relative variability of the viral genes in order to 
assess the correlation with the positive selection of the interacting host genes. 
Regardless of the distance measure used in both alignments, Env and its two 
subproteins together with Vpu and Rev were among the top 6 in the protein ranking. Pol 
and Pol-encoded proteins (RT, PR, IN) together with CA were among the 5 lowest 
ranked proteins. The only discordance among the distance measures and alignments 
were observed among the middle-ranked genes (Nef, Gag, Vif, Tat, MA, NC, Vpr, RT). 
5.4 Gene rank correlation 
To investigate the relative rates of evolution among the interacting host and virus genes 
we next calculated the correlation between the strength of positive selection acting on 
the host factors and the rate of evolution of the interacting viral genes. We calculated the 
correlation of the host factor ranks assigned according to the site-based and the sliding 
window scores and the viral gene ranks assigned according to the relative evolutionary 
rate measure. In the site-based ranking we restricted the host factors to the ones under 
positive selection as inferred from the LRT. Both the viral and host gene rankings were 
normalized to the [0,1] range. The same procedure was repeated on the positively 
selected genes inferred in the human-chimp comparison and correlated to the viral gene 
ranking based on the HIV-1/SIVcpz alignment. 
The ranks of interacting host and viral proteins showed only minor but significant (p < 
0.01) positive correlation (r = 0.18 in the site-based and r = 0.17 in the sliding window 
scoring). In the human-chimp comparison the sliding window ranking produced the only 
significant correlation (r = 0.14, p < 0.01). 
5.4.1 Interaction binning test  
Given the small but significant correlation of the ranks of interacting host and virus 
proteins we devised an interaction binning test to investigate the proximate relationships 
between interacting gene ranks. The interactions were grouped into bins defined by viral 
gene ranking. The ranks of host genes within bins were averaged. Bins of different sizes 
were slid along the viral gene ranking scale, advancing from one gene to adjacently 
ranked gene in each step. For each bin size we calculated the correlation between viral 
gene ranks and the averaged host gene ranks. Because of the small number of viral 
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genes (18) a symmetrical approach of averaging over viral gene ranks was not 
performed. We tested all 18 possible bin sizes and used the permutation procedures 
described below to test for the significance of the correlation obtained for the averaged 
binned ranks of each bin size. 
The test of all 18 bin sizes showed a markedly increased correlation of approximate 
ranks of interacting viral and host genes (Figure 5.5, left panel). For example, binning 
interactions over a bin of size 0.083, that averages host gene ranks interacting with 3 
viral genes neighboring in the viral gene ranking increases substantially the correlation 
to r = 0.78 in the site-based and r = 0.92 in the sliding window scoring (Figure 5.5, right 
panel). Permutation tests showed the significant correlations (p ≤ 0.05) in 14/18 bin sizes 
in the site-based ranking and in 13/18 in the sliding window ranking. In the human-chimp 
comparison only the correlation based on the sliding window score was significant for 
16/18 bin sizes, with the correlation of 0.93 on average and of 0.88 for the 0.083 bin 
size. The high correlations obtained after binning suggest that the viral genes of different 
evolutionary rates tend to interact with host factors under commensurate levels of 
positive selection. 
 
Figure 5.5 Correlation of the normalized ranks of the interacting host and viral proteins obtained from site-
based and sliding window scoring of the host genes and relative evolutionary rates of the viral genes 
in the comparison of the all four primate species and the alignment of all viruses. Left panel shows 
correlation coefficients of the ranks of interacting proteins averaged by bin size. Significant 
correlation coefficients (p ≤ 0.05) are indicated by filled dots, the gray box indicates correlation 
coefficients of ranks plotted in the right panel. Right panel shows a plot of viral and host binned 
ranks. The correlation coefficients obtained for each host gene scoring is indicated in the brackets, 
lines are fitted according to least sum of squares. 
5.4.2 Permutation procedures  
In order to assess the statistical significance of results of this study we developed 
permutation tests of the HIV-human interactions. The HIV-human interaction data can be 
represented by a bipartite graph with nodes representing host and viral proteins and 
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edges connecting interacting host and viral proteins. We designed two procedures of 
permuting the host-virus interaction network. The host-oriented test consists of retaining 
the degree of each of the host gene nodes in the network and randomly sampling a 
corresponding number of interacting viral genes from the set of all viral genes. The virus-
oriented test consists of retaining the degree of each viral gene node and randomly 
sampling a corresponding number of interacting host genes. Performing two different 
permutation tests allowed for testing if certain results were due to the differing numbers 
of interactions reported for different host and viral proteins. We developed additional 
permutation tests allowing for random node degrees in the network and found the 
permutation tests conserving aspects of the network topology to be more stringent in 
assessing the statistical significance of the observations in this study. We therefore used 
the host- and virus-oriented tests to assess statistical significance of the results of the 
presented analyses. 
5.5 Discussion 
Understanding the genome-wide selection pressure on HIV-interacting proteins can 
provide insights into the evolutionary dynamics of host factors, the genetic basis of 
differences between nonpathogenic and pathogenic lentivirus infection and the roles of 
individual genes in host-pathogen interaction and immunopathogenesis. Only two of the 
host species analyzed in this study are naturally infected with HIV/SIV (human and 
chimpanzee) moreover because these viruses have been recently introduced into their 
host species (Keele, Jones et al. 2009) the selection pressures observed in this study 
are not driven by modern lentiviruses. Even though the interaction data used is mainly 
human and HIV-1 specific, the majority of interactions are shared with SIVs and with 
other viruses. Many of the host factors found to be under positive selection interact with 
multiple pathogens so the selection pressures on the host factors are likely to be driven 
by those pathogens. However the comprehensive HIV interaction data offers opportunity 
for a broad study of the evolution of host-pathogen interactions. The interactions in the 
HIV-1 Human Protein Interaction Database are catalogued manually based on a 
literature screen and cannot be considered as fully validated. Nevertheless this screen 
for positive selection points to a narrow set of potentially interesting interactions that can 
be examined and validated individually. 
In this analysis we identify ~10% of the 1439 HIV-interacting genes as being under 
positive selection based on LRT of sites under positive selection in four primate species. 
Ortiz et al. (Ortiz, Guex et al. 2009) reported a similar fraction of genes as being under 
positive selection based on the analysis of 140 genes. Among the 62 proteins analyzed 
in both this study and by Ortiz et al. 13 are identified as being under positive selection in 
the Ortiz et al. study. Among these, 11 are confirmed in my study either by showing 
significant LRT or being within the upper quintile of the sliding window scores. The 
reasons for discrepancies between the two studies might lie in different criteria of which 
genes to analyze and an expanded number of species for the analysis of individual 
genes in the Ortiz et al. study.  
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Three screens using small interfering RNA (siRNA) have been reported (Brass, 
Dykxhoorn et al. 2008; König, Zhou et al. 2008; Zhou, Xu et al. 2008) that search human 
genes having effect on HIV infection – so called HIV dependency factors (HDFs). The 
overlap among the HDFs identified in the three studies and the proteins in the HIV 
interaction database is known to be small (Bushman, Malani et al. 2009). We scanned 
the results of one of the siRNA screening studies (Brass, Dykxhoorn et al. 2008) for the 
presence of genes under positive selection detected in my analysis. Among 32 genes 
common between this and Brass et al. studies only one protein (SP110) appeared to be 
under positive selection. 
Several HIV restriction factors have been shown to be under positive selection 
throughout primate evolution (Sawyer, Emerman et al. 2004; Zhang and Webb 2004; 
Sawyer, Wu et al. 2005; McNatt, Zang et al. 2009). TRIM5α, discussed in detail in 
chapter 2, restricts post-entry activities of the retroviral CAs in a species-specific manner 
(Stremlau, Owens et al. 2004; Towers 2005), and has apparently undergone multiple 
episodes of positive selection that predate the estimated origin of primate lentiviruses 
(Sawyer, Wu et al. 2005). The genetic changes that emerged as an effect of selection 
pressures by previous viral epidemics resulted however in a species-specific restriction 
of modern lentiviruses. Another type of restriction factors, cytidine deaminase enzymes 
APOBEC3G and APOBEC3F block the virus at a later than TRIM5α stage of reverse 
transcription and are packaged into nascent virions. The APOBEC family in primates 
consists of nine cytosine deaminases (cystosine and uracil) and two others that possess 
in vivo DNA editing functions (Sheehy, Gaddis et al. 2002; Turelli and Trono 2005). In 
the absence of the lentivirus accessory gene virion infectivity factor (Vif), APOBEC3G 
becomes incorporated into nascent virions and inhibits HIV activity by causing 
hypermutations that are incompatible with further replication. Thus, APOBEC3G and Vif 
are under selection to decrease and enhance, respectively, their interaction with one 
another, a genetic conflict resulting in the rapid fixation of mutations commonly seen in 
host-pathogen interactions. As with the primate TRIM5α family, APOBEC3G activity 
shows species-specific adaptations (Sawyer, Emerman et al. 2004) emphasizing that 
coevolution of lentiviruses was a prerequisite for adaptation to a new host after cross-
species transmission (Bogerd, Doehle et al. 2004). Thus, similar to TRIM5α, 
APOBEC3G clearly possessed an ancient role in defence against RNA viruses, a 
function that predates estimates of the emergence of today’s primate lentiviruses, that 
resulted in species-specific restriction of current RNA viral infections (Sawyer, Emerman 
et al. 2004; Zhang and Webb 2004). Both TRIM5α and APOBEC genes are reported in 
the study presented here to be under positive selection (Figure 5.2), which suggests that 
this large scale approach can point to factors relevant for the immunodeficiency virus 
infection. 
Several host factors not identified as being under positive selection in the LRT showed 
an elevated dN/dS ratio in the sliding window test. For example, tetherin, previously 
reported to be under positive selection (McNatt, Zang et al. 2009), did not show 
significant LRT but ranked among the top 5% of all HIV-interacting proteins in the sliding 
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window test. However, in order to be able to identify genes with small number of 
polymorphic sites in relatively long and conserved sequences we relied on the criterion 
of the significance of the LRT to assess positive selection. 
 
Figure 5.6 HIV-human protein interaction network. Viral proteins are represented by the largest dots. The 
shade of each dot indicates the rank of relative evolutionary rates of the viral proteins with dark 
colors representing a high rank and light colors representing a low rank. Host proteins are 
represented by smaller dots positioned among the interacting viral proteins. Nodes of the host factors 
discussed in the text are enlarged. Colors indicate the functional group to which the factors belong: 
blue - membrane-related proteins, red – innate immune response proteins, magenta – both. The 
intensity of the colors indicates the positive selection score in the site-based scoring with stronger 
colors representing a high rank and less intensive colors representing a low rank. Only host proteins 
with significant LRT in the comparison of the four primates are shown. The network was rendered 
using Cytoscape (Shannon, Markiel et al. 2003). 
The functional analysis of the HIV-interacting host factors under positive selection 
pointed to two functional groups showing evidence of positive selection: membrane-
related proteins and innate immune response proteins. These functional groups were 
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overrepresented among the subsets of genes positively selected in all four primates, in 
human-chimp comparison and human only as inferred from the SNPs analysis (Figure 
5.3). The interaction network of the virus proteins and the positively selected host 
proteins discussed below is visualized in Figure 5.6. Individual host factors pointed out in 
the text are labeled in this Figure. 
Among the membrane-related HIV-interacting proteins under positive selection we 
observed several that are known to interact with other pathogens. C-type lectin 
(CLEC4M) a transmembrane receptor expressed on the surface of dendritic cells and 
macrophages, known to bind gp120 (Gattegno, Ramdani et al. 1992), is a part of 
signaling pathways induced by other pathogens such as Mycobacterium tuberculosis 
(Srivastava, Manchanda et al. 2009), hepatitis C virus (Pöhlmann, Zhang et al. 2003) 
and ebola virus (Alvarez, Lasala et al. 2002). Intercellular adhesion molecule 1 (ICAM1), 
a cell surface glycoprotein expressed in endothelial cells and cells of the immune system 
involved in a range of interactions with the HIV (Chirmule, Oyaizu et al. 1994; Fais, 
Capobianchi et al. 1995; Lafrenie, Wahl et al. 1996; Tardif and Tremblay 2003) is a 
receptor used by the rhinovirus (Greve, Davis et al. 1989). Chemokine (C-X-C motif) 
receptor 3 (CXCR3), a G-protein-coupled receptor expressed in activated T cells, NK 
cells, and dendritic cells, suggested to interact with Nef (van Marle, Henry et al. 2004) 
and Tat (Poggi, Carosio et al. 2004), participates in the signaling cascade of the T cell 
activation in genital herpes simplex virus type 2 (Thapa and Carr 2009) and hepatitis C 
virus (Perney, Turriere et al. 2009) infections. Binding to the surface receptors of the 
host cell and internalization into that cell are the first steps of the viral infection; the 
genetic variability of the proteins expressed on the cell surface therefore represents a 
potential host defense mechanism to infection, preventing viral recognition and efficient 
cell entry. The genetic variation in membrane genes has been previously reported 
(Murphy 1993). This variation might have resulted from previous infections however can 
have impact on modern lentivirus restriction and primate species susceptibility to 
infection.  
We detected a substantial amount of genetic variation in the membrane gene CD3E 
(rank 17 in the site-based, 3 in the sliding window score), coding for a part of the T cell 
receptor CD3 complex (CD3-TCR). The highest concentration of positively selected 
residues was found in the protein extracellular and transmembrane domains (Figure 
5.7). The CD3-TCR complex is known to participate in the mechanism responsible for 
different levels of immune activation and T cell apoptosis in pathogenic HIV-human and 
nonpathogenic SIV-monkey infections (Schindler, Münch et al. 2006; Schindler, 
Schmökel et al. 2008). This and other examples of membrane proteins being under 
positive selection suggests that other proteins in this functional group might be relevant 
for differences in HIV pathogenesis.  
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Figure 5.7 Positive selection of the CD3E gene. Bars indicate the dN/dS ratio of the following sites in the 
protein. Different shades of the bars indicate following domains of the protein: signal peptide (light 
gray), extracellular (black), transmembrane (dark gray) and intracellular (light gray). Sites with a high 
probability of being under positive selection (p < 0.05) are indicated with blue bars and labeled with 
their position and amino acid in the human protein. Orange line traces the dN/dS ratio calculated in 
the sliding window test. Highest accumulation of positive selection can be observed in the 
extracellular domain of CD3E. 
Similar to the membrane-related genes, we found the innate immune response gene 
group to be significantly enriched among the positively selected genes. The innate 
immune response is the first line of defense against viral infection detecting virus 
particles, modulating signaling pathways leading to an increased interferon (IFN) 
production and inhibition of virus spread to limit pathogenesis. There is growing 
evidence that the variability in the innate immune response proteins among primate 
species might contribute to different levels of immune activation in immunodeficiency 
virus infections (Mandl, Barry et al. 2008; Ortiz, Guex et al. 2009).  
We found interferon regulatory factor 7 (IRF7) to be under positive selection both in the 
test of four primate species and in the human-chimp comparison. IRF7 is a 
transcriptional factor involved in signaling triggered by the Toll-like receptor (TLR) TLR7 
and TLR9 in response to the SIV infection (Mandl, Barry et al. 2008). Previous studies 
have shown that the genetic change in the primate IRF7 is correlated with the immune 
activation in SIV infection of primates (Mandl, Barry et al. 2008). Mutations in IRF7 might 
therefore be responsible for an altered TLR7 and TLR9 signaling leading to different 
levels of immune activation between pathogenic and nonpathogenic infections.  
Caspase 1 (CASP1), a member of cysteine-aspartic acid protease family is an example 
of innate immune response gene under positive selection in primates (rank 31 in site-
based and 26 in sliding window scoring) that is also located on a positively selected 
allele in humans. CASP1 is known to play a role in cellular apoptosis induced by HIV-1 
Vpr (Stewart, Poon et al. 2000) and gp120 (Ohnimus, Heinkelein et al. 1997). Caspase 
activation has also been shown to participate in the cellular defense against cowpox 
(Komiyama, Ray et al. 1994), baculovirus (Cartier, Hershberger et al. 1994), and dengue 
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virus (Nasirudeen and Liu 2009). HIV-1 interaction with the caspase-regulated apoptosis 
might play a role in limiting the host immune response to the virus and facilitating viral 
persistence.  
Among the high-scoring innate immune response genes under positive selection we also 
found Fas (APO-1, CD95) (rank 13 in the site-based and 46 in the sliding window 
scoring), a member of the tumor necrosis factor (TNF) receptor family. The Fas-
mediated pathway plays an important role in HIV-1 immunopathogenesis. Fas has been 
suggested to contribute to the loss of CD4+ T cells in progression to AIDS as a part of 
the TCR-CD3 signaling pathway (Badley, Pilon et al. 2000; Petit, Corbeil et al. 2001). 
High levels of positive selection in Fas among primates and its regulatory relationship 
with TCR-CD3 point to this molecular pathway being possibly differently regulated 
among primates and partially responsible for immunopathogenesis.  
Hyperactivation of the immune system in response to a pathogen recently introduced 
from another species can result in severe pathogenesis (e.g. hantavirus (Nichol, 
Spiropoulou et al. 1993)). Disentangling the interaction of the HIV with the innate 
immune response and the host-specific differences in primate species might thus be of 
therapeutic interest. The examples of innate immune response genes under positive 
selection relevant for diverse immune activation in HIV infection suggest that other 
genes reported by our analysis might merit further study. 
To gain further insight into the positively selected genes we grouped them according to 
their interacting viral genes and characterized each group with the use of the positive 
selection score, gene roles in the PPI network and the evolutionary rate of the 
corresponding viral gene. Among the gene groups, genes interacting with the viral 
envelope and its subunits show elevated scores of positive selection. In contrast, we 
found limited evidence of positive selection in the genes interacting with viral Pol-
encoded genes, with PR and IN in particular. 
In the context of their role in the PPI network and interactions with other pathogens the 
envelope and gp41-interacting genes revealed a significantly low local connectivity, 
centrality and number of interacting pathogens and pathogen groups. The same pattern 
was observed for the group of membrane-related genes. This less crucial role in the PPI 
and high specificity for the interacting pathogens might be key factors allowing for the 
accelerated evolution of the membrane and envelope-interacting genes. The less critical 
role of these proteins in the host biology makes them potential drug targets, for example, 
the chemokine receptor CCR5 is targeted by MVC (Westby and van der Ryst 2005). 
In contrast to the host proteins interacting with the viral envelope and its subunits we 
found significantly higher local connectivity and centrality in human PPIs of the host 
genes interacting with viral Pol-encoded genes. Together with their higher conservation 
this suggests that the crucial role of these highly connected genes in host cellular 
biology could be an evolutionary constraint. Pathogens might therefore interact 
preferentially with highly connected human proteins not only as a strategy to control 
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critical host molecular processes (Dyer, Murali et al. 2008) but also because the lack of 
variation makes them a static target for virus-host interaction.  
The high variability of the viral envelope gene and its subunits gp120 and gp41 (Hahn, 
Gonda et al. 1985; Holmes, Zhang et al. 1992) is in accordance with the high positive 
selection score of envelope-interacting and host membrane genes in general. Envelope 
proteins that participate in the crucial steps of binding to the cell receptors and 
coreceptors and membrane fusion (Deng, Liu et al. 1996; Berger, Murphy et al. 1999), 
are located on the surface of the virion and contain recognition sites for various adaptive 
immune responses. Thus changes in optimal host cell receptor affinity and evasion of 
host immune responses create selection pressure on the Env gene. Together with the 
positive selection acting on the host membrane genes it points to the viral recognition 
and host cell receptor affinity as processes in which both the viral and host genes 
undergo accelerated evolution driven by viral evasion and host suppression.  
Conversely, Pol-encoded proteins show the least genetic variation among viral proteins. 
These proteins perform essential enzymatic functions common to all retroviruses, such 
as RNA retrotranscription, DNA integration and protein maturation and are unsurprisingly 
among the most conserved HIV/SIV proteins. Host factors interacting with the Pol-
encoded proteins also show less genetic variation among the HIV-interacting genes, 
suggesting that these interactions tend to be the conserved parts of the host-pathogen 
interface. 
The significant correlation of the viral and host gene ranks based on the rates of gene 
evolution further supports the hypothesis of reciprocal evolutionary effects between 
interacting host and pathogen proteins (Woolhouse, Webster et al. 2002). Highly 
conserved processes tend to be those crucial for viral replication; those less conserved 
might not be essential for the virus survival but involve accessory proteins and might 
contribute to pathogenesis. The highest rates of genetic change tend to be in the 
processes acting on the viral envelope and host cell membrane as they involve viral 
evasion and host pathogen immune recognition. 
In this study we searched and characterized host defense factors under positive 
selection potentially involved in different responses to immunodeficiency virus infections 
in primates. Identifying genetic differences in the interacting proteins can open the way 
to biological testing of hypotheses regarding their role in various SIV/HIV infection 
phenotypes with different levels of immune activation. In addition to providing new 
insights into viral pathogenesis and host immunity, the approach presented here 
provides the potential for discovering new targets for antiviral therapies based on the 
knowledge of crucial elements of the host-pathogen interface and the pace of their 
evolution. 
5.6 Conclusions 
HIV has entered human population recently which likely contributes to its pathogenic 
nature (Hahn, Shaw et al. 2000). The fact that closely related to humans African primate 
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species are infected with viruses ancestral to HIV and do not develop the disease offers 
an invaluable setting for comparative studies in the search of differences crucial for the 
development of immunodeficiency. As illustrated by host restriction factors (Sheehy, 
Gaddis et al. 2002; Stremlau, Owens et al. 2004; Neil, Zang et al. 2008) the interspecies 
genetic differences in the HIV-interacting genes might account for the HIV pathogenicity 
in humans.  
The study presented in this chapter, comparing ~2500 HIV interactions among several 
host and virus species, was possible to accomplish only with the recent accumulation of 
the genomic (Karolchik, Kuhn et al. 2008) and interaction data (Fu, Sanders-Beer et al. 
2009). Even though the amount and type of data allows for large-scale genomic 
analyses of the host-pathogen interactions, one should bear in mind potential errors 
inherent to this kind of data. Interactions collected in the HIV-1 human interaction 
database were reported by different labs, according to varying experimental protocols 
and criteria. Primate genomes are not yet fully annotated and the inference of 
homologous genes based on alignment with human genome might fail if the genome 
sequence is incomplete. Not fully validated interactions can therefore result in false 
positives in a large-scale interaction analysis; missing gene sequences hinder detection 
of potentially important interactions. The results of a large-scale analysis on not entirely 
confirmed data should be subjected to careful interpretation and additional validation. 
Nevertheless, as underscored by the presented examples confirmed by other 
experimental studies, the approach shown here affords indicating interactions relevant 
for the differences in the virus pathogenicity among primates. Given the accumulation of 
sequence data, analyses on the scale of genome represent a powerful method to filter 
out information potentially interesting for the disease. 
Progressive growth and refinement of the genomic and interaction data will contribute to 
more reliable comparative studies of HIV-host interactions. Better validated and 
characterized interactions and a larger set of genomes of primate species naturally 
infected with SIV can increase the accuracy of this kind of analysis. A more targeted 
genomic study of SIV-infected monkey species is of high medical interest with a potential 
of providing information for the disease treatment. 
The study presented in this chapter pictures HIV-host interactions on the broadest, 
genomic scale. In contrast to the previous chapters, here all known HIV-host interactions 
are analyzed among all species whose genomic data was available. This large-scale 
analysis affords means to generate novel hypotheses on the reasons of virus 
pathogenicity, filter out host factors potentially important for the disease and direct 
further detailed research. 
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One hundred years ago pathogens such as polio or smallpox presented a substantial 
threat to human life worldwide. Among the most remarkable achievements of modern 
medicine is the complete eradication of natural smallpox (Behbehani 1983) owing to the 
worldwide vaccination program. The smallpox vaccine is based on live viruses that 
induce antibodies protecting an individual from future infections. This way induced 
immunity is effective and long-term because the Variola virus which causes smallpox 
does not evolve to escape prior immunity (Ryan and Ray 2004).  
In contrast, HIV appears to have an endless capacity to evolve to highly variable forms. 
Inducing long-term immunity against HIV is currently not possible due to the genetic 
flexibility of the virus and its capacity to rapidly escape host immune responses. Its high 
mutation and replication rates allow HIV to change continually in response to the 
selection pressure of host immune recognition and under the functional restriction of 
preserving its replicative fitness. Having a genome that codes only for few essential 
proteins, the virus is involved in a complex network of interactions with the host. Given 
the high variability of HIV and its dependence on the host for replication and spread only 
combined studies of the host and pathogen can provide causal information on the virus 
evolution. Understanding evolutionary forces shaping evolution of HIV might offer 
important insights for the search for effective and long-term anti-HIV treatments. 
Evolutionary constraints and selection pressures on the virus operate on different scales 
from individual proteins through viral populations to species. On the scale of the 
individual protein, an interacting molecule is under constraints to retain its biological 
function while evading host restriction and immune recognition. On the population scale, 
selection promotes survival of the fittest virus able to replicate, infect new cells and 
evade host recognition in the most efficient way. On the scale of species, those virus 
variants are selected that are capable of passing the bottleneck of interspecies 
transmission and adapting to a new host species. Only through comprehensive analyses 
of host-pathogen interactions on different scales are we able to approach the complexity 
of HIV evolution and pathogenicity. 
The work presented in this thesis represents an approach to analyze HIV-host 
interactions on different scales. Here we present a brief summary of the results, discuss 
their possible developments and propose their synthesis across the scales. 
6.1 The scales individually 
On the scale of individual interaction, the structural study of host TRIM5α and viral CA 
protein variants of different phenotypes pointed to their potential interaction site and 
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structural and physical determinants of their binding. The analysis of this interaction 
should improve with the determination of crystal structure of the SPRY domain of 
TRIM5α or its close homolog and an increased number of protein variants tested for their 
interaction. The crystal structure would improve the accuracy of the homology-based 
models, larger sets of experimentally tested protein variants would allow for a systematic 
search for sequence and physicochemical determinants of the interaction. In the 
absence of knowledge of the exact mechanisms of an interaction, structural models and 
their detailed analyses provide insights into the potential binding sites and the factors 
conditioning the interaction. However given the high variability of the virus and the large 
number of potentially interesting host-pathogen interactions, this approach is limited to 
their unrepresentative subset. 
On the scale of virus population, two studies presented in this thesis analyzed the highly 
variable V3 region of the HIV genome that is crucial for virus binding to the host 
coreceptors. The analysis of sequence space of the V3 loop pointed to the large 
variability of CXCR4- as compared to CCR5-binding viruses. Structural analysis of the 
V3 loop on the virus population scale resulted in a structure-based classification method 
of virus tropism and identification of physicochemical properties on the loop stem critical 
for the coreceptor usage. Both analyses reach beyond the classical methods for 
prediction of coreceptor usage and offer biological and evolutionary insights into 
coreceptor tropism. A potentially interesting direction of expanding the sequence space 
analysis is analyzing in the same manner virus population data obtained through deep-
sequencing of patients of known clinical condition. Tracing of evolutionary trajectories of 
entire virus populations in sequence space in relation to the patient clinical attributes 
would validate and expand the observations gained from the presented analysis. A 
highly interesting way of developing the structure-based coreceptor prediction method is 
to target it at predicting the MVC therapy outcome instead of the virus phenotype. With 
the increasing use of this entry inhibitor in patient treatment and the growing data 
documenting their clinical history, such models can gain both high interest and improved 
accuracy. 
The scale of virus population involves studies of seemingly unlimited number of virus 
variants. Such studies provide integrative models of virus quasispecies, enabling the 
analysis of their variation, dynamics and evolution. As relevant as these models are for 
the highly variable and large HIV populations in human hosts, models of viral 
populations in separation from the host and environmental factors that dictate their 
composition cannot explain the underlying biological mechanisms. The studies of virus 
populations presented in chapter 3 implicitly involve the virus interaction with the host 
chemokine coreceptors through virus tropism classification. The search for sequence 
and structure patterns within the virus classes allowed for drawing hypotheses about 
evolutionary patterns driving the emergence of each of the virus types and the structural 
and physicochemical determinants of the virus-coreceptor interaction. 
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On the scale of single cell, the study presented in this thesis integrated virus, host and 
environmental factors playing role in the virus cell entry. This study resulted in a 
comprehensive picture of the virus cell entry phenotypes. It indicated a preservation of 
the CCR5-tropic viruses as compared to more rarely observed CXCR4- and dual-tropic 
viruses. The models developed on the on scale of single cell represent a comprehensive 
description of the virus phenotype compared to the tropism classification, however, at a 
higher cost of describing an individual virus. With the increased number of viruses tested 
and characterized in the presented experimental and computational pipeline this 
approach will allow for prediction of virus phenotype based on V3 loop genotype. Such a 
predictive model represents a practical application of our approach in patient treatment 
with coreceptor blockers.  
On the broadest scale of genome all known HIV-human interactions were analyzed in 
the context of the evolutionary change in the interacting host and virus proteins. This 
large-scale comparative genomics study of host-pathogen interactions identified and 
characterized host factors harboring higher amounts of genetic change and thus being 
potentially important for the infection. Additionally, by linking evolutionary rates of 
interacting host and pathogen proteins, patterns in the evolution of the host-pathogen 
biology were found, involving conservation of processes crucial for the virus replication 
and higher genetic variability of proteins involved in interactions related to virus cell entry 
and immune recognition. The accuracy of this genomic analysis could be improved with 
the use of fully validated and characterized interactions and a larger set of genomes of 
primate species naturally infected with SIV. Given the role of retroviruses in primate 
evolution, the identification of genomic signatures in the proteins relevant for the 
infection can provide additional layers of data for analysis of contemporary susceptibility 
to HIV. Analysis on this scale offers a broad view of the HIV interaction with the host and 
a filter of the large amount of reported interactions to the potentially interesting ones. 
6.2 Multi-scale analysis 
Analyses of HIV-host interactions limited to an individual scale provide incomplete 
information on different aspects of specific interactions. A better understanding of the 
HIV infection can be obtained through a systems biology approach of integrated studies 
covering different scales. In the work presented in this thesis, several patterns emerge 
across the scales. 
The TRIM5α restriction factor, analyzed on the scale of individual interaction appeared 
also among the results of the study on the genomic scale. The importance of this 
restriction mechanism was both reflected by the variety of restriction phenotypes of 
chimeric TRIM5α proteins and by the high amounts of positive selection of this protein 
among the primate species. This indicates how an individual mutation changing the 
conformation or electrostatics at the protein interaction site can have implications on 
virus restriction and this way affect the spread of the pathogen in a population. A 
complete understanding of this defense mechanism can be therefore obtained through a 
multi-scale study – from protein to population.  
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The virus cell entry process is another key interface between the host and virus pictured 
on different scales in this thesis. High genetic variability of host membrane genes and 
virus envelope protein shown on the interspecies genomic and virus population scales 
reflects their complex evolutionary trajectories shaped by the dynamics of host 
recognition and pathogen evasion. On the scale of single cell the analysis of integrated 
effects of host, virus and environmental factors on the virus cell entry pointed to a 
comparable variability of the phenotypes of virus cell entry mechanism. This indicates 
how the complexity of the virus cell entry mechanism can be visible across the scales – 
from sequence to phenotype, from single cell to species. 
The examples of patterns visible across scales demonstrate that although there is much 
to learn on each scale, the deepest understanding of the HIV-host interactions can be 
gained from integrating across the scales. In the next section we describe an outlook on 
a non-reductionist, systems biology approach to study HIV-host interactions through 
integrating heterogeneous biological information. 
6.3 Outlook – systems biology approach to HIV research 
Possible scales and types of analyses of the HIV-host interactions on each of them are 
countless. An emerging approach to study HIV-host interactions is based on genome-
wide high-throughput information gained from recent and fast developing technologies of 
genome, transcriptome, proteome and siRNA screening. Large data sets generated 
using these new technologies can be analyzed in isolation however an integrative 
approach affords a broad, systems biology picture of HIV-host interaction measured 
genome-wide (Bushman, Malani et al. 2009; Telenti 2009). 
Genomic analyses advanced to the point where comprehensive analyses of the role of 
host genetic variation in the HIV infection can be performed. Coupling new 
developments in the sequencing technology with large amounts of patient data collected 
over the last decades of HIV surveillance allows for systematic search of human 
variations determining different clinical outcomes of the infection. Several studies 
searched for human genetic factors that modulate the disease based on genome-wide 
association studies (GWAS) of infected cohorts (O'Brien and Nelson 2004; Marmor, 
Hertzmark et al. 2006; Fellay, Ge et al. 2009). Fellay et al. (Fellay, Ge et al. 2009) 
examined over 2500 infected individuals of Caucasian origins for common genetic traits 
that would explain the variability in the viral load at set point and the disease 
progression. The study confirmed the essential role in the HIV infection played by the 
MHC region (Martin and Carrington 2005) especially variants located near HLA-B and 
HLA-C genes (de Bakker, McVean et al. 2006; Colombo, Rauch et al. 2008), and the 
chemokine receptor cluster on chromosome 3. The interpretation of the polymorphisms 
is however not clear (Stranger, Forrest et al. 2005). Moreover, the reported genetic 
variation accounted for only ~13% of the differences in the clinical outcomes. 
Beyond the information generated in host genetic studies, microarray technologies allow 
currently for genome-wide analyses of gene expression in infected cells in vitro and in 
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vivo in individuals with HIV (Hyrcza, Kovacs et al. 2007; Giri, Nebozyhn et al. 2009; 
Rotger, Dang et al. 2010). Several gene expression studies (Hyrcza, Kovacs et al. 2007; 
Giri, Nebozyhn et al. 2009; Rotger, Dang et al. 2010) pointed to a broad modulation of 
antiviral defense system, such as interferon response and intrinsic cellular defense, to 
modulation of genes involved in the cell cycle and degradation pathways and to the 
absence of expression patterns typical for effective control of viral replication. Similar 
comparative studies of pathogenic and non-pathogenic SIV monkey infections showed 
evidence of downregulation of interferon response in the non-pathogenic infection 
(Mandl, Barry et al. 2008). Notably, the IRF7 gene involved in this response was 
characterized as a host factor harboring high amounts of genetic change in the study on 
the genomic scale described in chapter 5. This indicates how gene expression and 
comparative genomic studies can provide complementary information in the search for 
differences in the lentivirus primate infection. 
Proteome analyses are still limited by the number of measurable proteins. Several 
studies (Chan, Qian et al. 2007; Ringrose, Jeeninga et al. 2008) screened expression 
levels of 2000-3200 proteins of HIV-infected individuals. The screens detected 15-21% 
of the measured proteins to be differentially expressed upon infection. Additionally 
changes were found in the abundance of proteins with known interactions with HIV. No 
integrated approaches have been used so far to analyze proteomic data in the context of 
other genome-wide studies of HIV infection. 
SiRNA transfection screen is a recent high-throughput technology enabling the 
identification of proteins potentially necessary for virus replication. Three siRNA studies 
(Brass, Dykxhoorn et al. 2008; König, Zhou et al. 2008; Zhou, Xu et al. 2008) targeted at 
coding RNA of >20,000 human proteins identified ~1000 proteins as potentially related 
to optimal viral replication. Only a small overlap across studies was found (Bushman, 
Malani et al. 2009) supposedly due to the novelty of the technology and differences in 
study design. However, among those genes that were shared by one or more studies, a 
functional pattern was observed (Fellay, Shianna et al. 2010). Notably, none of the 
screens identified genes that would restrict viral replication, i.e. whose silencing would 
result in greater viral production. 
The technologies described above allow for acquisition of different type of data on a 
genome-wide scale. None of the studies based on a particular technology fully explains 
the variation in the response to infection, which points to integrative approaches to this 
type of heterogeneous biological data as a potential way to obtain complementary 
information about the HIV infection. Individual examples of integrative studies of 
genome-wide data exist, e. g. combining transcriptome analysis with genetic variation in 
respective regulators (Rotger, Dang et al. 2010), however finding a limited overlap 
among different types of data and therefore offereing a limited interpretation of the 
results.  
The patterns of HIV interaction with the host are intricate. Their identification requires 
combining several layers of information – from genetic variation, through expression to 
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function. Eventually, integration of genome-wide data should provide comprehensive 
results that will complement or guide further experiments under the systems biology 
paradigm to study HIV infection. 
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